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Studies on tissue macrophage ontogeny have lead to a paradigm shift around alveolar
macrophages (AMs), demonstrating their ability to self-renew in a closed fashion,
without replenishment by circulating monocytes. AMs develop from foetal monocytes
that seed the lung before birth. These tissuemacrophages reside at the air-tissue interface,
where they coordinate the response to environmental stimuli. AMs not only act as
the first line of defence, but also orchestrate both the initiation and resolution of lung
inflammation. Additionally they perform pivotal trophic functions that support lung
development and maintenance of tissue homoeostasis. These manifold functions are
possible thanks to the extraordinary plasticity of AMs.
Multiple studies have shown that obese individuals present increased risk for different
medical conditions, including pulmonary diseases like asthma, lung fibrosis and higher
mortality rates from influenza. This complex disease affects not only the current
generation, but possesses far-reaching, transgenerational repercussions. For instance,
mouse models of maternal diet-induced obesity suggest an impaired lung development
in offspring.
Developmental immunotoxicity studies have pointed to a specially high sensitivity of
macrophages to alterations by early life environmental insults and foetal programming.
Paternal obesity can lead to epigenetic reshaping of the gametes and so alter foetal
development and impair pregnancy efficiency. Most importantly, obesity-induced
systemic inflammation can extend to the uterus and impact gene transcription in the
foetal lung. As this can induce a pro-inflammatory environment in the developing lung,
this thesis addresses the hypothesis, that the period of AM development can present
a window of vulnerability for programming effects by parental diet-induced obesity.
Specifically, the possible impact of pro-inflammatory priming effects of parental obesity
onAMmaturation and its expected long-lasting adverse consequences for the offspring’s
lung were studied.
For this thesis, a mouse model of diet-induced obesity was established on C57BL/6J
animals. Male and female mice were fed with either high-fat diet (HFD, 60 kJ%
fat) or low-fat control diet (LFD, 11 kJ% fat) for 12 weeks and mated at the age
of 15 weeks within diet groups. During this time, their body composition was
monitored weekly by time-domain nuclear magnetic resonance. HFD effectively lead
to increases in body weight, body fat and body lean mass in a sexual dimorphic
fashion. Changes in body composition were accompanied by hyperglycaemia and a
systemic inflammation, characterised by increased circulating levels of CXCL1 and IL6.
Direct effects of obesity on the lung inflammatory dynamics were analysed during an
endotoxin-induced acute lung inflammation. This challenge was chosen as a proxy for
a pro-inflammatory environmental stimulus on the lung. Only HF males presented
differences in the course of inflammation, displaying not only lower numbers of AMs at
steady state, but also a delayed initiation and resolution of inflammation. Even though
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polarization studies on AMs exhibited no differences between diet groups, HF diet
lead to impaired phagocytosis. These results confirmed that HFD effectively induces
obesity, hyperglycaemia and systemic inflammation, which can lead to alterations in lung
inflammatory dynamics in mice.
Although HFD caused direct effects in parent animals, it did not lead to a
pro-inflammatory placental gene expression, affect foetal body weights nor did it
compromise the structural development of the foetal lung. A reduced foetal viability
was however observed, leading to a relative risk of 5.6 in HF foetuses of being resorbed
before birth.
Offspring animals were further analysed two (P15) and ten weeks (P70) after birth.
In order to recognize intergenerational effects of parental obesity, offspring animals
were exclusively fed with LFD after weaning. Out of the three time points selected, the
strongest effects of parental diet were observed at P15 in a sexual dimorphic manner.
P15 HF female offspring displayed decreased body weights (p = 3.16E-3) and reduced
internal alveolar surface area, captured by increased manual measurements of mean
linear intercepts (p = 0.043). Parental diet had no effect in circulating inflammatory
cytokines of the offspring, but altered the leukocyte structure in pubs (p < 2.2E-16).
Intergenerational consequences of parental obesity vanished with age. P70 offspring
from both LF andHF parents presented similar bodyweights, similar lung inflammatory
dynamics after an LPS challenge of the lung and almost identical gene expression of
inflammatory markers in M0 and M1 alveolar macrophages.
Taking these results together, diet-induced obesity presented characteristic sexual
dimorphic effects that affected both parents and offspring. Intergenerational
repercussions of parental obesity were most evident through prenatal deaths as well
as through reduced body weights and altered morphology and leukocyte frequencies
in the lungs of HF pubs. However, these effects were transient and disappeared with
age. The experimental results presented in this thesis could not support the main
hypothesis of a long-term AM pro-inflammatory priming in offspring born to obese
parents. Further research on the offspring’s lung immunity and development, especially
on the consequences of different parental diet regimes and mouse genetic backgrounds
with emphasis on the role of leukocyte populations present in the developing lung, could
help identify genetic factors and immune cell populations involved in intergenerational
consequences of parental obesity for the offspring’s lung.
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Zusammenfassung
Studien zur Ontogenese von Gewebsmakrophagen haben zu einem Paradigmenwechsel
im Bezug auf Alveolarmakrophagen (AMs) geführt. Dabei wurde gezeigt, dass diese die
Fähigkeit besitzen, sich unabhängig von zirkulierenden Monozyten selbst zu erneuern.
AMs entwickeln sich aus fötalen Monozyten, die die Lunge noch vor der Geburt
besiedeln. Sie bleiben an der Grenze zwischen Luft und Lungengewebe, wo sie die
Reaktion auf Umweltstimuli koordinieren. Dabei agieren diese Makrophagen nicht
nur als erste Verteidigungslinie gegen Pathogene und eingeatmete Partikel, sondern
organisieren auch die Initiierung und Auflösung von Entzündungsprozessen. AMs
üben zudem zentrale trophische Funktionen aus, die die Lungenentwicklung und
Aufrechterhaltung der Homöostaste im Gewebe unterstützen. Diese vielfältigen Rollen
können AMs dank ihrer bemerkenswerten Plastizität erfüllen.
Studien haben gezeigt, dass Adipositas ein erhöhtes Risiko für Lungenerkrankungen
wie Asthma und Lungenfibrose birgt. Auch führt es zu einer erhöhten Sterberate infolge
von Influenza. Diese komplexeKrankheit hat generationenübergreifendeAuswirkungen.
Zum Beispiel wurde Diät-induzierte mütterliche Fettleibigkeit in Mausmodellen mit
einer möglichen Beeinträchtigung der Lungenentwicklung in den Nachkommen in
Verbindung gebracht.
Entwicklungsstudien zur Immuntoxizität haben zur Annahme einer außerordentlich
hohen Empfindlichkeit der Makrophagen auf fötale Programmierung geführt.
Mütterliche Fettleibigkeit kann eine systemische Entzündung hervorrufen, die bis
in den Uterus hineinreichen und die Genexpression der sich entwickelnden Lunge
beeinträchtigen kann. Zudem kann über epigenetische Veränderungen von Gameten
der fettleibigen Väter die Embryonalentwicklung negativ beeinflusst werden. Mit
der Annahme, dass die elterliche Fettleibigkeit zu einem pro-inflammatorischen
Lungenmilieu führen kann, befasst sich die vorliegende Arbeit mit der Hypothese,
dass die Entwicklung der AMs ein Zeitfenster erhöhter Anfälligkeit für schädliche
Programmierungseffekte durch elterliche Adipositas darstellt. Insbesondere der
mögliche Einfluss von pro-inflammatorischen Priming-Effekten der elterlichen
Fettleibigkeit auf die Maturation der AMs und die dadurch erwarteten langanhaltenden
schädlichen Auswirkungen auf die Lunge der Nachkommen wurden hierfür
untersucht.
Für diese Dissertation wurde ein Mausmodell für Diät-induzierte Fettleibigkeit in
C57BL/6J Tieren etabliert. Männliche wie weibliche Mäuse wurden 12 Wochen lang
entweder mit fettreicher Diät (HFD, 60 kJ% Fett) oder Kontrolldiät (LFD, 11 kJ%
Fett) gefüttert und im Alter von 15 Wochen innerhalb der Diätgruppen verpaart.
Die HFD führte zu einer sexuell dimorphen Zunahme von Körpergewicht, Körperfett
und magerer Körpermasse. Diese Veränderungen wurden von Hyperglykämie und
einer systemischen Entzündung mit erhöhtem CXCL1- und IL6-Spiegel im Blutplasma
begleitet. Direkte Auswirkungen der Fettleibigkeit auf die Dynamik einer durch
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Endotoxin-ausgelösten akuten Entzündung der Lunge wurden untersucht, wobei
LPS entzündliche Umweltreize auf die Lunge simulieren sollte. HF Männchen
wiesen nicht nur eine geringere Anzahl an AMs unter normalen physiologischen
Bedingungen auf, sondern auch eine Verzögerung in der Initiierung und Auflösung
der Lungenentzündung. Polarisierungsstudien an AMs zeigten keine Unterschiede
zwischen Diätgruppen, jedoch führte HFD zu einer beeinträchtigten Phagozytose. Die
beschriebenen Ergebnisse zeigen, dass die verwendete HFD in Mäusen zuverlässig
Fettleibigkeit, Hyperglykämie und eine systemische Entzündung auslöst sowie zu
Veränderungen von Entzündungsprozessen in der Lunge führen kann.
Obwohl HFD direkte Auswirkungen auf die Elterntiere hatte, führte die elterliche
Adipositas weder zu einer Entzündung der Placenta noch hatte sie einen Einfluss auf
die Körpergewichte oder Lungenmorphologie der Föten. HF Föten zeigten jedoch
eine reduzierte Lebensfähigkeit mit einem relativen Risiko einer pränatalen Resorption
von 5.6.
Die Nachkommen wurden zusätzlich zwei (P15) und zehn (P70) Wochen nach der
Geburt untersucht. Um intergenerationale Auswirkungen der elterlichen Fettleibigkeit
erkennen zu können, wurden die Nachkommen nach dem Absetzen ausschließlich
mit der LFD gefüttert. Weibliche HF P15 Nachkommen wiesen ein reduziertes
Körpergewicht (p = 3.16E-3) sowie eine verminderte innere Alveolaroberfläche auf
(p = 0.043), erkennbar durch erhöhte Messungen des Mean Linear Intercept. Die
elterliche Diät zeigte keine Effekte auf inflammatorische Zytokine im Blutplasma der
Nachkommen. Intergenerationale Einflüsse verschwanden mit zunehmendem Alter der
Nachkommen. P70 Nachkommen von HF wie LF Eltern wiesen keine Unterschiede
in Körpergewicht und Lungenstruktur, der Dynamik einer durch LPS induzierten
Lungenentzündung oder der Genexpression von Entzündungsmarkern in M0 und M1
AMs auf.
Zusammengenommen zeigte HFD charakteristische geschlechtsspezifische
Auswirkungen, die sowohl Eltern, als auch Nachkommen betrafen. Intergenerationale
Beeinträchtigungen zeigten sich am deutlichsten durch die erhöhte pränatale
Sterberate sowie das verminderte Körpergewicht und die veränderte Morphologie
und Leukozytenstruktur in den Lungen der HF Jungtieren. Jedoch waren diese Effekte
nur vorübergehend und verschwanden mit zunehmendem Alter der Nachkommen. Die
Haupthypothese eines langfristigen entzündlichen Primings vonAMs derNachkommen
fettleibiger Eltern wurde durch die experimentellen Ergebnisse dieser Thesis nicht
unterstützt. Weitere Untersuchungen der Effekte elterlicher Fettleibigkeit auf das
Lungenimmunsystem und die Lungenentwicklung der Nachkommen, mit Fokus auf
die Lungenleukozytenpopulationen vor dem Hintergrund unterschiedlicher Diäten
und genetischer Maushintergründe, könnten dazu beitragen, genetische Faktoren und
Immunzelltypen zu erkennen, die die intergenerationalen Auswirkungen der elterlichen
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1.1 Developmental origins of health and disease
Developmental origins of health and disease (DOHaD) aims to decipher how
environmental factors act on disease aetiology[1] with the final goal of preventing
non-communicable diseases[2]. It states that environmental insults on a developing
tissue early in life can lead to long-term and sometimes irreversible epigenetic and
phenotypic consequences. If stressors happen to take place during critical periods of
tissue growth and development they can lead to maximal repercussions[3]. The DOHaD
concept further proposes prevention of diseases and even health enhancement through
exposure to positive factors.
Vulnerable developmental periods are characterised by a high tissue plasticity and
therefore sensitivity to its environment. This contributes to high responsiveness towards
environmental stimuli and ensures a best phenotypic fit to promote survival[4]. These
periods however also pose windows of vulnerability, where tissue might adversely
develop upon exposure to stressors[5].
Programming[6] processes can take place in-utero[7], throughout perinatal age[8] and
during early childhood[9–11] - while organs still continue to adapt and develop. It even
can take place pre-conceptually[12,13].
After plasticity is lost with age, affected tissues might remain permanently committed
to phenotypical adaptations and be subject to irreversible developmental damage[14].
Consequences of this can be diverse, but specially deleterious if a mismatch between
environmental stimuli during early and adult life is present[15].
Epidemiologic observations of transgenerational disease after severe malnutrition in
the form of famines, e. g. the Dutch famine between 1944 and 1945[16] and the longer
famine of Leningrad between 1941 and 1944[17], paved the way for research in the field
of DOHaD. Originally, DOHaD focused on nutritional effects on the offspring[7,16,18].
Knowledge of developmental stressors has since grown[1]. Today it is well known
that exposure to different challenges during development - including inflammation[19],
infection[20,21], glucocorticoids[22], hypoxia[23], stress[24,25], pesticides[26], hormonal
perturbations[27,28], heavymetals[29,30] and other toxins[31,32] - can disrupt a healthy adult
phenotype. Depending on the specific insult, its duration and developmental time point
of occurrence, such challenges can impact particular tissues to specific extent, oftentimes
in a sexual dimorphic fashion[17,32]. The resulting physiological and behavioural
consequences can carry over beyond the first generation of progeny[33–36].
Several stressors have already been described around DOHaD of the lung. To name
a few, maternal smoking during pregnancy has shown to be a major factor that alters
fetal lung development and leads to an long term increased risk of respiratory adverse
conditions like asthma[37], pulmonary hypoplasia (underdeveloped alveoli and altered
airway morphology)[38,39] and chronic obstructive lung disease (COPD)[40]. Mechanical
1
ventilation during neonatal age can lead to bronchopulmonary dysplasia[41,42]. Likewise,
the exposure to ambient air pollution (air-borne toxins, including particulate matter
from combustion processes) during the final phase of lung development can lead to an
impaired lung growth and chronic deficits in lung function[43–45].
1.2 The lung
As themain organ of the respiratory system, the lung fulfils the vital task of gas exchange.
For this, the lung possesses an enormous inner surface with a fine air-blood barrier[46].
This huge gas exchanging area is mostlymade up by the pulmonary alveoli – the smallest
functional gas-exchange units of the lung. Alveoli are mostly found within the alveolar
sacs at the end of the basic units of respiration (acini)[47]. Further vital components of
the lung include the conducting airways (bronchi and bronchioles) that transport air to
the alveoli, a vast and effective vasculature[46] as well as a surfactant system providing
inflation stability[48] and immune modulation[49].
Three main periods of lung development are defined based on morphological
characteristics of the organ (Figure 1) – the embryonic, the foetal and the postnatal
periods. In the mouse, lung organogenesis starts with the formation of the anlage of the
two lungs, the establishment of the major airways and pleura between embryonic days
9.5 (E9.5) and E12 (human: 4-7 weeks). During this stage, two lung buds pouch out
of the ventral wall of the primitive foregut (endoderm) and grow into the surrounding
mesenchyme though repetitive cycles of branching morphogenesis[50]. This process is
highly dependent on the correct crosstalk between epithelial and mesenchymal cells
through factors like fibroblast growth factor 10 (FGF10), bone morphogenic protein 4
(BMP4), Sonic Hedgehog (Shh) and transforming growth factor beta (TGFb)[51].
The foetal period of lung development is subdivided into the pseudoglandular,
canalicular and saccular stages. During the pseudoglandular phase at the ages
E12.5-E16.5 (human: 5-17 weeks) the bronchial tree is formed through further branching
morphogenesis and the primitive airway epithelium as well as the first ciliated, goblet
and basal and smooth muscle cells begin to emerge[52,53]. At the end of this stage, the
acini are built, even though acinar epithelial cells are not yet fully differentiated[54].
During the second phase of the foetal lung development – the canalicular phase at
the ages of E16.5–E17.5 (human: 16–26 weeks) – the morphological distinction between
conducting and respiratory airways becomes possible thanks to the differentiation
of the epithelia. During this phase cuboidal epithelial cells differentiate into type
I (AECI; squamous, thin and flat cells covering most (>95%) of the inner surface
area of the alveolar ducts and sacculi; implicated in gas exchange to the blood) and
alveolar epithelial type II cells (AECII; AECI progenitors and surfactant producers)[55].
This allows for the recognition of the acinus (and in human also of the respiratory
bronchioles) for the first time. Further, intensive angiogenesis, the condensation of
mesenchyme through apoptosis and the close contact that the alveolar epithelium
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acquires with the capillary network lead to development of the primitive air-blood
barrier[51,56]. During this phase increased expression of VEGF and surfactant proteins
becomes apparent.
Lastly, during the saccular stage at the ages between E17.5 and postnatal day 4 (P4)
(human: 24–38 weeks) branching morphogenesis ceases in order to allow the start of
alveolarization[57]. This is characterized by the expansion of the respiratory area through
widening of the sacculi, further condensation of the mesenchyme and the formation of
the primary septa to enlarge the gas-exchange area. Depending on the animal species,
alveolarization can start already before birth – e. g. in precocial mammals like sheep[58].
Mice are insessorial mammals born during the saccular stage[59], while humans present
an early alveolar stage during term[60].
After birth (postnatal period of lung development) alveolarization continues as long
as the lungs are growing. The process of alveolarization is of biphasic nature[61,62]. It
is characterized by the formation of immature secondary septae between P4 and P21
(human: week 36, before birth) in a stage termed classical alveolarization and the final
maturation of secondary septae with the formation of further alveoli during the stage of
continued alveolarization (P14-P36; human: 2-21 years after birth). Septae immaturity
can be recognized by the presence of an inefficient double-layered capillary network.
Mature septae on the other hand are thinner and undergo a fusion process during
microvascular maturation (P4-P36; human: 3-21 years) where the two capillary layers
form a single-layer capillary network with high efficiency for gas exchange[63].
Figure 1: Morphological characteristics of the developingmouse lung. Histology of themurine
lung at representative phases of organogenesis: pseudoglandular stage (E14.5); canalicular stage
(E16.5); saccular stage (E18.5); terminal sac stage (P1); neonatal lung alveolarization stage (P14);
final alveolar maturation stage (adult). Scale bar: 100 μm. (Adapted from Warburton et al. 2010)
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1.3 Tissue macrophages
Macrophages (MFs, from Greek “big eaters”) are highly specialized leukocytes
belonging to the innate immune system of most metazoans. They were first described by
the embryologist Ilya Metchnikoff in the late 19th century in his “phagocytosis” (from
Greek “phagos” = to eat and “cyte” = cell) and “physiological inflammation” theories.
Metchnikoff quickly recognized the MF’s important role in preserving the integrity and
‘harmony’ in the organism by not only protecting it from foreign invaders (pathogens)
and clearing the body of unwanted cellular debris (injury repair), but also combating
“pathological inflammation”. He also hypothesized an ancient pluripotential autonomy
which enabled MFs to have a wide spectrum of functions[64].
MFs present peculiarmorphological characteristics and a coremacrophage expression
signature, which distinguishes them from other related cell populations like monocytes
and dendritic cells (DCs)[65–67]. MFs can be encountered in all tissues and display
a great functional diversity. This is not only evident through specialized functions
within different tissues[68], but also at specific developmental stages of the mouse.
During foetal development, MFs orchestrate organogenesis and tissue remodelling, and
aid in foetal liver erythropoiesis[69]. At a perinatal age, MFs further assist in organ
development, tissue regeneration and immune surveillance. In adulthood, they tightly
regulate inflammatory sequences, including the ones necessary for tissue repair and
wound healing[70].
1.3.1 Tissue macrophage ontogeny
Due to their gargantuan phenotypic heterogeneity, vast efforts have been made to
classify MFs. Following their description as phagocytes after 1892, MFs were classified
as part of the reticulo-endothelial system (RES).[71] After several attempts to separate
resident phagocytes (MFs) from their antecedents (monocytes), the term mononuclear
phagocyte system (MPS)was coined in 1972 byVan Furth and colleagues[72,73]. However,
the MPS was later expanded to encompass monocytes, MFs and DCs[74,75]. This
group of cells were thought to exclusively develop from committed bone marrow (BM)
progenitors. Circulating monocytes were said to continuously seed tissues at steady
state and replenish local tissue myeloid cell populations. However, this theory was
quickly challenged by the recognition of in situ “self-reproducing” capacity of MFs[76]
and the relative radioresistance[77–81] of some tissue macrophages (TMs) which lead to
questioning the effectiveness of macrophage depletion analyses.
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More contemporary studies presented evidence that MF populations in the adult gut,
dermis, spleen, liver, heart and serous cavities indeed partially derive from circulating
monocytes and thus could follow Van Furth’s model to some extent[82–88]. Nevertheless,
thanks to modern techniques like fate mapping analysis, nowadays it is well recognised
that several TMs are long-lived and have the ability to self-renew. TMs do not exclusively
derive from blood monocytes, but rather from local precursors established during
embryonic development[74,80,88–93]. TM populations like microglia[78,94], epidermal
Langerhans[77] and alveolar macrophage (AM)[81,95] niches are maintained (almost)
entirely locally throughout life[81,95–97].
The identification of different embryonic primordial cells that act as myeloid
progenitors during haematopoiesis facilitated a comprehensive division of the
haematopoietic process in three different “waves”. These are referred to as primitive,
transient-definitive[98] and definitive embryonic hematopoietic programs[99,100].
Embryonic haematopoiesis in the mouse starts with the first wave in the
extra-embryonic yolk sac (YS) at the embryonic day 7.0 (E7.0)[101], giving rise to
primitive erythroblast, megakaryocyte[102] and macrophage lineages (“early” Myb−
erythro-myeloid progenitors, EMPs)[103]. The latter develop into YS macrophages,
without passing through monocyte intermediates[101,103,104], and spread in the embryo
proper from E8.5 to E10 after blood circulation has been established (E8.5-E9.0)[105].
However, microglia (brain TMs) has been proposed to be the only adult TM population
derived from YS MFs[94].
The second wave of haematopoietic progenitors arises from the extra-embryonic
haemogenic endothelium (HE), formed between E8.0 and E8.25 in the YS. There,
multipotent precursors sequentially gain myeloid (EMPs)[106] then lymphoid
(lymphoid-myeloid progenitors, LMPs)[107] potential. EMPs (Kit+, Itga2b+, Myb+[103]
“late” EMPs) rapidly migrate to the foetal liver (FL) at E9.5, where they develop
into different myeloid cells[108], including FL monocytes (E12.5)[103]. FL monocytes
enter the circulation by E13.5. They colonize every tissue, except the brain (closed
blood-brain barrier)[90], dilute previously seeded YS MFs and give rise to most TM
populations[103].
Definitive haematopoiesis is established with the third haematopoietic wave. The
first immature HSCs are observed within the intra-embryonic HE of the para-aortic
splanchnopleura, which give rise to foetal HSCs in the aorta, gonads, and mesonephros
regions (AGM) between E8.5 and E10.5[109,110]. Mature-HSCs and pre-HSCs then
colonize the FL around E10.5[111] to establish definitive haematopoiesis after E12.5[112].
Following E15.5 and E17.5 respectively, they seed the spleen and BM[107], and drive the
generation of adult BM HSCs. However, typical HSC-derived haematopoiesis occur in
the BM around perinatal age and possibly only after birth[113].
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Although the embryonic origin of different TMs is well accepted, the exact identity of
primordial progenitors, their pathways of differentiation and precise transcription factor
specification have yet to be clearly defined. These unknowns have led to slightly different
models of TM embryonic ontogeny[99,103,114,115]. Likewise, the question of the extent in
which foetal HSCs or adult HSCs contribute to TM niches, specially during perinatal age,
remains unanswered[99,100].
Monocyte-derived macrophages can indeed complementary replenish prenatally
established TM populations under tissue stress circumstances like irradiation, infection,
sterile inflammation or macrophage depletion[116–122]. These monocyte-derived TMs
display almost identical gene expression profiles as their foetal-derived counterparts
once they have undergone a microenvironment-induced phenotypic transformation[122].
Nevertheless, even after successful tissue colonisation and acquisition of similar
functionality, unique gene-expression profiles and remainings of epigenetic hallmarks
can be observed in monocyte-derived TMs[122,123].
Figure 2: Tissue macrophage ontogeny. Macrophages can be derived from three different
embryonic hematopoietic waves. 1) The primitivewave starts at E7.0 in the YS blood and presents
the source of YSmacrophages fromwhich brainmicroglia are derived. 2) The transient-definitive
wave takes place in the extra-embryonic haemogenic endothelium (HE) between E8.0 and E8.25
from which foetal liver (FL) monocytes will ultimately develop at E12.5. FL monocytes gain
access to the circulation around E13.5 and infiltrate every tissue, giving rise to most adult TMs.
3) Definitive haematopoiesis commences between E8.5 and E10.5 within the intra-embryonic HE.
Hematopoietic stem cells (HSC) from this program seed the spleen and BM at E15.5 and E17.5
respectively, but HSC-derived haematopoiesis possibly occurs only after birth. HSC-derived




AMs are highly specialized mononuclear phagocytic cells located in the alveolar space
of the lungs[124], where they constitute the most abundant haematopoietic cell type at
steady state, forming over 90% of its cellular content[125]. A total of 3E5 to 1E6[126] AMs
are thought to reside in the alveoli of a mouse lung. Since the mouse lung is roughly
estimated to encompass between one and three million alveoli[127–129], a single AM is
said to be found in approximately every third alveolus[130]. In order to surveil the alveolar
lumen, AMs may migrate within a single alveolar sac, but also among multiple alveolar
sacs through connecting Kohn pores[131,132].
The tissue macrophages in the lung can be generally divided into two populations
depending on their localization: alveolar macrophages (AMs) that line the surface of
alveoli and interstitial macrophages (IMs) that reside in the pulmonary insterstitium
(lung parenchyme)[133]. Apart from the location where they reside, AMs can be
distinguished from IMs e. g. through flow/mass cytometric characterization based
on the expression of surface markers (AMs: ITGAX+, SIGLECF+, ITGAM-, H2-AB1-;
IMs: ITGAXint, SIGLECF-, ITGAM+, H2-AB1+)[134]. Additionally, each macrophage
population has unique phenotypic and functional profiles. AMs are a particularly
competent first line of defence with phagocytic potential, a strong microbicidal activity
through large production of reactive oxygen species (ROS), nitric oxide (NO), TNF and
IFNg. On the other hand, IMs can more efficiently release immune-regulatory cytokines
like interleukin 1 (IL1), IL6 and IL10, and better stimulate T-cell proliferation[135].
IMs can inhibit DC maturation and migration, preventing aberrant immune responses
to harmless aeroantigens (immunological tolerance in the sensitization phase of lung
immune responses)[136]. By contrast, AMs can restrict the expression of antigen-specific
antibodies after sensitization (effector phase of pulmonary immune responses) through
the suppression of T-cell activation and the regulation of plasma cell activity[137],
complementing immunosuppressive effects of IMs.
In their role as first line of defence at the air-tissue interface in the lung, AMs are
the first immune-competent cells to encounter inhaled antigens and therefore play an
important role in regulating immune responses of the lung[138]. Unquestionable is their
role as phagocytes – AMs can engulf viruses, bacteria, fungal cells, and a variety of
appropriately sized non-living particulates. Additionally, AMs can clear apoptotic and
necrotic cells through recognition of “eat me” signals like exposed phosphatidylserine or
calreticulin[139]. Through this so-called efferocytosis, AMs remove dying cells before they
release harmful intracellular content into the local microenvironment. Once engulfed,
particulates may be degraded by lysosomal enzymes or retained encapsulated within
the macrophages and transferred to lymph nodes draining the site or are cleared from
the airway by the mucociliary system[140]. Phagocytosis of many pathogens is mediated
by the AM toll-like receptors (TLRs)[141]. AMs also present scavenger receptors that
facilitate phagocytosis of particles coated with surfactant proteins A[142] and D[143],
which bind to a wide variety of bacteria and opsonize them.
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AMs support lung homoeostasis not only through their immune functions, but
also through trophic, regulatory and repair functions. Probably one of the most
prominent roles of alveolar macrophages include surfactant clearance[144]. These
phospholipoprotein complexes are synthesized and secreted by alveolar epithelial type
II cells[145]. Surfactant is of uttermost importance for the reduction of surface tension
and therefore for the correct inflation of the alveoli. Surfactant catabolism requires
stimulation of AMs by colony-stimulating factor 2 (CSF2) via the transcription factor
SPI1[146]. Disorders of surfactant homoeostasis brought about e. g. by genetic alterations
in any of the aforementioned genes can lead to pulmonary alveolar proteinosis and can
result in respiratory insufficiency.
1.4.1 Alveolar macrophage ontogeny
Mouse experiments employing a surgical-induced sharing of blood circulation
(parabiosis) and the analysis of proliferating cells (BrdU labelling) have shown that
the AM population is maintained almost entirely locally throughout life by self-renewal.
Guilliams et al.[81] could demonstrate in 2013 that this TM niche arises from FL
monocytes that seed the developing lung before birth at E14. Lung tissue stress (e. g.
irradiation) can indeed lead to replenishment of AMs by circulating adult HSC-derived
monocytes[81,91,92,119,121,123,147]. However, under tissue homoeostasis, at least 95% of AMs
are of foetal origin in 14 months old mice[123] and 87% of them can persist at least for 3.5
years after lung transplantation in humans[148].
FL monocytes are not the only haematopoietic cell population that seeds the foetal
lung. YS foetal macrophages populate the developing lung tissue after E8.5[91].
Even though these foetal cells have the potential to differentiate to mature AMs and
colonize the lung before FL monocytes, they underlay a competitive disadvantage in
colonizing the AM niche due to a lower expression of the CSF2 receptor and a lower
intrinsic proliferative potential[122]. For this reason, FL monocytes overcompete the YS
macrophage population after the first breath and give rise to the stable AM niche. Tan
et al. proposed 2016[149] after analysis of lineage tracing and parabiosis experiments in
mice, that the YS MF population remains in the lung interstitium and redistributes to
submesothelial and perivascular zones, generating a stable IMpopulation. Togetherwith
a third wave of IMs that dispersedly populates the lung interstitium and is maintained
by circulating progenitors, these authors propose the presence of three independent
populations of TMs in the lung, based on their origin[149].
Similar to the microglia (brain) and the Langerhans (skin) populations, the AM
niche remains stable, without significant displacement by MFs derived from adult
HSCs at steady state. This is why the brain, skin and lung are referred to as closed
tissues[99] with respect to such TM populations (see Figure 3). Only in extreme cases
of tissue stress like irradiation, lung injury or AM depletion, e. g. using diphtheria
toxin, monocyte-derived MFs will complementary replenish the prenatally established
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the AM population[91,92,119,121,147]. During this replenishment process, IMs provide
an intermediate pool between blood monocytes and AMs[120,123]. After successful
colonisation of the alveoli and the acquisition of a AM phenotype and functionality
though imprinting by the lung microenvironment[150], unique gene-expression profiles
and remaining epigenetic hallmarks can be observed in these monocyte-derived
AMs[122,123].
Figure 3: Contribution of macrophage populations to the AM niche. YS foetal macrophages
populate the developing lung tissue after E8.5 while FL monocytes arrive at around E14. Both
display a potential to differentiate to mature AMs and colonize the lung, however FL monocytes
present a competitive advantage due to a higher expression of the CSF2R and a higher intrinsic
proliferative potential. YS macrophage population is completely replaced by FL monocytes. The
lung is an example of a closed tissue, where the TM niche remains stable, without replacement
by adult monocyte-derived MFs. (Adapted from Ginhoux & Guilliams 2016).
The maturation of AMs depends strongly on alveolar type-II epithelial cell-secreted
CSF2[151]. The acquisition of a mature phenotype is characterised by, among other
features, the upregulation of Itgax and SiglecF[81] and the downregulation of Ly6C,
Itgam, Mmp12 and Pla2g7[152,153]. Interestingly, studies have shown that CSF2 is not
only important for the commitment, differentiation and survival of cells[154], but can also
have a dual role, both as a pro-inflammatory as well as a regulatory cytokine[155]. This
duality appears to be dependent on the dose of CSF2, the microenvironment were this
cytokine acts on target cells and the presence of other cytokines. While pro-inflammatory
molecules like IL1, IL2, TNF, and IFNg lead to an increased production and secretion of
CSF2, immune-regulatory cytokines such as IL10 and TGFb can down-regulate CSF2[156].
The incorrect regulation of CSF2 has already been implicated in the pathogenesis of
different immune disorders. A well described example is rheumatoid arthritis, a chronic
pro-inflammatory disease that leads to intense pain and degeneration of the joints due to
the uncontrolled expression of pro-inflammatory molecules by M1 macrophages (TNF,
IL1, IL6)[157]. In the context of the lung tissue, a dysregulation of CSF2 can lead to the
autoimmune disease pulmonary alveolar proteinosis[158].
CSF2 signalling in AMs induces the expression of PPARg[152]. This key transcription
factor (TF) acts as a nuclear receptor for several ligands, including polyunsaturated
fatty acids like arachidonic acid and its metabolites, and the antidiabetic drug
thiazolidinedione. Together with retinoid X receptors, PPARg forms heterodimers to
regulate gene transcription. PPARg is mostly known for its role as master regulator
of adipocyte differentiation and control of the expression of genes involved in lipid
metabolism[159].
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PPARg deficiency is specifically observed in AM from patients with pulmonary
alveolar proteinosis[160]. A similar phenotype can be induced in mice by the conditional
knockout of the Pparg[152], Csf2[151] or Csf2r genes[161]. This lung disease exhibits a
distinctive accumulation of surfactant in the alveolar space as well as large foam cells
– AMs engorged with intracellular lipid droplets due to their inability to metabolize
surfactant[162].
Another central molecule in the maturation of AMs is the actin-bundling protein
L-plastin. Its importance was presented by Todd et al. in 2016[153] with experiments
demonstrating that its expression in FL monocytes is crucial for their transmigration
into the alveoli by supporting podosome formation. These integrin-based organelles
are not only necessary for cell trafficking into the airspace, but also for AM retention.
Furthermore, these experiments showed the importance of L-plastin in Csf2 signalling,
since its absence resulted in failure to upregulate Pparg in developing AMs, despite
abundant presence of CSF2[153].
While FL monocytes downregulate Ly6C and upregulate Itgax shortly before birth,
it is until after the first breath that these maturing AMs express SiglecF[81] and are
recognized as mature AMs. Interestingly, this definitive AM differentiation occurs in
parallel with the development of the alveoli, starting in mice around embryonic day
E18.5 and completed after birth (as presented in Section 1.2). The first breath after birth
may be viewed as the lung’s first wound[163] and transforms the lung microenvironment
in ways that haven’t been fully defined yet. However, it has been demonstrated that the
exposure to the external, non-sterile environment and themechanical stress produced by
spontaneous ventilation play an essential role in the alveolar and immune development
of the lung[164]. Ventilation forces mechanically activate alveolar epithelial type 2 cells to
produce IL33 which in turn induce IL13 expression on type 2 innate lymphoid cells[165].
Besides the increased expression of Pparg induced by Csf2 signalling, the presence
of IL13 also stimulates AMs anti‐inflammatory, and tissue repair and remodelling
phenotype. This suggests an important role of M2 AMs in the final lung alveolarization
process[166].
1.4.2 Alveolar macrophage plasticity
Until recent years (1990s)[167], tissue macrophage’s extended functions beyond simply
“eating” and as first line of host defence remained unexplored. However, progress in
understanding their ontogeny as well as their interactions with other cells and the rest
of their microenvironment have lead to recognition of MF’s high adaptability. This
has allowed an appreciation of their critical roles in tissue health (normal) and disease
(abnormal tissue homoeostasis).
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Similar to other macrophages, AMs have the exceptional ability to quickly undergo
a plethora of functional and phenotypic changes as a response to microenvironmental
cues. This plasticity allows AMs to undertake their numerous functions in the lung. The
final goal of this polarization is the restoration of tissue homoeostasis. This response
occurs dynamically, following oscillations in the microenvironment. After signalling
ceases, AMs will ultimately return to their steady state functional status[167].
Macrophage polarization has been extensively characterized. However, this has been
mostly done in vitro using bone marrow derived macrophages and culture conditions
that only resemble extreme adverse tissue circumstances. These studies lead to the
M1/M2 nomenclature proposed for the polarization statuses of macrophages based
on studies of lymphocyte biology. Similar to the Th1/Th2 dichotomy, “classically
activated”[168] AMs (M1) can be induced by the presence of inflammatory factors
like TNF, IFNg, CSF2, microbial, and/or particulate matter[169], which are used as
proxies for lung injury, infection or inflammation. On the other hand, “alternatively
activated”[170] AMs (M2) might be generated by the addition of IL4, IL13, CSF1,
and/or components from parasitic organisms[171] to the culture medium as proxies
for injury-resolving, remodelling-inducing, and/or lung parasitic cues. It is important
to remark, that such extreme conditions are encountered rather seldom in vivo. The
continuum[172,173] of possible polarization statuses of macrophages is dynamic and
often presents overlapping M1 and M2 functions, depending on the particular tissue’s
physiological condition[70]. This observation has lead to the derivation of more
complex nomenclature and experimental guidelines[174] for the analysis of macrophage
polarization and approximation of in vivo conditions.
The analysis of fully polarized M1 and M2 macrophages has led to the recognition
of polarization biomarkers that help better describe the functional state of AMs in
vivo[175]. Polarizedmacrophages present characteristic cytokine, chemokine and receptor
(surface protein) expression. Different biochemical techniques can be employed for the
differential expression analysis of suchmolecules. Possibly themostwidely usedmethod
for such analysis at the gene expression level (mRNA) is real time polymerase chain
reaction. Flow cytometry represents an alternative approach for the characterization
of polarization at a protein level as well as for the validation of novel polarization
biomarkers[176].
To name a few examples, M1 AMs display increased expression of the genes Tnf, Il1,
Il12b, prostaglandin-endoperoxide synthase 2 (Ptgs2), chemokine (C-C motif) ligand
2 (Ccl2), Cxcl2 and Cxcl10 and of the membrane receptors TLR2, TLR4, CD16, IL1 R
type I and CD32. M2 AMs typically produce higher levels of resistin-like alfa (Retnla),
chitinase-like 3 (Chil3), Il10, Tgfb as well as of the IL1 receptor antagonist (IL1ra), the
type II IL1 decoy receptor, themannose receptor C type 1 (MRC1), scavenger receptors A
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and B, CD163 and CD14[170,176–178]. It has to be noted that this is not an exhaustive list of
polarization markers and that depending on the organism (e. g. human vs. mouse)[174],
strain[179] and tissue[65], such polarization markers will vary. It is crucial to take this into
account, when comparing results from different experimental setups.
The arginine metabolism represents a central pathway in macrophage
polarization[180]. In this context two enzymes play pivotal roles: arginase 1 (ARG1)
and nitric oxide synthase 2 (NOS2). They compete for the catabolism of arginine and
ultimately regulate the AM’s metabolic and immune response outcome. While ARG1
expression can be induced by M2 cues like IL4, IL13 over signal transducer and activator
of transcription 6 (STAT6) or alternatively by IL10, CSF1, and agonists of the peroxisome
proliferator-activated receptor transcription factors (PPARg and PPARd)[181], among
others, the transcription of NOS2 is under control of pro-inflammatory factors, such as
interferon gamma (INFg), tumour necrosis factor alpha (TNF) and IL1b, and others,
that act through STAT1 signalling[182].
A critical catabolic product of NOS enzymes is nitric oxide, which plays pivotal
roles in processes associated with vasodilatation, cytotoxicity and pro-inflammatory
immune modulation[183]. Ornithine on the other hand, is a catalytic product from
ARG1 activity and act as precursor for the production of polyamines (via ornithine
decarboxylase), which regulate cell proliferation and differentiation, and proline (via
ornithine aminotransferase), which is critical for the synthesis of collagen for wound
healing and tissue repair[184].
In this context, it is important to remark once more, that M1 and M2 are only two
extreme of a spectrum mostly defined by in vitro conditions.
1.4.3 Alveolar macrophages in health and disease
M1 responses are essential in the fight against bacterial and viral pathogens.
For an enhanced microbicidal and tumoricidal activity, classically activated AMs
produce reactive oxygen species and nitric oxide through the upregulation of NOS2.
Together with an increased secretion of pro-inflammatory cytokines as well as
neutrophil-recruiting and -activating chemokines, these factors confer AMs their
pathogen-killing abilities. Additionally, M1 AMs display enhanced antigen-presentation
abilities[178] as well as increased expression and secretion of matrix metalloproteinases
(MMPs) like MMP9, which allow AMs to migrate during inflammatory responses[185].
M1 AMs can be observed during acute infectious diseases, as in the case of infections
with S. pneumoniae[186] or rhinoviruses[187]. Excessive or prolonged pro-inflammatory
activation can however trigger collateral tissue damage due to the toxic activity of M1
products[172,185] and predispose tissue to neoplastic transformation[188].
12
During a “natural resolution of inflammation”[189] a transition from M1 to M2
polarization and/or apoptosis of M1 macrophages occurs. M2 macrophages are less
toxic to microbes and vulnerable host cells. They acquire anti-inflammatory and tissue
repair functions that facilitate wound healing after inflammatory processes[190]. M2
macrophages help clear parasites, reduce inflammation, promote tissue remodelling.
These macrophages are characterized by increased phagocytic activity[191], the
expression of the scavenging mannose[192] and galactose receptors[193]. The secretion
of ornithine and polyamines[184], cytokines like CCL17 and CCL22, and the expression
of molecules associated with development, angiogenesis and fibrogenic activity, e. g.
WNT ligands, platelet-derived growth factor (PDGF), TGFb and fibroblast growth factor
(FGF)[194] are important characteristics of M2 macrophages as well. Aberrant and
uncontrolled M2 activation of macrophages can however lead to increased microbial
survival and pathogenicity[165], induce fibrosis[70], exacerbate allergic reactions[195],
promote tumour progression and facilitate metastasis[196].
Both M1 and M2 macrophages have been implicated in several diseases, including
mayor lung diseases like asthma, cystic fibrosis, chronic obstructive pulmonary disease
(COPD) and pulmonary fibrosis[197–199]. Even though the pathogenesis of each of these
examples appears to be dominated by the presence of either one of the two polarization
statuses, increasing evidence demonstrate the involvement of both phenotypes in disease
development, where rather the correct phenotype switch between M1 and M2 becomes
compromised.
Asthma is a chronic, heterogeneous and complex inflammatory disease of the
airways. It is characterised by increased mucus production, airway remodelling
and hyperresponsiveness to different airborne agents, with symptoms like coughing,
wheezing, chest tightness and shortness of breath[200]. Elaborating on the aberrant
polarization of AMs during the development and advancement of this disease, it can
be observed that while M2-polarized AMs and their biomarkers strongly correlate
with asthma and its severity[201], so do M1-associated molecules. M2 AMs aggravate
airway inflammation in asthmatic mice[202], enhance collagen deposition and increase
lower airway hyperresponsiveness, mucus-secreting cell proliferation as well as collagen
deposition[203]. M2 macrophages also promote lung infiltration and activation of
inflammatory cells – especially of eosinophils[204]. M1 AMs on the other hand
might promote airway inflammation and hyperreactivity in atopic asthma through
TNF[205,206] and INFg as well as through the recruitment of eosinophils, but specially
of neutrophils[207]. Additionally, LPS-induced M1 MFs might play an important role in
the development of corticosteroid resistance[208].
In summary, a correct physiologic M1/M2 balance will determine the maintenance of
health and tissue homoeostasis or the development of disease. Such balancewill typically
depend on the specific tissue of interest[65,209] and can be influenced by multiple factors.
Studies on developmental immunotoxicity strongly suggest a specially high sensitivity of
MFs to alterations by early life environmental insults and foetal programming[210].
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In the case of the lung tissue, M2 polarization of AMs plays a crucial role
not only during development, but also during lung homoeostasis at steady state.
This M2 phenotype is pivotal during the final alveolarization phase, after the first
breath[165,211]. In general, TMs retain an M2 phenotype in healthy tissue[212,213]. Such
quiescent status is important in the lung to hinder unnecessary and tissue-damaging
pro-inflammatory signalling upon contact with innocuous airborne molecules. This
ground M2 polarization is evidenced by the poor antigen presentation[214] and lack of
co-stimulatory molecules, like CD86[215] on AMs, which lead to T-cell unresponsiveness
and hinder the activation of the adaptive immune system against harmless inhaled
antigens. Additionally, AMs at steady state show reduced phagocytic capacity
(compared with IMs), decreased respiratory burst and produce immunosuppressive
prostaglandins[209]. During homoeostasis, AMs also express other M2-associated
biomarkers like TGF[216], the mannose receptor C type 1 (Mrc1)[217], stabilin 1 (Stab1),
Cd200r[218], signal-regulatory protein alpha (Sirpa)[219] as well as reduced M1 markers
like Cd14 and H2-Ab[217].
Aging reduces the responsiveness of MFs to activation stimuli[213]. This can be
observed in aged mice through a blunted IL4 response with diminished Arg1, Chil3 and
Retnla expression inMFs comparedwith young animals[220]. This might be a reasonwhy
correct immune responses progressively deteriorates with age.
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1.5 Obesity
Obesity is a complex andmultifactorial pathological condition of increased accumulation
of excess body fat caused by an imbalance between energy intake and energy expenditure.
In humans, such dysregulation of energy balance is complex and has multifactorial
aetiologies[221]. It arises through interactions between the individual’s genetics,
development, its environment and multiple psycho-social factors. Even though the
heritability (portion of phenotype variability explained by genetic variation in a specific
environment) of excessive body fat is estimated to be high (40-70%[222–224]), genetics
alone cannot explain the present global rise in obesity[225,226]. It arises rather as result
of an unhealthy lifestyle, which very often is imposed by exposure to modern rural and
urban environments[227].
A myriad of concurrent diseases have been already associated with obesity[228].
These emphasize the systemic impact of a chronically sustained positive energy
balance and why this is highly critical risk factor for non-communicable diseases.
Examples of such include: hypertension, type 2 diabetes, cardiovascular disease,
gastroesophageal reflux disease, cholelithiasis, non-alcoholic fatty liver disease,
osteoarthritis, pancreatitis, gout, multiple forms of cancer, psychological conditions like
anxiety and depression, neurodegeneration, urinary incontinence, overall premature
death, infertility, obstructive sleep apnoea, and several other disorders of the respiratory
system[228].
Because of these strong comorbidities and its alarmingly high increasing rate during
the last four decades worldwide[229], obesity has been categorized as a pandemic[230,231].
In an attempt to introduce an easy-to-apply method for determining and categorizing
obesity in humans, the world health organization (WHO) has proposed six statuses of
nutrition[232] (see Table 2) for adults over 20 years of age by means of the body mass
index (BMI). This anthropometric index - also known as the Quetelet index[233] - is
calculated as the ratio of an individual’s weight to its squared height (kg/m2). Each
status was defined by its associated risk to different comorbidities[234,235] and serves as
an approximate surrogate of body fat mass.
Table 2: Nutritional status based on BMI. Adapted from www.euro.who.int
BMI [kg/m2] Nutritional status
Below 18.5 Underweight
18.5 – 24.9 Normal weight
25.0 – 29.9 Pre-obesity
30.0 – 34.9 Obesity class I
35.0 – 39.9 Obesity class II
Above 40 Obesity class III
However simple tomeasure, the BMI has caveatswhen applying it not at an individual
level, but on different ethnicities and individuals of different age or gender. Its definition
assumes that most variation in weight for a population of similar height is due to
body fat mass. However, it does not account for differences in body proportions nor
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does it discriminate between fat mass and lean mass[236]. This is why BMI alone is
not necessarily the best predictor of metabolic complications and additional data —
includingwaist circumference, skinfold thickness and biochemical analysis of circulating
glucose, triglycerides, free fatty acids (FFAs) and inflammatory markers — can leverage
the BMI’s shortcomings[237,238].
Historically, the view on obesity has changed from being a sign of wealth and well
being to a sign of an unhealthy lifestyle and increased risk for disease. Obesity has
become a massive source of economic burden worldwide[239]. And due to the diverse
psychological and physiological effects fat tissue implicates, it has gained increasing
scientific interest.
1.5.1 The adipose tissue
Collectively, adipose tissues form a large organ comprised of multiple fat storage sites. In
humans, the two largest depots have subcutaneous and visceral locations. Additionally,
fat depots can also be found in bone marrow, breast tissue, and ectopic regions like
muscle, liver, heart, lung andpancreas[240]. Increased visceral adipose tissue is associated
with an higher risk formetabolic complications like insulin resistance, dyslipidaemia and
overall mortality[241].
Two different types of central parenchymal cells can be distinguished within fat
tissue: white and brown adipocytes. Each one presents characteristic morphological and
functional traits. The former store energy in form of triglycerides (tri-ester of a glycerol
and three fatty acid molecules) and cholesterol in a single cytoplasmic lipid droplet
and can produce and secrete a large number of bioactive molecules. The latter contains
several smaller lipid droplets and are equipped with numerous uncoupling protein 1
(UCP1)-expressingmitochondria which allow for thermogenesis[242]. Brown adipocytes
can be found in large amounts at birth, but are reduced with age[243]. Event though
these two cell types arise out of two different pathways, white adipocytes can “brown”
into paucilocular cells (also referred to as “beige” adipocytes) with mixed characteristics
through cold exposure[244] or physical activity[245]. Interestingly, adipocyte turnover
during adulthood is relatively high, with a renewal rate of around 10% total adipocytes
per year[246].
The stroma supporting and sustaining adipocytes is comprised of connective tissue,
nerve, stromovascular, and immune cells. These stromal cells can make up to 50% of the
total cell amount in the adipose tissue[247].
Adipocytes derive from multipotent mesenchymal stem cells, which reside in the
vascular stroma of adipose tissue and in the bone marrow. These precursors also
have the capacity to develop into myocytes, chondrocytes, and osteocytes[248]. The
process of adipogenesis is initiatedwith the commitment of precursors to pre-adipocytes
16
through extracellular activators like insulin, IGF1, TGFb, BMP2 and BMP4[249]. These
signals integrate in the nucleus and culminate in the differentiation of mature adipocytes
through the activation of e. g. peroxisome proliferator-activated receptor 𝛾 (PPARg2,
known as the “master regulator” of adipogenesis) and CCAAT-enhancer-binding
protein 𝛼 (C/EBPa[250]).
1.5.2 The adipose tissue as an endocrine and immune organ
Contrary to previously supposed unique functions as bare energy storage and rather
inert protective layer against mechanical damage, white adipose tissue (WAT) has
profound local and global metabolic, endocrine and immune effects[251,252]. This
is achieved through the expression and secretion of a large number of bioactive
molecules with endocrine, immunological and neurological functions known as
adipokines[253,254]. Several different adipokines — including leptin, adiponectin, resistin,
visfatin, glucocorticoids, interleukin 6 (IL6), and tumour necrosis factor (TNF) — have
been already described[254,255], and many hundreds of potential candidates have been
identified[256].
WAT can produce unique profiles of adipokines (adipokinome) depending on its
location (e. g. subcutaneous vs visceral[257]), cellular composition (e. g. presence of
activatedmacrophages or hypertrophic adipocytes) and overall energy conditions (over-
vs undernutrition[258]). Adipocytes are sensitive to metabolic energy changes and can
mountmultiple feedback loops in a paracrine, autocrine and endocrine fashion. Through
such loops, adipocytes control the storage and mobilization of energy via crosstalk with
other tissues[259].
Adipose tissue can adapt to overnutrition through hyperplastic expansion involving
adipogenesis and hypertrophy of white adipocytes[260]. This process involves a transient
pro-inflammatory immune activation as part of the adaptive physiological response
to increased energy intake[261]. Inflammation can promote a homeostatic adipose
tissue remodelling. This is achieved through angiogenesis — leading to a better
nutrient and oxygen supply — and by limiting fat accumulation through temporary
insulin resistance[252]. However, chronic anabolic pressure from overnutrition can
mount a pathological and long-term pro-inflammatory immune program. This can
induce chronic insulin and catecholamine resistance as well as obesity-related metabolic
disorders like type 2 diabetes[252].
Despite advances in the study of cellular cross-talk mechanisms within the adipose
tissue, the precise triggers of long term obesity‑associated inflammation are not clear yet.
These however encompass different metabolic and immune events[252]. A well described
example involves the paracrine cross-talk between adipocytes and macrophages. Here,
macrophage-derived inflammatorymediators[262], like TNF, directly induce lipolysis and
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FFA release in adipocytes[263]. In turn, chemokines, i. e. leptin,[255] and FFAs secreted
from adipocytes activate and maintain a pro-inflammatory macrophage profile[264]. It
has been shown that FFAs can bind to the pattern recognition receptors (PRRs) Toll‑like
receptor 4 (TLR4) and TLR2, leading to induction of NF‑𝜅B signalling and cytokine
expression in macrophages[265].
Another pro-inflammatory trigger known to activate TLR4 during obesity is the rise
in circulating lipopolysaccharide (LPS) fromGram‑negative bacteria in the gut[266]. This
metabolic endotoxaemia results in part from increased intestinal permeability[267], but
also from microbial dysbiosis[268].
Hypertrophy-induced adipocyte stress can also lead to a pro-inflammatory immune
activation. Adipocyte stress emerges in great part from the limited responsiveness
of adipose tissue endothelium and extracellular matrix to remodelling needs during
the rapid adipocyte hypertrophy[269]. Hypoxia[270], mechanical[271] and oxidative
stress[272] build up as a consequence, which lead to pyroptosis[273]. This specialized
form of caspase-1 dependent pro-inflammatory programmed cell death causes
leaking of cytosolic components. Exposing the lipid droplet and other metabolic
damage-associated molecular patterns (DAMPs, e. g. ATP, ceramides, cholesterol
and urate crystals) from within the adipocyte leads to activation of PRRs, i. e.
TLRs and nucleotide-binding oligomerization domain containing protein-like receptors
(NLRs), especially the NLRP3 inflammasome[274]. Pyroptosis and the secretion
of pro-inflammatory adipokines and chemokines promote leukocytosis[251] and the
formation of crown-like structures containing pro-inflammatory macrophages[273].
Pro-inflammatory adipose tissue macrophages can make up to 50% of the cellular
content in adipose tissue of obese individuals[262]. These macrophages are known to
secrete large amounts of TNF, IL6 and IL1b — cytokines causally associated with insulin
resistance[262,275–277]. The more this macrophage population expands, the stronger will
be the accumulation of pro-inflammatory factors in adipose tissue and their release into
the circulation.
Sustained pro-inflammatory stressors can easily disrupt the microenvironment in
adipose tissue and perpetuate pro-inflammatory processes[252]. Such dysregulation
leads to the well known phenotype of chronic low-grade inflammation with elevated
pro-inflammatory factors in plasma, including leptin, resistin, IL6, IL8, CCL2, TNF and
C-reactive protein (CRP), IFNG, plasminogen activator inhibitor 1 and complement
component c3[278,279], and decreased adipokine concentrations with anti-inflammatory
properties, like adiponektin[280]. Interestingly, the anti-inflammatory cytokine IL10 is
also elevated during obesity. This appears to happen as an effort to maintain adipocyte
metabolic flexibility through suppression of lipolytic signals, amelioration of insulin
sensitivity, and recruitment of M2 macrophages to the adipose tissue[281].
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1.6 Obesity and the respiratory system
The ever-growing pandemic of obesity has been positively correlated with the
increased pathogenesis of multiple pulmonary diseases[282,283]. It is comorbid with
asthma[284], acute respiratory distress syndrome (ARDS[285]), obstructive sleep apnoea,
hypoventilation syndrome[286], pulmonary hypertension[287], COPD[288] and lung
fibrosis[289]. It complicates the pathogenesis of COPD[290] and is associated with
primary graft dysfunction after lung transplantation[291], higher mortality rates from
influenza[292,293], and idiopathic pulmonary fibrosis (IPF[294]).
Obesity has shown to impair cross-talk mechanisms between adipose tissue and the
brain[295], liver[296], muscle[297] and pancreas[298]. Several hypotheses for the explanation
of such pathological cross-talk mechanisms have been proposed[259]. These include
interactions through free fatty acids as well as through endocrine, immune and neural
factors. The presence of ectopically stored fat with toxic effects, and the altered
endothelial functions have been suggested as well[259].
Lung homoeostasis can be dramatically altered by obesity through a combination
of mass loading, endocrine and metabolic factors. A cross-talk between the adipose
tissue and the lung based on the mutual influence through inflammatory factors has
been proposed[299]. While pro-inflammatory adipokines in the circulation, e. g. leptin,
have shown to modulate lung immune responses[300], lung-derived pro-inflammatory
factors secreted into the circulation may as well amplify inflammation in the adipose
tissue[301].
In terms of mass loading, fat accumulation in the abdomen and thorax can directly
reshape biomechanical properties of the respiratory system[302]. This mechanical load
often leads to elevated pleural pressure as well as decreased lung volumes[303,304].
Consequently, functional residual capacity, compliance, expiratory reserve volume, and
total lung capacity tend to decrease with obesity, leading to increased respiratory work
load and impairment of the respiratory muscles[303–305].
Factors secreted by hypertrophic adipose tissue found in the circulation of obese
individuals can present pleiotropic effects and contribute to lung disease. An endocrine
consequence of obesity known to influence the respiratory system is the reduced
circulating concentration of the anti-inflammatory adipokine adiponectin. This factor
can inhibit eosinophilia and allergic airway inflammation[306]. Adiponectin deficiency
might be the link between obesity, asthma[284], COPD[307], vascular remodelling and
pulmonary hypertension[306] as well as ARDS[285]. Furthermore, raised levels of TNF
have shown to promote both emphysema and pulmonary fibrosis and increase general
lung inflammation[308]. TNF can also reinforce airway neutrophilic inflammation, as
showed in a model of ozone-induced lung inflammation[309].
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1.6.1 DOHaD: parental obesity and the offspring lung development
A large body of epidemiological as well as animal experiments have consistently
provided evidence of the intergenerational effects of famine on offspring’s metabolic,
cognitive, developmental and endocrine health[310]. In face of today’s obesity pandemic,
DOHaD research has shifted its attention to study long term consequences of parental
obesity on offspring. Initial epidemiological and animal studies have shown that
offspring born to obese mothers present similar metabolic and developmental outcomes
as those born to famine-exposed mothers – especially in terms of adverse metabolic
outcomes like increased risk for diabetes, obesity and the metabolic syndrome in later
life[311,312]. The specific effect of parental obesity as well as its plausible molecular causes
have been since studied in more detail.
Parental nutrition has become a major predictor of adverse long-term detriment in
offspring, including possible immune-related outcomes[313]. Obesity during pregnancy
is associated with higher risk of both maternal and foetal complications[314,315]. Foetal
neural tube defects, macrosomia, shoulder dystocia[316], increased overall foetal
mortality[317], preeclampsia[318], risks of cerebral palsy, attention-deficit disorder,
cognitive delay, and autism are some well described examples[319,320].
As the primary metabolic, respiratory, excretory and endocrine organ during
pregnancy, the placenta plays an essential role in shaping the intrauterine environment
for developmental programming[321]. For this reason, research on intergenerational
effects of obesity has focused on the role of maternal obesity on DOHaD. Metabolic and
inflammatory changes brought about by maternal obesity extend to the placenta[312].
This suggests an exposure of the foetus to an inflammatory environment and
elevated levels of free fatty acids during development[322]. The presence of increased
pro-inflammatory molecules (CRP and TNF) in the amniotic fluid of overweight
mothers[323] as well as of a systemic inflammation in offspring – apparent by an
increased abundance of pro-inflammatory cytokines in the foetal circulation (IL6, IL17A,
and IFNg[324]) – support this hypothesis. Maternal obesity has shown to directly
shape the morphology and gene expression in placental tissue[325]. Obese pregnant
mouse dams present an altered thickness of placental tissue layers as well as impaired
placental cell proliferation and gene expression[324]. Obesity also leads to increased
placental macrophage activation and elevated cytokine (Tnf, Il1b, Il6, Nlrp3, and Il10)
expression[324,326–328].
Effects ofmaternal obesity on the offspring’s organ development have been previously
studied. Metabolic organs like the liver[329–331], pancreas[332], muscle[333] and adipose
tissue, but also other organs like the brain[334–336] and gut have been described. The
presence of inflammation aswell as increased oxidative stress on these organs is common
for foetuses from obese mothers[324,337–339].
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The lung is not absent of parental obesity-induced detriments. Offspring of
obese women are at greater risk for respiratory complications at birth[340]. These
include the risk for respiratory distress syndrome (RDS[341]) as well as for persistent
pulmonary hypertension of the new-born[342]. Maternal obesity is associated with
increased susceptibility towheezing in early childhood[343,344] and asthma later in life[345].
Even though the exact mechanisms have not been discovered yet[346], rodent models
corroborate the link between maternal overnutrition and offspring’s innate airway
hyperresponsiveness[347,348].
Plausible determinants of maternal obesity that lead to pulmonary challenges in
offspring include the foetal exposure to stress hormones, high concentrations of
pro-inflammatory cytokines/adipokines, free fatty acids and glucose, oxidative stress,
placental inflammation and dysfunction as well as an involvement of intestinal or
lung microbiota[349]. Furthermore, maternal obesity might as well contribute to a
maladaptation of the pulmonary L-arginine/NO metabolism in offspring[350]. This
pathway is not only important for vascular contractility, structural integrity of the
blood vessels and angiogenesis[351], but also critical for the innate immune function[184].
Arginine-catabolizing enzymes, specifically nitric oxide synthases (NOS) and arginases,
tightly control the immune response under physiological and pathological conditions.
Critical immune, homoeostatic and regenerative behaviours of myeloid cells are
controlled by the arginine metabolism[180]. Importantly, many functions of macrophages
in the lung (and all other organs) depend on arginine pathways[184]. Therefore,
maladaptations in this metabolic pathway could compromise the lung immunity and
possibly the macrophage’s role in development and regeneration. Interestingly, rodent
models of maternal hypercaloric feeding have shown a detrimental effect on the severity
of viral lung infections[347].
It has been hypothesized that foetal inflammatory exposures may modulate postnatal
lung development and function[352]. Interestingly, in 2013, two authors[353,354]
independently provided experimental results showing that offspring born to HFD dams
can experience changes in lung structure and function that may be associated with
poorer outcomes in infants of obese mothers. In their publication in 2015, Mayor et
al. demonstrated increased expression of inflammatory markers in the placenta and
decreased foetal viability in the uterus ofHF dams. Their data suggested a reduced foetal
lung maturation with diminished expression of surfactant[354].
Additionally, in a rat model of maternal HFD feeding during pregnancy and lactation,
Song et al. could show that maternal HFD exposure might induce the recruitment
of inflammatory cells into the offspring lung at 12 weeks of age. HF rat offspring
displayed increased lung tissue remodelling with increased collagen deposition and
TGFb expression[355].
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1.6.2 Contribution of paternal diet
Due to the importance of the placenta in foetal development, most epidemiological and
experimental studies have focused on intergenerational effects from maternal diet on
offspring. Thanks to advancements in epigenetic studies, the importance of paternal
heritability has also been recognised[356]. Increasing evidence advocates epigenetic
mechanisms (like histone modifications and DNA methylation) in the control not only
of intergenerational effects caused by paternal obesity, but also their (transgenerational)
transmission to later generations[357].
It is important to note, that while transgenerational transmission stringently
refer to phenotypic consequences effects occurring in the second generation (F2)
for male-mediated or third generation (F3) for female-mediate alterations after
environmental exposure[358,359], effects spanning shorter periods are described as
parental or intergenerational. Therefore, the effects of parental obesity directly affecting
the developing embryo (F1) and the gametes that formed it are referred to as parental
(maternal/paternal) or intergenerational transmission.
Observations on the effects of paternal under- and overnutrition on progeny have
been made both in animal models as well as in human cohorts. High-fat or hypercaloric
diet has not only shown to affect sperm quality and quantity of fathers-to-be[360,361], but
also to reduce embryonic and foetal development, and impair pregnancy efficiency[362].
Importantly, offspring from obese fathers display increased risk for impaired insulin
sensitivity and adiposity[362]. Moreover, high-fat diet consumption in rats leads to a
strong programming effects in the pancreas, especially on female offspring[356]. These
HF female offspring present early 𝛽-cell dysfunction with impaired insulin secretion and
worsening of glucose intolerance in later life[363].
Based on such observations and following the idea of DOHaD, the term “Paternal
Origins of Health and Disease” (POHaD) has been proposed[364]. POHaD raises
questions about the similarity of disease development based on maternal and paternal
transmission and possible additive effect of HF of both parents on the early development
of diseases and long term consequences in offspring, especially for lung diseases.
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2 Hypothesis and aims
2.1 Background
The view on obesity has changed from a sign of wealth and well being to a sign of
an unhealthy lifestyle and increased risk for disease. The ever-increasing pandemic
of obesity has been associated with various comorbid disorders, including pulmonary
diseases like asthma, lung fibrosis and highermortality rates from influenza. Mechanical,
metabolic and inflammatory changes during maternal obesity extend to the placenta,
exposing the foetus to a pro-inflammatory environment.
As a result of studies on the developmental origins of health and disease, today it is
well known that environmental insults on a developing tissue early in life can lead to
long-term and sometimes irreversible epigenetic and phenotypic consequences, if such
stressors happen to take place during critical periods of tissue growth and development.
Parental obesity can act as such a developmental stressor.
Obesity is the result of a sustained positive energy balance. A long-lasting anabolic
pressure can cause adipose tissue hypoxia, lead to mechanical and oxidative stress with
pyroptosis of adipocytes and recruitment of pro-inflammatory cells. This finally elicits
a pathological pro-inflammatory immune activation in the adipose tissue with impaired
endocrine functions. Chronic overnutrition can therefore often be accompanied by high
circulating concentrations of pro-inflammatory cytokines and glucose. Dysregulation of
the physiology of in the adipose tissue can profoundly impair not only local, but also
global metabolic, endocrine and immune functions. For this reason, the adipose tissue
has been described as an endocrine and immune organ.
In addition to the release of inflammatory factors into the circulation, obesity can elicit
dyslipidaemia, characterized by increased free fatty acids (FFAs) in blood. Specially
saturated FFAs are capable of stimulating a pro-inflammatory reaction through the
activation of toll-like receptors 2 (TLR2) and 4 (TLR4) and a downstream nuclear factor
kappa B (NF-𝜅B) activation, leading to pro-inflammatory cytokine expression. FFAs
can aswell bring about endoplasmic reticulum stress and elevated production of reactive
oxygen species. These effects add to the adipocyte-derived inflammatory factors and can
lead to the well-known systemic low-grade inflammation associated with obesity.
Maternal obesity can increase placental oxidative stress, inflammation and
dysfunction. Due to the presence of pro-inflammatory molecules in the amniotic
fluid of obese mothers as well as in the foetal circulation, it is not surprising that parental
nutrition has become a major predictor of adverse long-term impairments in offspring,
including not only metabolic, but also immune-related adverse outcomes. Additionally,
epigenetic mechanisms can as well indirectly transmit detrimental physiological
adaptations to later generations. Paternal obesity might therefore as well play a decisive
role in the developmental origins of disease. In deed, paternal obesity has shown not
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only to affect sperm quality and quantity of fathers-to-be, but also reduce embryonic
and foetal development, and impair pregnancy efficiency. This raises the question of
possible maternal and paternal additive effects of obesity on the early development of
diseases, especially for the lung.
Recent studies around tissue macrophage (TM) ontogeny have lead to a paradigm
shift around these cells. Contrary to the believe that all TMs are replenished by
circulating monocytes, nowadays it is well recognised that, in several tissues, these cells
are long-lived and possess the ability to self-renew. The TM population that reside
at the air-tissue interface of the lung, the alveolar macrophages (AMs), develop from
foetal monocytes. These precursors seed the lung before birth and build a self-renewing
independent TM niche.
AMs extended functions beyond simply “eating” include the orchestration of both,
the initiation and the resolution of lung inflammation. AMs perform crucial trophic
functions that support lung development and lead to overall maintenance of tissue
homoeostasis. These numerous properties are only possible due to their impressive
plasticity. An impairment in such phenotypic versatility can greatly hamper AM’s
functions, compromising lung homoeostasis and leading to disease.
2.2 Objectives
Developmental immunotoxicity studies have suggested a specially high sensitivity of
macrophages to alterations by early life environmental insults and foetal programming.
Since macrophages exhibit pivotal roles in tissue development and because mouse
models of maternal diet-induced obesity suggest an impaired lung development in
offspring, this thesis proposes that the period of AM development might present a
window of vulnerability for programming effects by parental diet-induced obesity. This
hypothesis suggests an impact of parental obesity on AM maturation which leads to
a detectable pro-inflammatory AM primed state and long-lasting adverse functions in
the offspring’s lung. It supports the theory, that such long-term impairments will not
only manifest in form of a compromised lung structure, but also become apparent later
in life of the mouse offspring through a defective inflammatory response to an LPS
challenge.
Based on this proposition, the detection of an impaired AM differentiation
(reduced expression of markers like SiglecF), an altered number of AMs at steady
state, an impaired AM function (specially in the context of immunity and lung
development), and/or a defective AMM1 polarization could be expected. Because of the
pro-inflammatory nature of obesity (low-grade systemic inflammation), thiswork places
special emphasis on the pro-inflammatory effects of parental obesity. Therefore, analyses
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of the initial M1 AM polarization in vitro and the lung’s response to intratracheally
instilled LPS in vivo were performed. Because of the systemic effects of obesity, it is also
hypothesised that not only local effects in the lung, but also possible systemic alteration
of circulating pro-inflammatory factors are present in high-fat offspring.
The aims of this thesis were divided into two main categories. On one side, direct
effects of a HFD on mice body composition, circulating inflammatory factors and
inflammatory dynamics in the lung were studied on parent mice. On the other, the
inter-generational consequences induced by parental obesity were analysed on offspring
animals. For the latter, the impact of parental diet-induced obesity on the offspring’s
viability, body weight, inflammatory factors in the placenta, lung and blood as well as
consequences for their lungs, including their structure, gene expression and response to
an acute inflammatory challenge, were studied. In both cases, the consequences of the
HFD were specially inspected on the lung inflammatory dynamics and the polarization
of alveolar macrophages. In order to reach the goals set for this thesis, three main
methods needed to be established in the lab: a mouse model of diet-induced obesity,
a mouse model of LPS-induced acute lung inflammation, and a multi-colour flow
cytometric approach for analysing immune cell populations in the lung.
2.3 Experimental setting
Based on previous studies and experience from our cooperation partner Dr. Jan Rozman
at the German Mouse Clinic, a high-fat diet (HFD) with 60 %kJ fat content was selected.
In accordance with Mayor et al.[327], the duration of the diet was of 12 weeks. However,
the contrary to their experimental design, HFD contained a higher energy content
(60 %kJ vs. 42 %kJ) for the effective and prompt induction of obesity in C57BL/6J mice.
Moreover, in order to narrow down HFD-induced effects, a purified diet for both low-fat
(LF) and high-fat (HF) animals was employed. This way, possible effects due to different
micronutrient and fibre contents in the HF and control diets were excluded. Similarly to
normal chow, the low-fat control diet (LFD) contained 11 %kJ fat. (Refer to Section 3.1.2
for a detailed feeding protocol).
The characterization of the diet-induced of obesity was centred around three main
effects of a HFD on the mouse physiology. First, the consequences of HFD on the
body composition, which was analysed by means of NMR. This method provided the
granularity needed to detect differences in body composition parameters, not only based
on diet, but also on the animal’s sex. Second, the presence of a systemic low-grade
inflammation was expected to develop after the induction of obesity. For this purpose,
circulating cytokine concentrations were analysed in plasma by multiplex immunoassay.
The third parameter of interest, was the development of hyperglycaemia as a proxy for
a disturbed glucose metabolism. A graphical representation of the overall experimental
design can be observed in Figure 4.
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In order to analyse direct effects of a HFD on the lung’s ability to mount an
immune response, obese and lean animals were intratracheally challenged with LPS.
The goal of this test was to detect possible differences in the dynamics and strength of
a pro-inflammatory reaction in the lung. Additionally, direct effects of HFD-induced
obesity on the murine AM population were analysed in vitro by polarizing this cells
with LPS. Their characterization was performed by the analysis of gene expression with
qPCR. The presence of a systemic low-inflammation as well as hyperglycaemia and
hyperlipidaemia was expected to alter the normal pro-inflammatory reaction against
LPS.
The main hypothesis in this thesis was centred around the impact of parental obesity
on the offspring’s AM population. These effects were inspected by introducing an
LPS challenge to the offspring’s lungs as well as the in vitro polarization of their AMs.
However, further inter-generational effects of parental HFD feeding were analysed, too.
In order to detect the repercussions of parental obesity along the offspring’s development,
three different time points of analysis were selected: the foetal age of embryonic day 18.5
(E18.5), the neonatal age of twoweeks after birth (P15) and a young-adult[365] time point
in the mouse life of 10 weeks of age (P70). While the strongest effects of parental obesity
were expected to appear during the foetal development, long-term consequences were
also anticipated. In order to recognise sequelae of parental obesity and prevent direct
diet-induced outcomes, offspring animals were exclusively fed with LF control diet after
weaning. Body weights, the lung structure and inflammatory gene expression in the
lung were analysed at all three of the time points selected. Additionally, circulating
cytokinesweremeasured at the ages of P15 and P70. Long-term inter-generational effects
of parental diet were inspected in P70 offspring, especially during the induction of lung
inflammation and polarization of AMs with LPS.
Previous reports have consistently shown the presence of a strong sexual dependence
on effects brought about by HFD and/or obesity. In order to recognize possible
sexual dimorphic consequences of the experimental design employed for this thesis, all
comparisons were performed not only after grouping individual subjects by diet, but
also by sex.
During planning and execution of all animal experiments, following the 3Rs
(Replacement, Reduction and Refinement) guiding principles for more ethical use of














































































































































































Figure 4: Experimental design. Parent WT C57BL/6J mice were fed with either HFD (60 kJ%
fat) or LFD (11 kJ% fat) for 12 weeks before mating. During this time, body composition was
monitoredweekly byNMR. Parent animalswere kept on the samediet until their sacrifice. Mating
took place at 15 weeks of age with a female:male ratio of 2:1. Breeding efficiencies of 3.2 offspring
per dam for the HF group and of 3.9 for the LF control group were taken into account. Both HF
and LF offspring were exclusively fed with LFD after weaning. Parent mice were sacrificed and
dissected at 30 weeks of age, while offspring at E18.5 (embryonic day 18.5), P15 (postnatal day
15) or P70 (postnatal day 70).
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3 Materials and methods
3.1 Animal experiments
3.1.1 Ethics statement
All animal experiments were conducted in conformity with the FELASA Guidelines and
Recommendations, the German animal welfare law and approved by the institutional
animal welfare committee (“committee for animal experiments and animal facility” of
the Helmholtz Zentrum München) as well as by the District Government of Upper
Bavaria (approval number: 55.2-1-54-2532-46-2016)
3.1.2 General mouse housing and feeding
Wildtype (WT) C57BL/6J mice were obtained from Charles River, Sulzfeld, Germany,
housed and bred in the animal facilities at the Institute of Lung Biology and Disease
(iLBD) or theGermanMouseClinic (GMC),Helmholtz ZentrumMünchen, Neuherberg,
Germany, under specific-pathogen-free (SPF) conditions. Animals had access to food
(standard chow, Altromin 1314; high-fat (HF), Ssniff EF D12492(II) mod. 60 kJ% fat
(tallow) E15741-347; low-fat (LF), Ssniff EF control E15000-047) and water ad libitum.
Special diet composition is presented on Figure 4 and in Table 3.
A maximum of 3-4 animals were kept in isolated ventilated cages (IVC-Racks,
BioZone, Margate, UK) supplied with filtered air. Housing rooms were maintained at
room temperature of 23 ± 2 °C and constant humidity (relative humidity 60 ± 5%) with
a 12 h light/dark cycle (lights on from 06:00 to 18:00).
Possible outbreaks of infectious diseases in animal groupswere controlled by constant
monitoring of the mouse well being (appearance, mood and feeding). Additionally, for
every study group, sentinel animals were tested for the presence of pathogens. There
were no pathogenic outbreaks during any of the studies.
3.1.3 High-fat diet feeding protocol
WT C57BL/6J mice were purchased directly after weaning at 3 weeks of age. Special
dieting of animals started on the sameday of delivery. Individual animalswere randomly
assigned to either HF diet (HFD, 60 kJ% fat) or LF control diet (LFD, 11 kJ% fat) and fed
for 12 weeks before mating. Parent animals were kept on the same diet assigned at the
beginning of the experiment until their sacrifice.
To better follow the principles of the 3Rs (Replacement, Reduction and Refinement),
number of mattings needed for diet experiments were calculated using breeding
efficiencies of 3.2 offspring per dam for HFD-fed mice and of 3.9 for LFD control
groups.
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Breeding took place at 15 weeks of age with a female:male ratio of 2:1. Daily matutinal
vaginal plug and delivery checks were performed, and day of plug and delivery were
recorded for mouse age calculation. The day of plug detection was defined as day 0.5 of
gestation. On day 18.5 of gestation (E18.5), females were euthanised, and the number of
gestational and resorbed sacs were documented.
Born offspring from both groups (HF and LF) were fed after weaning exclusively
with LFD. Offspring were analysed at embryonic day 18.5 (E18.5), 2 weeks after birth
(postnatal day 15, P15) or at the age of 10 weeks (postnatal day 70, P70). Please refer to
Figure 4 for a graphical representation of the experimental design.
Table 3: Diet composition
Chow [Altromin
1314]





Crude Nutrients [%] [%] [%]
Crude fat 5 4.2 34
Crude protein 22.6 20.8 24.1
Crude fibre 4.5 5 6
Crude ash 7.1 5.6 6.1




Metabolizable Energy 13.8 MJ/kg 15 MJ/kg 21.4 MJ/kg
Fatty acids [%] [%] [%]
C12:0 — — 0.03
C14:0 — 0.02 1.03
C16:0 0.52 0.45 8.06
C16:1 — 0.02 0.78
C17:0 — — 0.38
C18:0 0.16 0.19 5.61
C18:1 0.9 1.07 12.13
C18:2 2.14 2.12 2.37
C18:3 0.29 0.26 0.33
C20:0 0.014 0.02 0.04
C20:1 0.018 — 0.01
C20:4 — — 0.07
Amino acids [%] [%] [%]
Lysine 1.14 1.71 1.98
Methionine 0.32 0.73 0.83
Met+Cys 0.64 0.82 1.28
Threonine 0.83 0.93 1.07
Tryptophan 0.29 0.27 0.31
Arginine 1.49 0.76 0.88
Histidine 0.55 0.66 0.76
Valine 1.07 1.42 1.64
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Table 3: Diet composition (continued)
Chow [Altromin
1314]





Isoleucine 0.97 1.09 1.25
Leucine 1.71 2.05 2.36
Phenylalanine 1.06 1.11 1.29
Phe+Tyr 1.82 2.22 2.57
Glycine 0.96 0.43 0.5
Glutamic acid 4.37 4.69 5.41
Aspartic acid 2.19 1.55 1.79
Proline 1.39 2.39 2.76
Alanine 1.03 0.68 0.79
Serine 1.13 1.24 1.43
Vitamins per kg per kg per kg
Vitamin A 15000 IU 15.000 IU 15.000 IU
Vitamin D3 600 IU 1.500 IU 1.500 IU
Vitamin E 143 mg 150 mg 150 mg
Vitamin K 3 mg 20mg 20mg
Vitamin C 36 mg 30 mg 30 mg
Thiamin (B1) 18 mg 16 mg 16 mg
Riboflavin (B2) 12 mg 16 mg 16 mg
Pyridoxine (B6) 9 mg 18 mg 18 mg
Cobalamin (B12) 0.024 mg 30 µg 30 µg
Nicotinic acid 36 mg 49 mg 45 mg
Pantothenic acid 21 mg 56 mg 55 mg
Folic acid 2.4 mg 19 mg 19 mg
Biotin 250 µg 310 µg 310 µg
Choline-Chloride 600 mg 1.040 mg 2.300 mg
Inositol not indicated 80 mg 80 mg
Minerals [%] [%] [%]
Calcium 0.71 0.9 1.05
Phosphorus 0.51 0.63 0.61
Sodium 0.2152 0.19 0.2
Magnesium 0.2 0.21 0.17
Potassium 1.02 0.97 1
Trace elements per kg per kg per kg
Iron 191 mg 166 mg 139 mg
Manganese 77 mg 98 mg 82 mg
Zinc 84 mg 65 mg 56 mg
Copper 14 mg 14 mg 12 mg
Iodine 1.5 mg 1.2 mg 0.97 mg
Selenium 0.25 mg 0.14 mg 0.13 mg
Cobalt 0.37 mg 0.15 mg 0.13 mg
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3.1.4 Body mass and body composition analysis
Weight and body composition of parent animals were weekly monitored for 12 weeks
after start of special dieting. Bodymass was assessed by a scale, while body fat and body
lean mass were measured with a time-domain nuclear magnetic resonance (TD-NMR)
analyser (MiniSpec LF50, Bruker BioSpin MRI, Ettlingen, Germany).
TD-NMR provided precise measurements of lean tissue and body fat in live mice
without the need of anaesthesia. To conduct the measurement, unsedated single mice
were placed in a plastic restrainer (sample tubes with a diameter of 50 mm) and
introduced into the magnet of the scanner for up to 5 minutes until measurement was
completed. Prior to data acquisition the analyser was calibrated using a mixture of seeds
with known fat and water content.
3.1.5 Embryonic tissue dissection
18 days after a positive vaginal plug test (E18.5), dams were euthanised by cervical
dislocation. Uteri of dams were carefully exposed and excised using ring‐shaped tip
forceps (Carl Roth, Karlsruhe, Germany) to prevent puncturing the embryos.
Foetal tissue dissections were performed on a glass petri dish (dish diameter 13 cm,
dish height 3 cm) coated with 3-5 mm of the silicone rubber Elastosil RT 601 (Wacker,
Munich Germany) and filled up with 1x DPBS. Phosphate-buffered saline prevented
tissue drying, while the elastomeric rubber allowed anchoring of foetuses with 1 cm
long stainless steel minutien pins with a rod diameter of 0.2 mm (Fine Science Tools,
Heidelberg, Germany).
Following the excision of uteri, foetuses were quickly euthanised under a binocular
(Leica Microsystems, Singapore) by carefully cutting the cervical nerves directly after
separation from the placenta. Special attention was paid not to cut through the trachea
to prevent bleeding into the lung septum. Placentas were collected, snap frozen in liquid
nitrogen and kept at -80 °C until further analysis.
Left lobes of foetal lungswere incubated at 4 °C over night in 4%PFAandhistologically
prepared (see Section 3.3.2). Right lung lobes were snap frozen and stored at -80 °C until
further processing.
3.1.6 Intratracheal intubation and instillation
P70 (or older) mice were IP administered with completely antagonizable anaesthesia
using the combination of medetomidine (12-20 𝜇g/kg), midazolam (0.12-0.2 mg/kg)
and fentanyl (1.2-2 𝜇g/kg) (MMF). MMF injection volumes were calculated based on
individual mouse body weights. Drying of animal eyes was prevented with eye cream
(Bayer Vital, Leverkusen, Germany).
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After assessment (e. g. with toe-pinch test) of anaesthetic depth (surgical
anaesthesia), mice were intubated non-surgically[366] using a olive-tipped 23 G reusable
feeding needle (UNIMED, Lausanne, Switzerland) inserted 10 mm into the trachea. For
this, animals suspended at a 60° angle by the upper incisors with a string attached to a
plexiglass support. The trachea was then transilluminated with a cold light LCD fibre
optic illuminator (Schott, Duesseldorf, Germany)while holding themouse’s tonguewith
a curved micro-spatula for the effective intratracheal insertion of the cannula.
50 𝜇l of air, followed by 0.1 𝜇g E. coli O55:B5 endotoxin (Sigma-Aldrich, Saint Louis,
USA) diluted in 50 𝜇l PBS, and further 100 𝜇l of air were instilled with a 1 ml syringe
(B. Braun Melsungen, Germany) after verifying the successful placement of the cannula
through inspection of pressure changes (animal breathing) with a self-constructed
pneumotachograph. Control mice were instilled only with PBS, applying the same
instillation volumes (50 𝜇l of air, followed by 50 𝜇l PBS and further 100 𝜇l of air).
After careful removal of the cannula from the trachea, the animal was delicately
dismounted from the support and SC injected with an MMF-antagonizing mixture of
antipamezol (0.06-0.1 mg/kg), flumazenil (12-20 𝜇g/kg) and naloxon (28.8-48 𝜇g/kg)
(antagonist; concentrations for mouse body weights ranging between 24 and 40 g).
Animal health condition was monitored 1, 3 and 24 h after MMF-antagonization.
3.1.7 Blood and plasma analysis
After effective euthanasia with an IP injection of a lethal dose of anaesthesia
(500 mg/kg ketamine, 6 mg/kg xylazine), the retro-bulbar vein plexus of the mouse
was punctured with a glass capillary coated with lithium-heparinat (Hirschmann
Laborgeräte, Eberstadt, Germany). Up to 1ml of blood from each animalwas collected in
lithium-heparinat-coated tubes (Kabe Labortechnik, Nümbrecht-Eisenroth, Germany).
After mixing by inversion, blood was incubated at room temperature (RT) for 30-60 min
and centrifuged for 15 min at 3500 g. Plasma (supernatant) was separated, snap-frozen
and kept at -80 °C until further analysis.
The concentrations of pro-inflammatory mouse cytokines (IFNg, IL1b, IL2, IL4,
IL5, IL6, CXCL1, IL10, IL-12p70, and TNF) in the plasma were determined by
high-performance multiplex (10 assay spots per well) electrochemiluminescence
immunoassay (Mesoscale MESO QuickPlex SQ 120) in cooperation with
Dr. Aguilar-Pimentel at the Institute of Experimental Genetics (IEG), Helmholtz
Zentrum München.
Quantitative blood glucose measurements from freshly isolated whole blood samples
were performed with the Accu-Chek Aviva Connect blood glucose monitoring system
(Roche Diagnostics, Mannheim, Germany).
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3.1.8 Bronchoalveolar lavage
Micewere euthanisedwith an IP injection of a lethal dose of anaesthesia (see Section 3.1.7)
and their death was ensured by exsanguination. Bronchoalveolar lavage (BAL) was
performed by cannulating the trachea with a plastic catheter (Introcan Safety IV 20
G, B. Braun Melsungen, Melsungen, Germany) and infusing the lungs ten times with
1 ml of cold PBS lacking the bivalent cations Ca2+ and Mg2+ (DPBS 1X, Gibco, Dublin,
Ireland).
Lavages of each animal were collected into two separated pools – one from the first
and second lavages, another from the third to the tenth lavages – and centrifuged (350 g,
10min, 4 °C). The cell-free supernatant from the first pool was separated into three tubes,
snap-frozen in liquid nitrogen and kept at -80 °C until further biochemical analysis.
For each animal the cell pellets fromboth BALpoolswere resuspended in 1ml Roswell
Park Memorial Institute (RPMI) 1640 medium (Gibco, Dublin, Ireland) supplemented
with 10% foetal bovine serum (FBS; gibco, New Zealand) and the number of living cells
was determined with the trypan blue exclusion method.
3.1.9 Differential counting of bronchoalveolar lavage cells
3e4 BAL cells per animal were centrifuged (400 rpm, 6 min) on a glass slide
with a bench-top cytocentrifuge (Shandon Soudern Products, Cheshire, England).
Preparations were stained with May-Grünwald-Giemsa (Merck KGaA, Darmstadt,
Germany). Two differential cell counts per animal were manually performed by
counting two hundred cells with the aid of a differential cell counter (Karl Hecht,
Sondheim, Germany). With this method, polymorphonuclear leukocytes (PMNs),
mononuclear cells (alveolar macrophages, monocytes and dendritic cells), eosinophils,
and multinucleated giant cells were distinguishable.
Alternatively, cell pellets fromboth lavage poolswere resuspended in 1ml FACSbuffer
(see formulation on Table 12) and counted by flow cytometry using CountBright absolute
counting beads (Thermo Fisher Scientific, Eugene, USA) (refer to Equation 1). Living





After setting PMT voltages on cytometer and prior to flow cytometric analyses,
compensation controls were performed. For each fluorochrome, amixture of one drop of
blank beads and one drop of anti-REA compensation beads for REA antibodies (Miltenyi
Biotec, Bergisch Gladbach, Germany), or one drop of OneComp eBeads compensation
beads (Invitrogen, California, USA) for any other antibody, were mixed with 1-2 𝜇l of
antibody and incubated at room temperature for 10minutes. The suspensionwas diluted
with 1 ml of FACS buffer and measured for instrument calibration.
Live/dead compensation controls were achieved with a 1:1 mixture of live:death
PBMCs, cell culture cells, or primary cells. For the generation of the dead fraction, cells
were incubated for 10 min at 95 °C, or treated with 5 µM staurosporin for 1.5 h, and
washed with 1 ml FACS buffer (350 g, 5 min) prior to treating with DAPI (1:400, 5 min,
Miltenyi Biotec, Bergisch Gladbach, Germany) or fixable “Viobility Dye” (1:100, 15 min,
RT, Miltenyi Biotec, Bergisch Gladbach, Germany). Fixable viability dye-treated cells
were again washed with 1 ml FACS buffer (350 g, 5 min) before mixing with the live
fraction. DAPI stained cells were analysed without prior washing.
Compensation matrices were calculated automatically on the BD FACSDiva software
(BD Biosciences, San Jose, USA) after manually selecting (1D gating) for the negative
and positive populations for each of the 8 or 10 fluorochromes.
3.2.2 Flow cytometric immunophenotyping of bronchoalveolar lavage cells
Flow cytometric immunophenotyping of BAL cells presents a precise method to reliably
analyse single cells within the alveoli. Differential cell counting of BAL cells by flow
cytometry was accomplished following an 8-color staining protocol. The selection of the
markers and the manual gating protocol employed in this thesis was based on previous
works from Misharin et al.[217], Ellis et al.[367] and Yu et al.[368].
Up to 2e5 lavage cells of each animal were transferred to a 5 ml FACS tube, washed
with 1ml FACS buffer (350 g, 5min) and resuspended in 100 𝜇l of a 1:100 viability fixable
dye:FACS buffer solution. After mixing, cells were incubated at RT for 15 min in the
dark and washed with 1 ml FACS buffer. After centrifugation (350 g, 5 min), BAL cells
were resuspended in 50 𝜇l antibody cocktail (see panel on Table 4) and incubated on
ice for 15 min in the dark. After washing (1 ml FACS buffer; 350 g, 5 min), cell pellet
was resuspended in 300 𝜇l FACS buffer and 50 𝜇l of CountBright Absolute counting
beads (Molecular Probes, Eugene, USA) were added for the quantification of absolute
cell numbers in the lavages (refer to Equation 1).
Stained cells were analysed on a BD FACSCANTO II cytometer (BD Biosciences, San
Jose, USA) at the iLBD of the Helmholtz Zentrum München. Compensated single cell
data was exported as FCS files using the BD FACSDiva software. Flow cytometry data
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sets were manually gated with FlowJo (FlowJo LLC, Ashland, USA) to distinguish cell
populations based on the expression of the 8 markers. Alternatively, unsupervised
learning algorithms were applied to single cell data after manual quality control to
semi-automatedly distinguish BAL cell populations. Statistics were computed using R
(The R Foundation for Statistical Computing, Vienna, Austria).





𝐷 = 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑠𝑎𝑚𝑝𝑙𝑒 𝑎𝑠 𝑐𝑒𝑙𝑙𝑠/𝜇𝑙 (1)
𝑤ℎ𝑒𝑟𝑒 ∶
𝐴 = 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐𝑒𝑙𝑙 𝑒𝑣𝑒𝑛𝑡𝑠
𝐵 = 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑏𝑒𝑎𝑑 𝑒𝑣𝑒𝑛𝑡𝑠
𝐶 = 𝑎𝑠𝑠𝑖𝑔𝑛𝑒𝑑 𝑏𝑒𝑎𝑑 𝑐𝑜𝑢𝑛𝑡 𝑜𝑓 𝑡ℎ𝑒 𝑙𝑜𝑡 𝑢𝑠𝑒𝑑 (𝑏𝑒𝑎𝑑𝑠/50 𝜇𝑙)
𝐷 = 𝑙𝑎𝑣𝑎𝑔𝑒 𝑣𝑜𝑙𝑢𝑚𝑒 𝑢𝑠𝑒𝑑 𝑓𝑜𝑟 𝑎𝑛𝑎𝑙𝑦𝑠𝑖𝑠 (𝜇𝑙)
Table 4: 8-color staining panel for flow cytometric immunophenotyping of mouse
bronchoalveolar lavage cells
Antigen Fluorochrome Host/ Isotype Clone/ ID Final conc. Dilution
FCGR1 PE rh / IgG1 REA286 3 µg/ml 1:50
H2-AB1 APC-Vio770 rh / IgG1 REA813 1 µg/ml 1:150
ITGAM PE-Vio770 rh / IgG1 REA592 1.2 µg/ml 1:25
ITGAX FITC rh / IgG1 REA754 3 µg/ml 1:50
LY6C PerCP-Vio700 rh / IgG1 REA796 3 µg/ml 1:50
LY6G VioBlue rh / IgG1 REA526 3 µg/ml 1:10




3.2.3 Flow cytometric immunophenotyping of whole lung cells
In order to acquire a thorough view of the immune system in mouse lung, the the BAL
staining protocol was augmented to a 10-color panel for the differential cell counts of
whole lung immune cells.
After euthanasia with an IP injection of a lethal dose of anaesthesia and
exsanguination through an incision in the inferior vena cava, mice lungs and heart were
exposed by carefully opening the thoracic cavity. Lungs were perfused with 5-10 ml cold
PBS. PBS was injected into the right ventricle and allowed to exit through an incision in
the left atrium. 1 ml dispase (Corning, Massachusetts, USA) was instilled into the lungs
after intratracheal intubation of mice. Spilling of dispase out of the lung was prevented
with two sutures on the trachea. Lungs were preparated out of the chest cavity and
incubated at RT in 1.5 ml dispase in a 50 ml tube.
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Dispase-treated lungswere filtered through 70 𝜇mstrainers (Miltenyi Biotec, Bergisch
Gladbach, Germany) and collected in a 50 ml tube. Not fully digested tissue was
scraped through the filter with a cell scraper while rinsing with FACS buffer until 7 ml
cell suspension was obtained. Cell suspensions were again filtered through 70 𝜇m
strainer. Cells were pelleted by centrifugation (350 g, 5 min), resuspended in 5 ml FACS
buffer and counted by flow cytometry using CountBright Absolute counting beads (see
Equation 1).
5e5 dissociated whole lung cells per animal were transferred to a 5 ml FACS tube
and washed with 1 ml FACS buffer (350 g, 5 min). BAL cells were incubated with
unlabelled anti-CD16/CD32 antibody (rat/IgG2a, clone 93, 0.5 mg/ml, eBioscience, San
Diego, USA) for 5 min in order to reduce Fc-receptor mediated binding of test antibodies
and resuspended in 100 𝜇l antibody cocktail (see panel on Table 5). For staining, cells
were incubated on ice for 15 min in the dark. After washing with 1 ml FACS buffer
(350 g, 5 min), the cell pellet was resuspended in 400 𝜇l of a 1:400 DAPI:FACS buffer
solution.
Stained cells were analysed with a BD FACSLSR II cytometer (BD Biosciences,
San Jose, USA) at the Comprehensive Pneumology Center (CPC) of the Hemlholtz
Zentrum München. Compensated single cell data was exported as FCS files using the
BD FACSDiva software. FCS files were manually gated with FlowJo and population
numbers and statistics were computed using R. Alternatively, immune cell populations
were semi-automatedly clustered and counted using unsupervised machine learning
algorithms.
Table 5: 10-color staining panel for flow cytometric immunophenotyping of mouse whole lung
cells
Antigen Fluorochrome Host/ Isotype Clone/ ID Final conc. Dilution
CD24A Alexa Fluor700 rat / IgG2b M1/69 5 µg/ml 1:100
FCGR1 PE rh / IgG1 REA286 3 µg/ml 1:50
H2-AB1 APC-Vio770 rh / IgG1 REA813 1 µg/ml 1:150
ITGAM PE-Vio770 rh / IgG1 REA592 1.2 µg/ml 1:25
ITGAX FITC rh / IgG1 REA754 3 µg/ml 1:50
LY6C PerCP-Vio700 rh / IgG1 REA796 3 µg/ml 1:50
LY6G VioBlue rh / IgG1 REA526 3 µg/ml 1:10
PTPRC VioGreen rh / IgG1 REA737 3 µg/ml 1:50
SIGLECF APC rh / IgG1 REA798 3 µg/ml 1:50
Viability DAPI - - 25 ng/ml 1:400
3.2.4 Gating strategy
The manual gating strategy generated for this thesis was based on previous works from
Misharin et al.[217], Ellis et al.[367] and Yu et al.[368]. Compensated single cell fluorescent
data was imported to FlowJo using its graphical user interface. Each fluorescent
channel was transformed with FlowJo’s biexponential function and its axis minimum
and maximum were adjusted to the range of the fluorescent intensities.
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Sequential manual gates were applied on bivariate histograms. In order to better
distinguish cell clusters, two-parameter histograms were displayed in density plots.
Refer to Figure 31 for the gating strategy of whole lung leukocytes.
After removing cell debris (FCS-A, SSC-A) and dead cells (SSC-A, viability/DAPI),
(live) singlet cellswere selected (FCS-A, FSC-H). Leukocytes (PTPRC+)were gated from
the singlet population and lymphocytes (ITGAX−, ITGAM−) were subdivided into B
(CD24A+, H2-AB1−) and T-cells. Inflammatory T-cells could be distinguished by the
presence of LY6C.
From the not-lymphocytes, singlet cells group (notLymph), neutrophils (PMNs)
could be identified by the expression of LY6G. From the not-PMN cell population
(notPmn), monocytes (FCGR1+, ITGAM+) and natural killer cells (NK cells, FCGR1−,
ITGAMmed) were identified by their low SSC-A and missing expression of H2-AB1
(monoNk). Inflammatory and resident monocytes were separated on a LY6C-ITGAX
density plot, where inflammatory cells were recognized by the presence of LY6C.
The not-monocyte/NK population (notMonoNk) was further split into macrophages
(FCGR1+), dendritic cells (CD24A+, FCGR1−, H2-AB1+) and eosinophils (CD24A+,
SIGLECF+, H2-AB1−). Lastly, alveolar (SIGLECF+), inflammatory (SIGLECF−,
LY6C+) and interstitial macrophages (SIGLECF−, LY6C−) were identified on a
SIGLECF-LY6C-histogram.
3.2.5 Semi-automated immunophenotyping of lavage and whole lung cells
Manual gating has been the standard procedure to analyse low dimensional single
cell data for many years. However, with the technical advancements in mass[369] and
flow cytometry[370] and the increasing capacity to generate large and high-dimensional
data sets, manual analysis of single cell data becomes harder to reproduce due to its
subjectiveness[371], its susceptibility to bias[372] and the difficulty to recognize small
cell populations[373]. Computational methods based on dimensionality reduction have
proven[374] to help the analysis of big flow cytometric data[375], allowing automation,
standardization and reproducibility of procedures for the recognition of cell populations,
especially small/rare ones[373].
The semi-automated method for immunophenotyping of lavage and whole lung cells
applied in this thesis was inspired by the work of Nowicka et al.[376] published in
2017.
Fluorescent channels of compensated flow cytometry data were transformed with
FlowJo’s biexponential function and its axis minimum and maximum were adjusted
to the range of the fluorescent intensities. Single cell data was cleaned by manually
gating for the singlet cell population, as mentioned in Section 3.2.4. This “gating set” was
imported into R using the packages CytoML[377] and flowWorkspace[378]. Cytometry
data was analysed by applying three different unsupervised learning algorithms for
clustering and dimensionality reduction. Data was scaled and centred before it was
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clustered by training a self-organizing map and building a minimal spanning tree with
the FlowSOM package[379]. 20 subclusters were built applying consensus clustering[380]
on the 100 flowSOM clusters. Finally, t-distributed stochastic neighbour embedding[381]
(tSNE) was performed on 8e3 randomly selected cells to visually inspect the subclusters.
Analysing these plots, together with 1D and 2D histograms of the clustered cells and
their marker expression, the clusters were manually grouped and labelled with expected
immune cell population names.
3.3 Histology
3.3.1 May-Grünwald-Giemsa staining of cytospins
Cytocentrifuged specimens were left at RT to dry over night. Four glass cuvettes
containing 1) undiluted May-Grünwald’s eosine-methylene blue solution (Merck,
Darmstadt, Germany), 2) tap water, 3) 1:20 dilution of Giemsa’s azur eosin mthylene
blue solution:tap water (Merck, Darmstadt, Germany), and 4) tap water were prepared
for staining.
Cytospin slides were successively immersed in the four cuvettes and incubated for 1)
10 min, 2) 2 min, 3) 15 min, and 4) 2 min. Excessive water on sample slides was carefully
removedwith a tissue and cytospinswere let dry at RT over night before covering stained
cells with Entellan (Merck, Darmstadt, Germany) and cover slips. Manual cytospin
counts were performed after hardening of mounting medium over night.
3.3.2 Lung tissue preparation
Mice were euthanized and intratracheally intubated. After lung perfusion (see
Section 3.2.3), lungs were filled with formaldehyde solution made from 4%
paraformaldehyde powder in PBS (4% PFA) with a constant pressure of 25 cm 4%
PFA for 10 min. The trachea was sutured to prevent spilling of fixing solution, and lungs
were incubated at 4 °C in 4% PFA over night. Fixing solution was exchanged with 70%
ethanol and lungs were kept at 4 °C until further preparation.
Fixed lobes were cut into 2 mm thick slices. For each subject, slices were pooled
in embedding cassettes and automatedly embedded in a Leica TP1020 benchtop tissue
processor (Leica Biosystems Nussloch GmbH, Nussloch, Germany) following the
protocol presented on Table 6.
After completing the process of dehydration, clearing and infiltration, tissue samples
were externally embedded in paraffin wax (Merck, Darmstadt, Germany) using a cold
module (Thermo Scientific, Runcorn, UK).
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Formalin-fixed, paraffin-embedded (FFPE) tissues were hardened at 4 °C over night.
6 𝜇m thick tissue sections were cut with a ZEISS HYRAX M 55 rotary microtome
(MICROM, Walldorf, Germany) and stretch-dried on glass slides with a specimen
stage-stretching table (MEDAX, Neumünster, Germany). Dried sections were then
deparaffinized through two 5 min changes of xylene and re-hydrated through a
descending series of alcohol to water, consisting of two changes of absolute ethanol, and
one 1 min change of each 90%, 80% and 70% ethanol solutions.
Slides were briefly washed in distilled water, nuclear-stained with Mayer’s hemalum
solution (Merck, Darmstadt, Germany) for 5 min, and briefly dipped in alkalinized
water, and 0.1% HCl-EtOH. After washing for 10 min with tap water, specimens were
dipped in distilled water and incubated in 0.5% eosin (Merck, Darmstadt, Germany) for
8 min.
For better preservation, tissue sections were dehydrated again through a series of
alcohol solutions in ascending concentration. Sections were briefly dipped in 70%, 80%,
90% and 96% EtOH, and two 1min changes of absolute ethanol. After two 5min changes
in xylene, slides were mounted with Entellan and cover slips.
Table 6: Lung tissue embedding protocol
Station Medium Time
1 70% EtOH 1 h
2 80% EtOH 1 h
3 96% EtOH 1 h
4 96% EtOH 2 h
5 96% EtOH 2 h
6 100% EtOH 1 h
7 100% EtOH 2 h
8 100% EtOH 2 h
9 xylene 1 h
10 xylene 2 h
11 paraffin wax 1 h
12 paraffin wax 2 h
3.3.3 Stereological analysis
Quantitativemorphometric analysis of neonatal (P15) and young-adult[382] (P70)mouse
lungs was performed on 6 𝜇m thick hematoxylin and eosin (HE) stained FFPE tissue
sections (see Section 3.3.2). Slides were blindly analysed by design‐based stereology
on an Olympus BX51 light microscope equipped with the new Computer Assisted
Stereological Toolbox (newCAST, Visiopharm, Hoersholm, Denmark).
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Tissue sections were mounted on the microscope and a “super image” was created by
stitching images captured with the 2x objective. Lung tissue area was manually defined
using the selection tool of the software. Using the 20x objective, 20-30 fields of view
per subject were selected by the software using simple uniform random sampling across
multiple sections.
A line grid (line spacing of 530.57 𝜇m) and points (line length per point of 88.08 𝜇m)
were superimposed on lung section images. Intercepts of lines with alveolar septa (Isepta)
and points lying on air space (Pair) were manually counted (for an example of manual
counting see Figure 5). Mean linear intercepts (Lm) were calculated for each animal
following Equation 2.
Since this measure (Lm) is partly dependent on the structural size of the lung
(absolute surface area) as well as on changes on the lung volume. Changes in the
latter may be induced by disease (e. g. due to loss of elastic recoil in emphysematous
lungs)[383], but can also be introduced by technical errors during isolation and fixation –
e. g. by irregular pressures during inflation with PFA or during bronchoalveolar lavage,
due to lung puncture and other errors. For this reason, lung volumes were measured
after fixation and samples with outlying measurements in volume where excluded from
the stereological analysis. For this, only lungs with volumes within the 25th and 75th
percentiles of the volume measurements were randomly sampled.
Figure 5: Manual quantitative morphometric analysis of mouse lung tissue. Example of an
HE stained FFPE tissue sections of a young-adult (P70) mouse lung under the 20x objective of an
Olympus BX5 lightmicroscope. A line grid (line spacing of 530.57𝜇m)andpoints (line length per
point of 88.08 𝜇m) were superimposed on lung section images. Intercepts of lines with alveolar
septa (Isepta, blue lines) and points lying on air space (Pair, red ”P”) were manually counted.
Mean linear intercepts (Lm) were calculated following Equation 2.
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𝐿𝑚 =
∑ 𝑃𝑎𝑖𝑟 × 𝐿𝑝
∑ 𝐼𝑠𝑒𝑝𝑡𝑎 × 0.5
(2)
𝑤ℎ𝑒𝑟𝑒 ∶
𝑃𝑎𝑖𝑟 ∶= 𝑔𝑟𝑖𝑑 𝑝𝑜𝑖𝑛𝑡 𝑙𝑦𝑖𝑛𝑔 𝑜𝑛 𝑎𝑖𝑟 𝑠𝑝𝑎𝑐𝑒
𝐿𝑝 ∶= 𝑙𝑖𝑛𝑒 𝑙𝑒𝑛𝑔𝑡ℎ 𝑝𝑒𝑟 𝑝𝑜𝑖𝑛𝑡 (88.08 𝜇𝑚)
𝐼𝑠𝑒𝑝𝑡𝑎 ∶= 𝑖𝑛𝑡𝑒𝑟𝑐𝑒𝑝𝑡 𝑏𝑒𝑡𝑤𝑒𝑒𝑛 𝑎𝑙𝑣𝑒𝑜𝑙𝑎𝑟 𝑠𝑒𝑝𝑡𝑢𝑚 𝑎𝑛𝑑 𝑔𝑟𝑖𝑑 𝑙𝑖𝑛𝑒𝑠
3.3.4 Digital image analysis
Digital image analysis was performed in cooperation with Dr. Annette Feuchtinger
and Dr. Andreas Falko Parzefall at the Core Facility Pathology and Tissue Analytics of
the Helmholtz Zentrum München. After visual inspection for quality control of the
stained tissue sections Dr. Andreas Falko Parzefall, histological slides were scanned
with an AxioScan.Z1 digital slide scanner (Zeiss, Jena, Germany) equipped with a
20x magnification objective. Images were evaluated using the commercially available
image analysis software Definiens Developer XD2 (Definiens AG, Munich, Germany)
by Dr. Annette Feuchtinger following a previously published procedure[384] at the Core
Facility Pathology and Tissue Analytics.
A rule set was defined to detect and quantify the alveolar space within each lung lobe,
based on morphology, size, pattern, shape, neighbourhood and special colour features.
The quantified parameter were the alveolar and septal area [𝜇m2], the length of border
between septum and air [𝜇m], the total lung area [𝜇m2], the total number of alveoli as
well as the ratio between air and septal areas. Statistical analysis of digital image analysis
results were performed with R.
3.4 Enzyme-linked immunosorbent assay
Cytokine concentration in BAL fluid was analysed by sandwich enzyme-linked
immunosorbent assay (ELISA). All ELISA kits were purchased from R&D Systems,
Wiesbaden-Nordenstadt, Germany (refer to Table 10 for a list of all ELISA kits used in this
work). Assays were performed following all recommendations and the general ELISA
protocol from the provider. All incubation periods were performed at RT, in the dark
and covering the 96-well microplate with an adhesive sealer. Between each assay step,
all wells of the microplate were washed with an auto-washer three times with 400 𝜇l of
a PBS dilution of 0.05% Tween 20 (Sigma-Aldrich, Taufkirchen, Germany) with a pH of
7.4. All measurements were performed in duplicate.
After dilution of capture antibody to theworking concentration in PBS, themicroplate
was coatedwith 100𝜇l of the dilution and incubated at RT over night. Wellswere blocked
for 1 h with 300 𝜇l of a 1% BSA solution in PBS, pH 7.4, and filled with 100 𝜇l BALF
or cytokine standards diluted in PBS containing 1% BSA. After an incubation of 2 h at
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RT, 100 𝜇l of the detection antibody, diluted in PBS containing 1% BSA, were added to
each well and microplate was incubated for another 2 h. 100 𝜇l of the working dilution
of streptavidin conjugated to horseradish-peroxidase were added to each well and after
20 min incubation 100 𝜇l of a 1:1 mixture of H2O2 : Tetramethylbenzidine was added to
each well. The colour reaction was carefully monitored for a maximum of 15 min and
50 𝜇l of a 2 N H2SO4 solution was added to the colour mixture in each well to stop the
colour reaction.
After ensuring that no bubbles were present in any of the wells, optical density was
measured at 450 (signal) and 570 nm (correction) using a Tecan NanoQuant infinite
M200 PRO microplate reader (Tecan Austria, Salzburg, Austria). After subtracting the
correction from the signal OD values and normalizing all signals by subtracting the OD
values from wells without sample (PBS), OD values were exported using the Magellan
Software V7.1 SP1 (Tecan Austria, Grödig, Austria) and analysed in R. For the creation
of a calibration curve, a second-order polynomial regression was fit using the exported
values. The cytokine concentration of each BALF sample was then predicted by applying
the fittedmodel to each normalizedODvalue and averaging the predicted concentrations
of the technical duplicates.
3.5 Analysis of alveolar macrophages
3.5.1 Alveolar macrophage isolation
Freshly isolated BAL cells (see Section 3.1.8) of two mice were resuspended in
RPMI-1640 medium supplemented with 10% FBS (gibco, New Zealand), 0.05 mM
2-mercaptoethanol (Sigma-Aldrich, Taufkirchen, Germany), 100 U/ml Penicillin and
100 µg/ml Streptomycin (Gibco, Dublin, Ireland) (MHS-medium; Table 12). AMs were
purified byplating 1-2E5 cellswith 1mlMHSmediumperwell on plastic 12-well plates at
37 °C and 5 % CO2 for 60 min and washing off non-adherent cells twice with 37 °C-warm
PBS.
3.5.2 Alveolar macrophage polarization
In vitro polarization of primary alveolar macrophages (AMs) was performed exclusively
on cells isolated from (LPS-)untreated healthy mice. Classical activation (M1) of AMs
was achieved by incubating the adherent cell fraction with MHS medium containing
1 𝜇g/ml LPS (Sigma-Aldrich, Taufkirchen, Germany) for 50 min or 24 h. For
an alternative (M2) activation, AMs were incubated with MHS medium containing
20 ng/ml IL-4 for 24 h. Control cells (M0) were incubated for the same period of time
as M1 or M2 AMs in plain MHS medium. All incubation steps were performed at 37 °C
and 5 % CO2.
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After washing twice with 37 °C-warm PBS and carefully aspirating the remaining
supernatant, cells were directly lysed with lysis solution of RNA preparation kit in their
wells while scraping with the pipette tip. Lysed suspensions of each pool was collected
into a 1.5 ml reaction tube, snap frozen and stored at -80 °C until RNA isolation.
3.5.3 Alveolar macrophage phagocytosis assay
1E5 freshly isolated primary AMs (see Section 3.5.1) per well were incubated on a 96-well
plate for 1 h at 37 °C and 5 % CO2. All wells were filled with 200 𝜇l MHS-medium
(see formulation on Table 12). Culture medium in control wells was supplemented with
10 𝜇M of the mycotoxin and F-actin polymerization inhibitor cytochalasin D (Gibco,
Dublin, Ireland) to suppress phagocytosis. AMs were washed with 1x live cell imaging
solution (Molecular Probes, Eugene, USA) and incubated with 100 𝜇l of a suspension
containing 0.5 mg/ml pHrodo red zymosan A bioparticles (life technologies, Eugene,
USA) in 1x live cell imaging solution for 60 min. For a correct dispersion of the particles,
the suspension was briefly vortexed and sonicated for 5 minutes in an ultrasonic water
bath directly before pipetting it to the wells. The incubation of the cells with the
zymosan particles was performed in an incubator without CO2 influx to avoid artificial
acidification of the buffer.
After washing cells with 37 °C-warm 1x live cell imaging solution, 100 𝜇l Accutase
(Sigma-Aldrich, Taufkirchen, Germany) were added to each well and AMs were placed
back in the incubator for up to 10 min to detach cells from the plate. 300 𝜇l FACS
buffer were added to each well and fluorescence intensities of uptaken particles (585 nm
emission maximum) were measured on a BD FACSCANTO II cytometer at the iLBD of
the Helmholtz Zentrum München (488 nm blue laser, 585/42 “PE” filter).
3.6 RNA isolation and reverse transcription
RNA from lung and placenta tissues was isolated using the RNeasy Plus Mini Kit
(QIAGEN, Hilden, Germany), while RNA form AMs was isolated using the Quick-RNA
MicroPrep kit (ZYMO RESEARCH, California, USA) following the manufacturer’s
recommendations. Lung and placenta tissues were mechanically homogenized in 600 𝜇l
lysis buffer in a tube containing Lysing Matrix D (MP Biomedicals) for 30 s at a speed of
6500 on a MagNA Lyser Instrument (Roche Diagnostics GmbH, Mannheim, Germany).
Directly after homogenization, lysateswere centrifuged atmaximum speed for 3min and
supernatant transferred to gDNA eliminator columns for further RNApreparation.
For the RNA isolation ofAMs, bronchoalveolar lavages from two animalswere pooled,
platted on 12-well plates and incubated with MHS-medium at 37 °C and 5 % CO2 for
60 min. After washing off non-adherent cells with warm PBS, AMs were lysed with
200 𝜇l lysis buffer. Lysates were collected in 1.5 ml reaction tubes, shock-frozen in liquid
nitrogen and stored at -20 °C until further RNA preparation.
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After total RNA purification, tissue RNA was eluted in 50 𝜇l and AM RNA
in 12 𝜇l RNA free water. Directly after elution, RNA concentration and purity
was quantified with a NanoDrop ND-1000 spectrophotometer (peqlab Biotechnologie,
Erlangen, Germany).
For synthesis of complementary DNA (cDNA), up to 1 𝜇g in 10 𝜇l total RNA were
transferred to 0.2 ml thin-walled microtubes for PCR (Thermo Fisher Scientific, UK)
incubated with 1 𝜇l of random nonamers with a concentration of 0.1 mM for 5 min at
70 °C on a PCR- thermal cycler (MJ Research, Hamburg, Biozym, Germany). After 5 min
incubation on ice and 10 min at RT, 9 𝜇l of a master mix containing 4 𝜇l 5x first strand
buffer, 2 𝜇l 10x dithiothreitol 0.1 M, 1 𝜇l Superscript II reverse transcriptase 200 U/𝜇l
(Invitrogen, California, USA), 1 𝜇l RNase inhibitor 40 U/𝜇l and 1 𝜇l 4 dNTP mix 10 mM
eachNEB (Thermo Fisher Scientific) were added to each sample and reaction tubes were
incubated for 1 h at 42 °C. After inactivation of the reverse transcriptase at 70 °C for
15 min, samples were diluted 1:5 in DEPC- and nuclease-free UltraPure Distilled Water
(Invitrogen, California, USA) and stored at -20 °C until qPCR analysis.
3.7 Real-time polymerase chain reaction
Primer designwas performed onlinewith theNCBI’s primer blast tool[385] targeting primer
melting temperatures around 61.5 °C with a maximal melting temperature difference
between primer pairs of 1.5 °C. Primer selection was also limited to primer pairs binding
to exon junctions or exon-spanning regions and leading to PCR product sizes between
80 and 140 base pairs. Please refer to Table 7 for the list of primer sequences employed in
this thesis.
qPCR analysis was performedwith a LightCycler 480 II (Roche Diagnostics, Rotkreuz,
Switzerland). For each sample, 10 𝜇l of a qPCR master mix containing 6 𝜇l LightCycler
480 SYBRGreen I Master (Roche, Mannheim, Germany), 3.5 𝜇l DEPC- and nuclease-free
UltraPure Distilled Water (Invitrogen, California, USA) and 0.5 𝜇l primer mix (10 𝜇M
each), were pipetted to each sample well of a 96-well Lightcycler plate (SARSTEDT AG
& Co. KG, Nürnberg, Germany). 2 𝜇l cDNA (see Section 3.6) or water as no template
controls were added to wells containing master mix and the plate was sealed with an
optically clear adhesive seal (Thermo Scientific, Wilmington, USA). All samples were
analysed using two technical replicates.
The qPCR protocol consisted of a pre-incubation period of 6 min at 95 °C, followed by
45 amplification cycles composed of a denaturation phase of 8 s at 95 °C, an hybridization
period of 12 s at 60 °C and an polymerization interval of 15 s at 72 °C. A single
acquisition of the SYBR green fluorescence intensity was performed at the end of the
polymerization interval. For quality control, a melting curve program was run directly
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after amplification. This consisted of a continuous increase of temperature from 65 °C to
97 °C with a ramp rate of 0.11 °C/s and the acquisition of the SYBR green fluorescence
intensity every 5 s. The LightCycler protocol was finished with a cooling period of 10 s
at 40 °C.
The identification of the threshold cycle (CT) was performed automatically by the
LightCycler 480 software (Roche Diagnostics, Rotkreuz, Switzerland) with the second
derivative maximum method. CT values were exported as text files and analysed with
R. Three house keeping genes (Actb, Hprt, Gusb) were used as internal control. These
three genes were selected after identifying the most stably expressed control genes in the
tissues of interest employing the geNorm method[386].
The quantification of the relative expression of the genes of interest was performed
using the ΔCT method[387]. For each sample, the average of the CT values from
technical replicates was computed and the average of all control genes was subtracted
from it (ΔCT). The relative quantity of each gene of interest was then calculated by
exponentiating 2 to the power of -ΔCT (2 -ΔCT).
Table 7: Primer sequences
Gene RefSeq Forward (5’->3’) Reverse (5’->3’)
Arg1 NM_007482.3 ggcagaggtccagaagaatgg tgagcatccacccaaatgacac
Bmp4 NM_007554.3 acttcgaggcgacacttctacag actggagccggtaaagatccc
Ccl17 NM_011332.3 ctctgcttctggggacttttct agtaatccaggcagcactctc
Ccl2 NM_011333.3 ttaaaaacctggatcggaaccaa gcattagcttcagatttacgggt
Chil3 NM_009892.3 atggcctcaacctggactgg tgtctttctccacagattcttcctc
Cxcl2 NM_009140.2 aagtttgccttgaccctgaagc gttcttccgttgagggacagc
Fgf10 NM_008002.4 tgagaagaacggcaaggtcag gacggcaacaactccgatttc
Fzd1 NM_021457.3 actttgtgccgaagcactcc tccagcaaccaaagcagcag
Fzd10 NM_175284.3 cgccgatcatggagcagttc ctcatccgagccgttgttgg
Fzd7 NM_008057.3 ggtgtgtggtcagtgctgtg tgggtcgctctggatagctg
Ifng NM_008337.4 aggaactggcaaaaggatggt atgttgttgctgatggcctg
Igf1r NM_010513.2 cccgacctcgctgtgg agctgctgatagtcgttgcg
Il12b NM_001303244 ttgaactggcgttggaagcac tcttgggcgggtctggtttg
Il6 NM_031168.2 ggagcccaccaagaacgatag cagcatcagtcccaagaaggc
Kdr NM_010612.3 ctagctgtcgctctgtggttc ttgtcagtatgtctttctgtgtgc
Lef1 NM_010703.4 ctcaggagccctaccacgac cgggtcgctgttcatattggg
Mmp2 NM_008610.3 tggcaccaccgaggactatg gttgcccaggaaagtgaaggg
Mmp9 NM_013599.4 ctattcggcctgcaccacag cttctccgttgccgtgctc
Nkx2-1 NM_009385.3 caggacaccatgcggaacag ccgcccatgccactcatattc
Nlrp3 NM_001359638 gtacccaaggctgctatctgg gcagccctttcgagggtctc
Nos2 NM_001313921 atgactcccagcacaaaggg ctcttgcggaccatctcctg
Pdgfa NM_008808.4 gtgcccattcgcaggaagag caggaagttggccgatgtgg
Pdgfra NM_001083316 cgcggaacctcagagagaatcg ctgaggaccagaaagacctggtg
Pdpn NM_010329.3 aacaaccacaggtgctactgg tgctgaggtggacagttcctc
Pparg NM_001127330 gagatcatctacacgatgctggc cgcaggcttttgaggaactc
Ptsg2 NM_011198.4 caacacctgagcggttac gttccaggaggatggagt
Retnla NM_020509.3 gctaactatccctccactgtaacg caagcacacccagtagcagtc
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Table 7: Primer sequences (continued)
Gene RefSeq Forward (5’->3’) Reverse (5’->3’)
Saa3 NM_011315.3 agccaaagatgggtccagttc atgtcagagtaggctcgcca
Sftpb NM_147779.2 aggctatgccacaggcaatg caggtgatgtgggcatcctg
Sftpc NM_011359.2 caaagaggtcctgatggagagtcc accacaaccacgatgagaagg
Sftpd NM_009160.2 tggtcgtgatggacgggatg gttcgccagcagagccattc
Shh NM_009170.3 gcaggtttcgactgggtctac aacagccgccggatttgg
Tgfb1 NM_011577.2 taatggtggaccgcaacaacg tgcttcccgaatgtctgacg
Timp3 NM_011595.2 cacatgctctcccagccatc accagcttctttcccaccac
Tnf NM_001278601 gatcggtccccaaagggatg gtggtttgtgagtgtgagggt
Tnfrsf11a NM_009399.3 tgcagctcaacaaggatacgg ccctggtgtgcttctagctttc
Vegfa NM_001025250 agccagcacataggagagatgag tggctttgttctgtctttctttgg
Wnt10b XM_006520892 cgcggtttccgtgagagtg ccgttaccaccagcttgcc
Wnt2 NM_023653.5 tcggtggaatctggctctgg tcacacatcaccctggaggag
Wnt3a NM_009522.2 tcggatacctcttagtgctctgc gcacagagaatgggctgagtg
Wnt5a NM_009524.4 ggcatcggagatggaactgc ctcggctcatggcgttcac
Wnt7b NM_009528.3 acaatgaggcgggcagaaag cctcgcggaacttaggtagc
3.8 Statistical analysis
Experimental raw data was imported, wrangled and analysed over the integrated
development environment (IDE) RStudio 1.3.959[388] in the language for statistical
computing and graphics R, versions 3.5.2 or 4.0.0[389]. R packages employed are listed in
the references[378,379,390–409]. Graphical representations of analysed data were generated
also in R. This thesis was written making use of the R Markdown framework[399,403,408]
and LATEX[410].
Descriptive statistical analysis of experimental results consisted of the following
steps:
After loading raw data files into R, a first exploratory examination was performed.
This consisted of the identification of the type of variables in the data, the presence
of missing values and potential outliers as well as the qualitative visualization of the
distribution of the data points along their respective scales. Outlier removal was
performed only in cases where there was a strong evidence of technical errors. The
visualization of data was an important step during exploratory analysis, which also
allowed for a first qualitative impression of possible differences between groups. Data
wrangling allowed the organization of observations (samples) and variables (measured
attributes) into a “tidy”[411] format for downstream analytics. Data compression was
achieved by the computation of summary statistics to recognize the central tendency,
dispersion, shape of the underlying distribution and dependence between variables.
Depending on the type of variable analysed, assumptions of appropriate statistical
inference tests were assessed before the actual statistical comparison between groups
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(hypothesis testing). The evaluation of the normal distribution and, for instance, was
an important step in the control of the required assumptions. This was performed
qualitatively with the help of QQ-plots as well as quantitatively by applying the
Shapiro-Wilk normality test. In order to test for the homogeneity of variance across
groups, the Levene test was also employed.
The significance level 𝛼 was set to 0.05. The test decision was based on p-values
from hypothesis testing results. To prevent the inflation of false positive rates, p-value
correction techniques were implemented in the case of multiple comparisons. The
more conservative Bonferroni correction (family-wise error rate correction) was used in
confirmatory analyses – i. e. results that were already published somewhere else and
experimentally verified – while the Benjamini-Hochberg correction (false discovery rate
correction) in rather exploratory analyses.
Table 8: Software
Software Name Manufacturer
BD FACSDiva Software Version 6.1.3 BD Biosciences, San Jose, USA
BD FACSDiva Software Version 8.0 BD Biosciences, San Jose, USA
FlowJo 10.5.3 FlowJo LLC, Ashland, USA
LightCycler 480 Software SP4 version 1.5.0.39 Roche Diagnostics, Rotkreuz, Switzerland
Magellan Software V7.1 SP1 Tecan Austria, Grödig, Austria
OLYMPUS cellSens Dimension 1.14 OLYMPUS CORPORATION, Tokyo, Japan
R versions 3.5.1 and 4.0.0 The R Foundation for Statistical Computing,
Vienna, Austria
RStudio version  1.3.959 RStudio, Boston, USA
Tecan NanoQuant infinite M200 PRO Tecan Austria, Salzburg, Austria
VIS - Visiopharm Integrator System Version
6.0.01765
Visiopharm, Medicon Valley, Denmark
Table 9: Equipment
Equipment Name Cat. No. Company
ABI PRISM® 7500 detection system Applied Biosystems, Foster city, CA,
USA
Accu-Chek Aviva Connect 06919138001 Roche Diagnostics GmbH, Mannheim,
Germany
Axioplan 451887 Carl Zeiss Microscopy GmbH, Jena,
Germany
BD FACSCanto II 338962 BD Biosciences, San Jose, USA
CB 150 incubator 9140-0001 Binder, Tuttlingen, Germany
Centrifuge: Eppendorf 5415D Eppendorf, Hamburg, Germany
Centrifuge: Sigma 3K18 Sigma, Osterode am Harz, Germany
Cold Module for Embedding A81000105 Thermo Scientific, Runcorn, UK
Counter AC-12 345-12 Karl Hecht, Sondheim, Germany
CR422 refrigerated centrifuge 23173 Pabisch, München, Germany
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Table 9: Equipment (continued)
Equipment Name Cat. No. Company
Ferrari manual counter L10 ferrari
Forceps with ring-shaped tip L00.1 Carl Roth, Karlsruhe, Germany
HistoStar cold module HS0147B1103 Thermo Scientific, Runcorn, UK
Incubator Heraeus BBD 6220 51020241 Thermo Electron, Langenselbold,
Germany
KL 1500 LCD fiber optic illuminator KL1500LCD Schott, Duesseldorf, Germany
Lacrymal olive-tipped needles
(0.60 x 33 mm. 23G x 1 3/8”)
27.140 UNIMED, Lausanne, Switzerland
Leica M80 binocular MEB132 Leica Microsystems, Singapore
Leica TP1020-1-1 benchtop tissue
processor
042230535 Leica Biosystems Nussloch GmbH,
Nussloch, Germany
LightCycler 480 II /96 28340 Roche Diagnostics, Rotkreuz,
Switzerland
MagNA Lyser Instrument 41337317 Roche Diagnostics GmbH, Mannheim,
Germany
Mastercycler nexus eco / nexus
gradient
6332 Eppendorf, Hamburg, Germany
MESO QuickPlex SQ 120 AI0AA-0 MESO SCALE DIAGNOSTICS,
Maryland, USA
Mikro-Dismembrator S 00313 Sartorius Stedim, Göttingen, Germany
MIKRO 220R centrifuge 2205 Hettich, Tuttlingen, Germany
MiniSpec body composition
analyzer
LF50 Bruker BioSpin MRI, Ettlingen,
Germany
Minutien pins 26002-20 Fine Science Tools, Heidelberg,
Germany
Multipipette E3 H42845F Eppendorf, Hamburg, Germany
NanoDrop® ND-1000
spectrophotometer
ND-1000 peqlab Biotechnologie, Erlangen,
Germany
Neubauer improved bright-line BR717810 Brand, Wertheim, Germany
OLYMPUS BX51TF OLYMPUS CORPORATION, Tokyo,
Japan
OLYMPUS DP72 OLYMPUS CORPORATION, Tokyo,
Japan
PCR- thermal cycler : PTC-225 MJ Research, Hamburg, Biozym,
Germany
Reusable feeding needles 18064-20 Fine Science Tools, Heidelberg,
Germany
Sartorius precision scale R160P Sartorius, Göttingen, Germany
Shandon cytospin 2 cytocentrifuge 59900101 Shandon Soudern Products, Cheshire,
England
Specimen stage-stretching table 14332 MEDAX Gmbh & Co. KG, Neumünster,
Germany
Thermomixer compact 5350 Eppendorf, Hamburg, Germany
Universal 32 R centrifuge 1610 Andreas Hettich, Tuttlingen, Germany
XS205 DualRange precision scale X205BDU Mettler Toledo, Greifensee, Switzerland
ZEISS Axiovert 135 LCB 0725 Lauda, Lauda-Königshofen, Germany
ZEISS HYRAX M 55 43773 MICROM, Walldorf, Germany
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Table 9: Equipment (continued)
Equipment Name Cat. No. Company
Zetasizer Nano Series ZEN3600 Malvern instruments limited,
Worcestershire, UK




Annexin V Apoptosis Detection Kit- APC 88-8007-74 eBioscience, San Diego, USA
Mouse CCL17/TARC DuoSet ELISA DY529 R&D Systems, Minneapolis, USA
Mouse CCL2 DuoSet ELISA DY479 R&D Systems, Minneapolis, USA
Mouse CSF2 DuoSet ELISA DY415 R&D Systems, Minneapolis, USA
Mouse CXCL1 DuoSet ELISA DY453 R&D Systems, Minneapolis, USA
Mouse Fas Ligand/TNFSF6 DuoSet ELISA DY526 R&D Systems, Minneapolis, USA
Mouse IL1a/IL-1F1 DuoSet ELISA DY400 R&D Systems, Minneapolis, USA
Mouse IL1b/IL-1F2 DuoSet ELISA DY401 R&D Systems, Minneapolis, USA
Mouse Lactate Dehydrogenase, LDH
ELISA Kit
E1864m USCNLIFE
Mouse LIX DuoSet ELISA DY443 R&D Systems, Minneapolis, USA
Mouse Serum Amyloid A Quantikine
ELISA Kit
MSAA00 R&D Systems, Minneapolis, USA
Pierce BCA Protein Assay Kit 23225 Thermo Fisher Scientific
Quick-RNA MicroPrep kit R1051 ZYMO RESEARCH, California,
USA
RNeasy Plus Mini Kit 74136 QIAGEN, Hilden, Germany
Table 11: Chemicals and reagents
Reagent Cat. No. Manufacturer
1x live cell imaging solution A14291DJ Molecular Probes, Eugene, USA
2-mercaptoethanol M3148 Sigma-Aldrich, Taufkirchen, Germany
3,3’,5,5’-Tetramethylbenzidine
(TMB) Liquid Substrate System for
ELISA
T0440 Sigma-Aldrich, Taufkirchen, Germany
Accutase A6964 Sigma-Aldrich, Taufkirchen, Germany
Antisedan (Atipamezol) 5 mg/ml 10000449 Prodivet pharmaceuticals, Barcelona,
Spain
BEPANTHEN Eye and Nose Cream 1578681 Bayer Vital, Leverkusen, Germany
Bovine Serum Albumin (BSA) A2153 Sigma-Aldrich, Taufkirchen, Germany
CD16/ CD32 (93) 14-0161-81 eBioscience, San Diego, USA
CD24A-Alexa Fluor 700 (M1/69) 101836 BioLegend, San Diego, USA
cell tracker red CMTX C34552 Invitrogen, California, USA
CountBright Absolute Counting
Beads
C36950 Molecular Probes, Eugene, USA
cytochalasin D PHZ1063 Gibco, Dublin, Ireland
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Table 11: Chemicals and reagents (continued)
Reagent Cat. No. Manufacturer
DAPI staining solution 130-111-570 Miltenyi Biotec, Bergisch Gladbach,
Germany
Dispase 354235 Corning, Massachusetts, USA
DNaseI A3778 AppliChem, Darmstadt, Germany
dNTP Mix (10 mM each) R0192 Thermo Fisher Scientific
Dormicum (Midazolam) 5 mg/1
ml
10145376 Roche, Mannheim, Germany
Dulbecco’s Phosphate Buffered
Saline (DPBS) (1X)
14190-094 Gibco, Dublin, Ireland
Elastosil RT 601 A 9104437067 Wacker, Munich Germany
Elastosil RT 601 B 9104437067 Wacker, Munich Germany
Entellan new 107961 Merck KGaA, Darmstadt, Germany
Ethanol absolute for analysis 100983 Merck KGaA, Darmstadt, Germany
Ethylenediaminetetraacetic acid
disodium salt dihydrate (EDTA)
ED2SS Sigma-Aldrich
FCGR1-PE (REA286) 130-118-684 Miltenyi Biotec, Bergisch Gladbach,
Germany
Fentanyl 0.1 mg/2 ml injection
solution
2084366 Janssen, Neuss, Germany
Fetal Bovine Serum (FBS) 10091148 Gibco, New Zealand
Flumazenil injection solution 1
mg/10 ml
4470990 HEXAL, Holzkirchen, Germany
Giemsa’s azur eosin mthylene blue
solution
109204 Merck KGaA, Darmstadt, Germany
H2-AB1-APC-Vio770 (REA813) 130-112-233 Miltenyi Biotec, Bergisch Gladbach,
Germany
HEPES Buffer Solution (1 M) 02968 Gibco, Dublin, Ireland
high-fat, Ssniff EF D12492(II) mod.
60 kJ% fat (tallow)
E15741-347 SSniff Spezialdiäten, Soest, Germany
Histosec pastilles 111609 Merck KGaA, Darmstadt, Germany
ITGAM-PE-Vio770 (REA592) 130-109-287 Miltenyi Biotec, Bergisch Gladbach,
Germany
ITGAX-FITC (REA754) 130-110-837 Miltenyi Biotec, Bergisch Gladbach,
Germany
ketamine 10% 00218 medistar, Ascheberg, Germany
LightCycler 480 SYBR Green I
Master
04887352001 Roche, Mannheim, Germany
Lipopolysaccharides from
Escherichia coli O55:B5
L2880 Sigma-Aldrich, Saint Louis, USA
low-fat, Ssniff EF control
E15000-047
E15000-047 SSniff Spezialdiäten, Soest, Germany
LY6C-PerCP-Vio700 (REA796) 130-111-920 Miltenyi Biotec, Bergisch Gladbach,
Germany
LY6G-VioBlue (REA526) 130-110-449 Miltenyi Biotec, Bergisch Gladbach,
Germany
MACS Comp Bead Kit, anti-REA 130-104-693 Miltenyi Biotec, Bergisch Gladbach,
Germany
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Table 11: Chemicals and reagents (continued)
Reagent Cat. No. Manufacturer
May-Grünwald’s eosine-methylene
blue solution modified
101424 Merck KGaA, Darmstadt, Germany
Mayer’s hemalum solution 109249 Merck, Darmstadt, Germany
Mistosec pastilles 1.11609.2504 Merck, Darmstadt, Germany
Narcanti (Naloxon) 0.4 mg/ml
injection solution
3338219 Braun, Melsungen, Germany
Omnifix-F 1 ml syringe 9161406V Braun, Melsungen, Germany
OneComp eBeads Compensation
Beads
01-1111-42 Invitrogen, California, USA
PBS Dulbecco w/o calcium w/o
magnesium
L182-10 Biochrom, Berlin, Germany
Penicillin-Streptomycin 15140122 Gibco, Dublin, Ireland
pHrodo Red Zymosan Bioparticles
Conjugate for Phagocytosis
P35364 Thermo Fisher Scientific
primers (see primer table) metabion international, Planegg,
Germany
ProLong Gold antifade with DAPI P36935 Invitrogen, California, USA
Proxylaz (Xylazin) 3100408.00.00 bela-pharm, Vechta, Germany
PTPRC-VioGreen (REA737) 130-110-803 Miltenyi Biotec, Bergisch Gladbach,
Germany




10777019 Invitrogen, California, USA
Roswell Park Memorial Institute
(RPMI) 1640 medium
21875-034 Gibco, Dublin, Ireland
Roticlear A538.2 Carl Roth, Karlsruhe, Germany
SEDIN 1 mg/ml injection solution
(medetomidine hydrochloride)
Pharma partner, Hamburg, Germany
SIGLECF-APC (REA798) 130-112-333 Miltenyi Biotec, Bergisch Gladbach,
Germany
standard chow 1314 Altromin, Lage, Germany
SuperScript II reverse transcriptase 18064014 Invitrogen, California, USA
tri-sodium citrate dihydrate 6430 Merck, Darmstadt, Germany
TWEEN 20 T2700 Sigma-Aldrich, Taufkirchen, Germany
UltraPure Distilled Water 10977-035 Invitrogen, California, USA
Viobility 405/520 Fixable Dye 130-109-814 Miltenyi Biotec, Bergisch Gladbach,
Germany
ZEISS HYRAX M 55 Microtome 9905120 MICROM GmbH
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DNase I 25 µg/ml

















4.1 HFD induces obesity, systemic inflammation and
hyperglycaemia
4.1.1 HFD leads to increases in bodyweight, body fat and body leanmass in a sexual
dimorphic fashion
To test the hypothesis of transgenerational high-fat diet (HFD)-induced alveolar
macrophage (AM) priming, a mouse model for obesity in C57BL/6J mice was generated.
Animals were fedwith purified diets containing either 60 kJ% fat (HF) or 10 kJ% fat (LF).
Before mating at the age of fifteen weeks, their body composition was monitored weekly
for a total of twelve weeks with a time-domain nuclear magnetic resonance (TD-NMR)
analyser. HF diet led to increases in body weight and body fat in both male and female
animals (Figure 6). When comparing diet groups, these increments, especially in body
fat and body lean mass, occurred in a sexual dimorphic fashion.
In HF females, differences in all three body composition parameters were obvious
from week five on after start of diet (Figure 6A, C and E). In HF males, substantial
differences in body fat were detected already after the first week on diet (Figure 6D),
and in body weight after the seventh week on diet (Figure 6B) compared to LF control


































































Time on diet [weeks]
Diet: LF HF
Figure 6: High-fat diet leads to an increase in body composition parameters in a sexual
dimorphic way. Body weight, body fat and body lean mass of HF (red) and LF (blue) diet
fed animals were monitored weekly with a time-domain nuclear magnetic resonance (TD-NMR)
analyser. Body composition differences compared to week 0 (starting time point of dieting) are
displayed as a function of time under diet (nLF = 12, nHF = 20). Mean composition values and
SEM for each time point are mapped on the plot. While an increase of all three body composition
values of HFD female animals was obvious fromweek 5 on, an increment in body fat of HFDmale
mice compared to LF control group was evident from week 1 on, and in body weight from week
7 on. Sexual dimorphism was especially prominent on body fat and body lean mass differences
betweenHF and LF groups. Wilcoxon rank sum test with Benjamini-Hochberg p-value correction
for multiple testing (78 comparisons): * p < 0.05, ** p < 0.01, *** p < 0.001.
4.1.2 HFD induces systemic inflammation and hyperglycaemia
HF-induced obesity in C57BL/6J mice is characterized by the presence of
pro-inflammatory factors in the circulation and insulin resistance.[412] To further
characterise the established model of diet-induced obesity, the ability of HFD to
induce signs of systemic inflammation and metabolic deregulation was tested. For this,
plasma concentrations of pro-inflammatory cytokines C-X-C motif chemokine ligand 1
(CXCL1), interferon gamma (IFNG), interleukin 1 beta (IL1B), IL2, IL4, IL5, IL6, IL10,
54
IL12 (p70) and tumour necrosis factor (TNF) were evaluated by 10-plex immunoassay
(Figure 7). At 25 weeks of age, elevated levels of blood glucose and plasma levels of
the pro-inflammatory cytokines CXCL1 and IL6 revealed signs of hyperglycaemia and
systemic inflammation in HF animals. While these observations were similar for both
sexes, HF male mice (Figure 7B) exhibited to some extent higher concentrations of
IL6 (15.7 pg/ml; median difference of 12.6 pg/ml between diet groups) than females
(8.11 pg/ml; median difference of 4.2 pg/ml between diet groups) and increased levels
of IL2 compared to LF controls. On the other hand, HF female animals presented less
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Figure 7: Increased levels of glucose in blood and pro-inflammatory cytokines in plasma
evidence presence of a systemic inflammation and glucose metabolism impairment by HFD
feeding. At 25 weeks of age, cytokine concentrations in plasma were measured by 10-plex
immunoassay, glucose concentrations in blood with a blood glucose meter. Female (A) and
male (B) HF mice (n = 10-12) presented elevated glucose, CXCL1 and IL6 concentrations.
Interestingly, only male HF animals showed increases in IL2, and female LF animals raised INFg
concentrations. Wilcoxon rank sum test with Benjamini-Hochberg p-value correction formultiple
testing (20 comparisons): * p < 0.05, ** p < 0.01, *** p < 0.001.
4.2 HFD distorts the course of lung inflammation and alveolar
macrophage’s phagocytosis
4.2.1 HF males display altered inflammatory lung dynamics
Knowing that the exposure to HFD elicits systemic metabolic and inflammatory
changes in mice, its effect on lung inflammatory dynamics was tested by a model of
endotoxin-induced acute lung inflammation. 30-week old female and male mice were
intratracheally instilled with 0.1 µg LPS and the numbers of bronchoalveolar lavage
(BAL) neutrophils and macrophages as well as the concentration of protein in BAL fluid
(BALF) were followed for 72 h (Figure 8). HF females did not show any differences in
any of the three parameters compared to LF control groups (Figure 8A, C and E). These
female mice were previously bred at the age of 15 weeks.
Inflammatory dynamics of HF male animals were shifted to the back of the time
course. I. e. male HFmice presented a delayed initiation of inflammationwith decreased
counts of BAL neutrophils 24 h after LPS instillation as well as a delayed resolution
72 h after the challenge with increased neutrophils counts(Figure 8B). The macrophage
numbers of both PBS-instilled and LPS-challengedHFmales were lower than those of its
corresponding LF control groups 24 h after instillation. Furthermore, mononuclear cell
counts (“macrophages”) of HF males 72 h after instillation were increased, compared to
cell numbers of the control diet group (Figure 8D). Differences in the start and resolution
of lung inflammation between HF and LF males were not visible at the protein level in
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Figure 8: HFD shifts lung inflammatory dynamics during endotoxin-induced acute lung
inflammation in male mice. 30 week old animals were intratracheally challenged with 0.1 µg
LPS. (A-D) Neutrophils and macrophages were counted on cytocentrifuged preparations from
BAL. (E,F) Protein concentrations acquired by BCA analysis of BALF showed no difference
between diet groups. (B) HF males presented a shift in the inflammatory response with
delayed recruitment of neutrophils to the lung 24 h after LPS instillation (delayed initiation
of inflammation) and increased cell counts 72 h after the challenge (delayed resolution). (D)
Reduced number of macrophages were measured in BAL 24 h after PBS and LPS instillation,
while these counts increased 72 h after the start of the challenge. Wilcoxon rank sum test: * p <
0.05, ** p < 0.01, *** p < 0.001.
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4.2.2 HFD impairs phagocytosis in alveolar macrophages of male mice
Next, in order to describe the extent to which alveolar macrophages (AMs) are
involved in initial phase of the previously described shift of LPS response in the lung
(delayed initiation of inflammation), these tissuemacrophages (TMs)were isolated from
untreated mice and analysed by qPCR. For this, lavage cells from 25-week old mice were
platted with MH-S medium and purified by adherence. AMs were either classically
activated (M1) with 1 µg/ml LPS for 50 min for the analysis of their pro-inflammatory
polarizability or incubated in MH-S medium for the examination of their ground
polarization status at steady state (M0 AMs). Pro- (M1: Cxcl2, Il12b, Il1b, Nlrp3, Saa3,
Tnf) and anti-inflammatory (M2: Chil3, Pparg) marker expression was quantified by
qPCR for each of the 8 groups (Figure 9 and Figure 10).
The incubation of AMs with LPS effectively led to increased expression of
pro-inflammatory markers when comparing respective M0 and M1 data (p < 0.001,
Appendix, Table 14). However, comparisons of the marker expression between diet
















































Alveolar macrophages at steady state (M0)
Figure 9: No effect of HFD on expression of AM polarization markers at steady state. AMs
were isolated from untreated mice (n = 5-6) at 25 weeks of age by bronchoalveolar lavage and
purified by adherence. Pro- (M1: Cxcl2, Il12b, Il1b, Nlrp3, Saa3, Tnf) and anti-inflammatory (M2:
Arg1, Chil3, Pparg, Retnla) marker expression was quantified by qPCR and normalized (relative
quantity, RQ) to three housekeeping genes (Actb, Hprt, Gusb). Neither female (A) nor male (B)
mice presented any changes in gene expression due to HFD feeding. Welch two sample t-test


















































Activated alveolar macrophages (M1)
Figure 10: No effect of HFD on the in vitro M1 polarizability of AMs. AMs isolated from
untreated mice (n = 5-6) at 25 weeks of age were incubated with 1 µg/ml LPS for 50 min for M1
(classical/pro-inflammatory) activation. Gene expression of pro- (M1: Cxcl2, Il12b, Il1b, Nlrp3,
Saa3, Tnf) and anti-inflammatory (M2: Arg1, Chil3, Pparg, Retnla) markers was analysed by
qPCR and normalized (relative quantity, RQ) to three housekeeping genes (Actb, Hprt, Gusb).
Polarization of AMs was successful with clear increases in gene expression of M1 markers (p
< 0.001, Appendix, Table 14). Neither female (A) nor male (B) mice presented any changes
in the polarizability of their AMs in vitro due to HFD feeding. Welch two sample t-test with
Benjamini-Hochberg p-value correction for multiple testing (16 comparisons).
As mentioned in Section 1.4.2, AMs are not only of highest importance for the
initiation, but also for the resolution of lung inflammation. Processes of utmost
relevance in the resolution of lung inflammation are the efferocytosis of apoptotic
neutrophils[413] and removal of debris by phagocytosis[414]. To investigate the effect of
HFD on AM phagocytosis and phagosome maturation, AMs isolated from BAL were
incubated with pHrodo zymosan particles and analysed by flow cytometry. These
particles emit fluorescence in the presence of an acidic milieu, like the one present
60
in mature phagolysosomes[415]. Cell counts of fluorescence-emitting AMs in females
were unaffected by HFD. However, pHrodo-positive AMs numbers from HF male
mice were reduced compared to the control group (Figure 11). This pointed to either
an impaired phagocytic uptake of particles or to a delayed or defective phagosome























Figure 11: HFD impairs phagocytosis in HF males. AMs were isolated from bronchoalveolar
lavages of mice, incubated with pHrodo zymosan particles and analysed by flow cytometry.
Zymosan particle phagocytosis byAMs female animals remained unaffected by diet. The amount
of AMs from HF males positive for the phagocytosis test were reduced, pointing to impaired
phagocytic uptake or defective phagosome maturation (n = 4). Welch two sample t-test with
Benjamini-Hochberg p-value correction for multiple testing (2 comparisons): ** p < 0.01.
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4.3 Parental obesity reduces foetal viability and delays weight gain
after birth
Parent mice were mated 12 weeks after continuous feeding with either HFD or LFD.
Aiming to describe the effect of parental diet-induced obesity on foetal outcomes,
viable foetuses were counted and weighted 18.5 days after positive vaginal plug test.
Additionally, the number of resorbed foetal sacs were quantified. HF dams exhibited
increased foetal death (22%) compared to LF dams (4%) (Figure 12A). However, foetal

































Figure 12: Parental obesity increases E18.5 foetal sack resorption with no repercussions on
body weights of viable foetuses. (A) 18 days after positive vaginal plug test, number of vital
E18.5 foetuses and resorbed sacks (miscarriages) per dam (n = 3) were counted. Ratios between
miscarriages and viable foetuses pointed to increased number of miscarriages during gestation
and consequently a decreased total number of vital foetuses from dams fed with HFD (ratioHF =
77.8%) compared to the female LF control group (ratioLF = 96.0%). Fisher’s exact test for count
data: * p < 0.05. (B) E18.5 foetal body weights (nE18.5 = 10-12) were not affected by parental
diet-induced obesity. Wilcoxon rank sum test.
Offspring’s body weights were further determined at two weeks (postnatal day 15,
P15), and at ten weeks (P70) of age (Figure 13). No differences in body weights were
observed in P15 male offspring nor at the age of P70. Yet, body weights of HF female
offspring were reduced at the age of P15 compared to the LF control group (Figure 13A).
These observations were transient, since a catch-up in bodyweight occurred after the age
of two weeks, leading to similar body weight measurements of the HF and LF female
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Figure 13: Non-persistent body weight reduction of female offspring by parental obesity.
Offspring body weights (nP15 = 16-26, nP70 = 22-25) were assessed at postnatal day 15 (A) and
postnatal day 70 (B). Only a transient decrease in body weights of HF female offspring was
observed at two weeks of age (P15) compared to the female LF control group (A). Two sample
t-test with Benjamini-Hochberg p-value correction for multiple testing (4 comparisons): *** p <
0.001.
4.4 No effect of parental obesity on placental inflammatory gene
expression
Different authors have previously suggested sexual dimorphic alterations in the
placentas from HFD dams. Importantly, mRNA expression of several pro-inflammatory
cytokines has shown to be increased after maternal HFD feeding, including Il1b, Nlrp3
and Tnf[324,327,416]. The presence of an altered pro-inflammatory environment in the
placenta of E18.5 HF foetuses could in part explain the observed increase in foetal sack
resorption. To analyse the effect of parental diet-induced obesity on the expression
of inflammatory markers in the placenta 18.5 days after conception, placentas from
HF and LF dams were collected and analysed by qPCR. The relative expression of the
pro-inflammatory markers Saa3, Nos2, Ptgs2, Ccl2, Il6, Il1a, Il1b, Tnf, Cxcl2, Nlrp3 and
Il12b as well as of anti-inflammatory markers Tgfb, Chil3, Retnla and Arg1 was assessed
(Figure 14). In order to stratify the data and test for sexual dimorphic effects, sex of the
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Figure 14: No effect of parental obesity on E18.5 placental gene expression. 18.5 days after
positive vaginal plug test, LF and HF dams (n = 3) were euthanized and placentas were
collected (nFemale = 9-12, nMale = 11-12). Foetal sex was determined by the analysis of embryonic
internal reproductive organs. Pro- (Ptgs2, Ccl2, Il1a, Il6, Il1b, Cxcl2, Nlrp3, Il12b, Nos2,
Saa3, Tnf) and anti-inflammatory (Chil3, Arg1, Retnla, Tgfb) gene expression was quantified
by qPCR and normalized (relative quantity, RQ) to three housekeeping genes (Actb, Hprt,
Gusb). No differences in gene expression was observed for any of the analysed genes in E18.5
female (A) nor in male (B) placentas. Welch two sample t-test on log-transformed data with
Benjamini-Hochberg p-value correction for multiple testing (30 comparisons).
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Placentas from HF animals presented no alterations in the expression levels of
any of the analysed inflammatory markers compared to LF control placentas. A
sexual dimorphic qualitative trend of increased gene expression of pro-inflammatory
markers was observed in placentas from HF female embryos compared to LF control
placentas (Figure 14A). However, differences between parental diet groups did not lead
to rejection of the null hypothesis. No difference in expression nor a trend was detected
for the expression of inflammatory markers in placentas from male E18.5 foetuses
(Figure 14B).
4.5 Parental obesity has no effect on offspring’s circulating cytokine
levels
Even though there was no evidence pointing to the presence of inflammation in the
placenta at an embryonic age, the possibility of its systemic onset after birth due
to parental obesity could not be excluded. In order to assess long-term effects at a
systemic level, the concentration of 10 cytokines were examined in the plasma of P15
and P70 offspring by multiplex immunoassay (Figure 15 and Figure 16). No difference in
circulating offspring’s cytokine concentrations between respective parental diet groups
were measured, neither at the age of P15 nor at P70. A trend of increased concentrations
in the TH2 cytokines IL4, IL5 and IL10 was observed in plasma of P70 HF female
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Figure 15: No effect of parental diet-induced obesity on circulating cytokines of P15 offspring.
Cytokine concentrations in plasma from two weeks old offspring were measured by 10-plex
immunoassay (n = 13). Cytokine levels were not affected by parental obesity, neither in female
(A) nor in male (B) P15 offspring. Wilcoxon rank sum test with Benjamini-Hochberg p-value
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(A) Plasma cytokines of P70 female offspring
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Figure 16: No effect of parental diet-induced obesity on circulating cytokines of P70 offspring.
Plasma cytokine concentrations of P70 mice were measured by 10-plex immunoassay (nLF = 5,
nHF =6). Nodifferences betweenparental diet groups in plasma cytokine levels of P70 female (A)
nor male (B) offspring were detected. A trend of increased concentrations in the TH2 cytokines
IL4, IL5 and IL10 was observed in plasma of P70 HF female offspring (A). Wilcoxon rank sum
test with Benjamini-Hochberg p-value correction for multiple testing (20 comparisons).
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4.6 Parental obesity delays final alveolarization in lungs of female
offspring
Additionally to the increases in pro-inflammatory marker expression in placentas of
HF dams, Mayor et al.[327] presented in their publication an impaired foetal lung
developmentwhich extended until postnatal day 15. Lungs fromHF-fed dams presented
reduced structuralmaturation and lower expression of surfactantmRNA. To testwhether
the gene expression of selected developmental and inflammatory markers in the foetal
lungwas affected by parental HFD, lungs fromE18.5 foetuseswere isolated and analysed
by qPCR. The developmental stage as well as the morphology of these lungs were
additionally investigated by semiquantitative grading and image analysis of FFPE,
HE-stained lung specimens, respectively.
Out of 33 markers inspected in E18.5 lungs by qPCR, the gene expression of Fgf10,
Pparg, Bmp4 and Ccl2 was influenced by parental diet-induced obesity in a sexual
dimorphic fashion (Figure 17). Gene expression patterns of these four markers were
similar for both sexes, with increased mRNA levels of Fgf10 and Bmp4 and lower
gene expression of Pparg and Ccl2. However, while mRNA quantities of these four
genes displayed differences between parental diet groups in lungs from female foetuses





































































































































































































































































































































































































Figure 17: Gene expression of developmental and inflammatorymarkers is altered by parental
obesity in E18.5 foetal mouse lungs. Lungs from E18.5 foetuses were isolated and their right
lobes were analysed by qPCR. Gene expression of developmental and inflammatory markers
(Bmp4, Fgf10, Fzd1, Fzd10, Fzd7, Igf1r, Lef1, Mmp2, Mmp9, Nkx2-1, Pdgfra, Pdpn, Sftpb,
Sftpc, Sftpd, Shh, Timp3, Tnfrsf11a, Vegfa, Vegfr2, Wnt2, Wnt3a, Wnt7b, Ccl2, Ptgs2, Cxcl2,
Il12b, Il1a, Il1b, Nlrp3, Arg1, Chil3, Pparg, Tgfb) was quantified relative to three housekeeping
genes (Actb, Hprt, Gusb). Lungs (n = 12) from both female (A) and male (B) E18.5 HF
groups displayed elevated expression of Bmp4 and decreased levels of Ccl2 compared to LF
control groups. Additionally, female embryos presented higher expression of Fgf10 and lower
mRNA levels of Pparg compared to its respective LF control group (A). Welch two sample t-test
on log-transformed data with Benjamini-Hochberg p-value correction for multiple testing (66
comparisons): p < 0.05.
In spite of the observed alterations in gene expression of Fgf10, Pparg, Bmp4 and Ccl2
by parental obesity, no signs of relevant morphological pathological alterations were
visible during semiquantitative grading of lung maturity in E18.5 foetuses (Table 13).
Lungs of all E18.5 groups were categorized as being in the terminal saccular phase of
lung development. Additionally, image analysis of the lung slides (Appendix, Table 15)
corroborated negative findings from semiquantitative grading, displaying no effect of
parental diet on foetal lung morphology.
Table 13: Semiquantitative grading of foetal lung maturity. Tissue sections (n = 9) from
left lobes of FFPE E18.5 foetal lungs were HE-stained and semiquantitatively graded. Grading
stages were defined based on the work of Warburton et al. 2010 and Mayor et al. 2015.
Grade 0: pseudoglandular stage of lung development; Grade 1: canalicular stage; Grade 2:
canalicular/terminal saccular stage; Grade 3: terminal saccular stage; Grade 4: terminal saccular/
alveolar stage.
Group Male-LF Male-HF Female-LF Female-HF
Grade (mean +− SD) 3 +− 0 3 +− 0 3 +− 0 3 +− 0
To test for effects of parental obesity on lung alveolarization, left lung lobes from P15
and P70 offspring lungs were also fixed, HE stained and examined by histology and
automatic image analysis. For histological investigation, blind analysis by design-based
quantitative morphometric stereology was performed (Figure 18). Mean linear intercept
(Lm) measurements of P15 HF female offspring were increased compared to the LF
control group (Figure 18A). Similar to the effect on bodyweights of these female offspring,
alveolar lung structure differences between parental diet groups were detectable only
at two weeks of age. Lm measurements of P70 HF female were similar to their
corresponding LF controls (Figure 18B). No evident differences in Lm were observable
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Figure 18: Transient sexual dimorphic impairment of lung alveolar structure by parental
obesity at P15. Left lungs (nP15 = 6-7, nP70 = 3-4) from P15 and P70 offspring were isolated,
filled with formaldehyde solution with a constant pressure of 25 cm 4% PFA for 10 min and fixed
overnight. 6 µm thick FFPE tissue slices were HE stained, and blindly analysed by design-based
quantitative morphometric stereology. (A) Mean linear intercepts (Lm) of HF female P15
offspring were remarkably increased compared to its corresponding LF control group. (B)
Comparable Lm measurements between parental diet groups at 10 weeks of age. One-sided two
sample t-test with Holm p-value correction for multiple testing (4 comparisons): * p < 0.05.
In order to verify manual Lm measurements, automatic image analysis of the lung
slides was performed (Appendix, Table 15). This assay included the quantification of
the alveolar, septal and lung areas as well as the total number of alveoli, the total
length of the border between septum and the air space (border septum-air). After
multiple test correction, no differences in the automatic image analysis measurements
were detected. Therefore, automatic analyses could not corroborate the results from
manual Lm quantification.
4.7 Parental obesity transiently alters the gene expression and
leukocyte population composition in the offspring’s lung
Having observed the morphological changes in the lungs of HF pubs, in order to
determine further impact of parental obesity on the offspring’s lung after birth, right
lungs lobes from P15 offspring were isolated and inspected by qPCR. Gene expression
levels of eleven markers of lung development and/or inflammation in the P15 offspring
lung were evaluated by qPCR (Arg1, Ccl2, Cxcl2, Fgf10, Il12b, Il1b, Pparg, Retnla, Tnf,
Tnfrsf11a and Wnt3a). Parental diet induced sexual dimorphic changes in the gene
expression of Ccl2, Il1b, Pparg, Tnfrsf11a, and Wnt3a (Figure 19). The expression of
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Pparg, Ccl2 and Il1b was reduced in the lung of P15 HF male offspring, compared to
the respective LF control group (Figure 19B). On the other hand, the gene expression of
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Figure 19: Parental HFD alters gene expression of developmental and inflammatory markers
in the P15 mouse lung. Lobes from right lungs from P15 mice were isolated (nFemale = 10-13,
nMale = 6-11) and the gene expression of developmental and inflammatorymarkers was analysed
by qPCR. Gene expression levels were normalized relative to three housekeeping genes (Actb,
Hprt, Gusb). Gene expression of developmental markers Tnfrsf11a and Wnt3a in lungs from HF
diet groups of both sexes was increased compared to LF control group. (B) Additionally, male
offspring presented prominent decreases in gene expression of pro-inflammatory cytokines Ccl2
and Il1b as well as of the anti-inflammatory-acting, developmental marker Pparg compared to LF
control group. Welch two sample t-test with Benjamini-Hochberg p-value correction for multiple
testing (22 comparisons): p < 0.05, p < 0.01.
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4.7.1 Parental obesity alters leukocyte population frequencies in the P15 offspring’s
lung
Murine alveolar macrophages finish their maturation after birth[81]. To control for the
presence of mature AMs and test for the influence of parental diet-induced obesity
on the development of leukocyte populations in the lung, whole lungs from 2-week
old offspring were analysed by flow cytometry. A 10-colour panel was employed
for staining whole lung cell suspensions from P15 mice. After quality control and
pre-processing, three unsupervised learning algorithms were applied to single cell
fluorescence data. Pre-processing steps of flow cytometry data included biexponential
transformation, removal of doublets, debris and dead cells as well as gating for
leukocytes (PTPRC+). A self-organizing map was used for dimensionality reduction
and unsupervised generation of 100 initial clusters. Consensus clustering, together with
manual merging of clusters were then employed to further aggregate initial clusters.
t-distributed stochastic neighbour embedding (tSNE) was utilized to graphically control
for correct subclustering. Eleven leukocyte populations (Figure 20A)with uniquemarker
expression patterns (Figure 20B) were identified in the P15 lungs.
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Figure 20: Flow cytometric immunophenotyping of the P15 mouse lung revealed eleven
leukocyte populations. Whole lungs from 28 P15 offspring mice (nLF = 5-6, nHF = 7-10) were
perfused, isolated and dissociated. Lung cell suspensions were analysed with a 10-colour flow
cytometry panel (ITGAM, ITGAX, CD24A, PTPRC, H2-AB1, LY6C, LY6G, FCGR1, SIGLECF and
Viability). Quality-controlled single-cell data was analysed with unsupervisedmachine learning.
(A) Two-dimensional tSNE projection of lung cells displays a good separation of the eleven
cell clusters. (B) Self-organizing map and consensus clustering algorithms for semi-automated
cell clustering were applied on the collected single-cell fluorescence data for the identification
of eleven cell clusters with unique marker expression patterns. One-dimensional density plots
(flow cytometry histograms) present the relative expression of ITGAM, ITGAX, CD24A, PTPRC,
H2-AB1, LY6C, LY6G, FCGR1 and SIGLECF on each of the leukocyte populations identified in
the P15 mouse lung.
Out of the eleven leukocyte populations, six of them presented frequencies greater
than 5% of the total leukocyte cell numbers. Five minor populations with frequencies
smaller than 5% of the total leukocyte cell numbers were also detected (Figure 21B).
Alveolar macrophages were detected in the P15 lungs of both female and male P15
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offspring. This TM population presented the expected expression patterns of cell surface
molecules (Figure 20B) typical for AMs of adult mice (ITGAX+, FCGR1+, SIGLECF+,
Figure 25B). The comparison of these markers between parental diet groups displayed
no differences in mean fluorescence intensity (data not shown). Compared to the total
number of leukocytes detected in whole lungs, AMs exhibited relative cell frequencies of
10 - 12%. The contrast in cell frequencies of AMsmeasured between parental diet groups
did contribute to the overall differences between observed in the omnibus chi-squared
test, but these were not as marked (around 1 %) as for other of the populations detected
(Figure 21B)).
Inference on differences between parental diet groups was performed with a
chi-squared test on relative population counts. Considerable differences in cell
frequencies were observed between parental HF and LF groups of both female and male
offspring (Figure 21A). T-cells displayed the highest contribution (standardizedPearson’s
residuals) to the magnitude of the computed chi-squared values (𝜒2female = 4768.4,
p-value < 2.2e-16 ***, 𝜒2male = 7373.8, p-value < 2.2e-16 ***), followed by eosinophils
and LY6C+ monocytes (Figure 21A). Interestingly, the B-cell leukocyte population was
the most prominent in the lungs of P15 offspring in term of cell frequencies (Figure 21B))
comprising up to 40.2 of the total leukocyte cell numbers.
Sexual dimorphism was observed during the comparison of the relative cell numbers
of the eleven leukocyte populations. While differences in T-cells and eosinophils
contributed to the overall discrepancy in cell numbers between parental diet groups of
both sexes, LY6C+ monocytes played amore important role for these differences inmales,
while this was the case for neutrophils in female offspring (Figure 21A). Furthermore,
B-cells, interstitial macrophages as well as resident monocytes played a bigger role in


























































































Figure 21: Analysis of single standardized Pearson’s residuals from chi-squared tests discloses
contribution of individual cell clusters to the observed differences between P15 diet groups.
Cell cluster proportions were compared between parental diet groups for female (A) and male
(B) offspringmicewith the Pearson’s chi-squared test of homogeneity. Frequency counts showed
not to be identically distributed across different populations (𝜒2female = 4768.4, p-value < 2.2e-16
, 𝜒2male = 7373.8, p-value < 2.2e-16 ). To further investigate the statistically significant omnibus
chi-squared test results, the contribution of each cell cluster to the magnitude of the computed
chi-squared valueswasweighedwith their standardized Pearson’s residuals. Immune cell cluster
two exhibited the greatest standardized Pearson’s residual for both male and female groups. It
also showed to be the second largest cell cluster for all groups.
Overall, the impact of parental obesity on the relative composition of leukocyte
populations in the lungs from P15 offspring was more pronounced in male than female
animals (Figure 21A and Figure 22). In order to visualize the distance (dissimilarity)
between individual mice based on leukocyte population structure, multidimensional
scaling (MDS)was performed on population frequencies and plotted on a 2-dimensional
space (Figure 22). 2-D mapping of MDS dimensions showed high similarity between
individual P15 offspring belonging to the same parental diet group and evident
distance (high dissimilarity) between offspring of different parental diet groups. Such
dissimilarity between HF and LF offspring was more obvious for male (Figure 22B) than
for female offspring.
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Figure 22: Multidimensional scaling based on leukocyte frequencies exhibit distance between
LF andHF P15 offspring in a sexual dimorphic fashion. Kruskal’s non-metric multidimensional
scaling (ordinal MDS) of standardized Euclidean distances was computed from the proportion
matrix of the eleven identified immune cell populations in the P15 offspring lung. Similarity
between individual mice was mapped on a two-dimensional space. To further stress the
distance between offspring belonging to different parental diet groups, convex hulls were plotted
around the individual samples. HF offspring presented high similarity to each other and high
dissimilarity to LF offspring. This pattern was more pronounced for male (B) than female (A)
offspring. As presented in Figure 21, frequencies in T-cells displayed the highest contribution to
the observed differences between parental diet groups.
4.8 No effect of parental obesity on endotoxin-induced acute lung
inflammation
As stated in Section 1.4.2, AMs have critical roles in the initiation and resolution of
lung inflammation. Hence, pro-inflammatory priming effects on offspring’s AMs by
parental obesity were expected to influence the inflammatory dynamics during an in vivo
endotoxin-induced acute lung inflammatory challenge. To test for such changes that
could hint at long-term priming effects of AMs, young-adult male LF and HF offspring
were exposed at ten weeks of age (P70) to a “mild” intratracheal LPS-induced acute lung
inflammatory challenge.
In order to find an adequate dose of LPS, an initial dose response analysis in chow-fed
C57BL/6J mice was performed. This examination revealed a dose-dependent neutrophil
recruitment to the airspace. Higher LPS concentrations were associated with increased
neutrophil counts (Figure 23A). Furthermore, macrophage counts on cytocentrifuged
preparations from BAL decreased with increasing concentrations of LPS (Figure 23B). A
dose of 0.1𝜇gLPSpermouse (equivalent to a dose of 4.3𝜇g/kg at an average bodyweight
of 23.1 g) induced a considerable level of acute lung inflammation, characterized by an
increase in the absolute numbers of neutrophils in BAL without macrophage depletion
within 24 h after intratracheal instillation.
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Figure 23: LPS dose response analysis on C57BL/6J mice. Chow-fed C57BL/6J mice were
intratracheally instilled with five different doses of LPS (n = 5-13). Single instillations with
LPS concentrations ranging from 0.01 to 2 𝜇g were performed and total neutrophils (A) and
macrophages (B) in bronchoalveolar lavages were counted on cytocentrifuged preparations 24 h
after instillation. A dose of 0.1 𝜇g LPS per mouse (equivalent to a dose of 4.3 𝜇g/kg at an average
body weight of 23.1 g) induced a strong influx of neutrophils without macrophage depletion
within 24 h after intratracheal instillation. Doses higher than 0.1 𝜇g lead to a severe loss in
macrophage counts in BAL.
To test for the effect of parental diet-induced obesity on lung inflammatory dynamics,
10-week old male offspring were intratracheally challenged with the selected dose of
0.1 𝜇g LPS per animal. Directly before (0 h) and during the inflammatory challenge
(6, 24, 48 and 72 h post instillation), the presence of inflammatory factors secreted into
the lung air space was analysed by ELISA. The concentration of seven pro-inflammatory
cytokines (colony stimulating factor 2 (CSF2), CXCL1, CXCL2, CXCL5, IL1b, IL1a and
TNF) and the acute-phase protein serum amyloid A3 (SAA3) were quantified in BALF
(Figure 24). Most pro-inflammatory mediators analysed in the BAL fluid (CXCL1,
CXCL2, CSF2, IL1a, TNF) reached a maximum in concentration 6 h after instillation and
returned to baseline levels at 72 h. Especially TNFdisplayed a strong peak at 6 h after LPS
instillation. Two of the mediators analysed – CXCL5 and SAA3 – reached their highest
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Figure 24: Parental high-fat diet has no effect on chemokine release in bronchoalveolar lavage
of P70 male offspring after LPS instillation. 10-week old male offspring were intratracheally
challenged with 0.1 µg LPS (n = 6). Inflammatory dynamics were monitored for 6, 24, 48 and
72 hours after instillation. Concentrations of the inflammatory factors CXCL1, CXCL2, CXCL5,
GM-CSF, IL1a, IL1b, SAA3 and TNF in bronchoalveolar lavages were analysed by sandwich
ELISA. With the exception of CXCL5 and SAA3, pro-inflammatory mediators in the BAL fluid
reached a maximum in concentration 6 h after instillation and returned to baseline levels at 72 h.
CXCL5 and SAA3 reached their highest concentration at 24 h after instillation. No differences in
the concentration of the examined factors in the air space were observed between parental-diet
groups at any time point. Welch Two Sample t-test with Benjamini-Hochberg p-value correction
for multiple testing (40 comparisons)
A trend of decreased concentrations of CSF2, CXCL2, IL1a, IL1b and TNF in the
parental HF diet group was noticed before the the start of the acute lung inflammation
(0 h). However, no differences in the secretion of pro-inflammatory cytokines were
observed between parental diet groups at any of the analysed time points. Contrary to
results from previous publications showing that LPS induced acute lung inflammation
does not cause increases of IL1b in the air space[417], the comparison between time points
0 and 6 did display higher concentrations of the bioactive form of IL1b (p = 0.013) after
LPS instillation. If split by parental diet, a trend in higher IL1b quantities was observed
for the HF group at 6 h compared to 0 h. However, after such split, differences between
both time points did not reach statistical significance.
In order to test for a complete return of the concentrations of inflammatory factors
secreted into the lung air space at the end of the challenge, their levels were compared
between untreated mice (0 h) and animals 72 h after LPS instillation. The concentrations
of all factors, except SAA3 (p= 0.039 for both parental diet groups) andCXCL2, returned
to steady state levels. Interestingly, differences in CXCL2 levels between both time points
were only observed for the HF group (p = 0.039).
Because of the similar release of pro-inflammatory factors into the airspace after
LPS instillation, LF and HF offspring were expected to present a similar recruitment
of immune cells into the lumen of the lung during the LPS challenge. Leukocyte
dynamics in the airspace were followed by flow cytometric analysis of BAL cells. An
eight-colour antibody panel was employed to analyse cell surface markers on BAL
leukocytes (PTPRC+) and track the presence of 14 immune cell populations at 0, 6, 24,
48 and 72 h after LPS instillation (Figure 26 and Figure 27). BAL cells were isolated and
directly stained with fluorochrome-conjugated antibodies targeting the surface markers
protein tyrosine phosphatase, receptor type, C (PTPRC), integrin alpha M (ITGAM),
integrin alpha X (ITGAX), Fc receptor IgG high affinity I (FCGR1), lymphocyte
antigen 6 complex, locus G (LY6G), lymphocyte antigen 6 complex, locus C1 (LY6C),
histocompatibility 2, class II antigen A, beta 1 (H2-AB1) and sialic acid binding Ig-like
lectin F (SIGLECF). Flow cytometric immunophenotyping was performed with the help
of unsupervised clustering algorithms (Figure 25A) and names of immune cell clusters
were assigned based on expression patterns of surface markers (Figure 25B).
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Figure 25: t-SNE projection of cell populations identified by flow cytometric
immunophenotyping in BAL after endotoxin challenge. (A) 14 cell populations were
identified in the lavage of male animals. Flow cytometric immunophenotyping was performed
with the help of the three unsupervised clustering algorithms as described in Section 3.2.5:
self-organizing map and consensus clustering aided in the definition of leukocyte cell clusters,
while t-distributed stochastic neighbour embedding (t-SNE) helped for the dimensionality
reduction and improved visualization of FACS data on a two-dimensional projection. (B)
Names of immune cell clusters were assigned based on expression patterns of the surface
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Figure 26: Parental obesity does not alter immune cell dynamics during an endotoxin-induced
acute inflammation in the P70 male offspring lung. Flow cytometric immunophenotyping of
lavage cells from 10-week old male offspring challenged with 0.1 µg endotoxin was performed
at 6, 24, 48 and 72 hours after instillation. 14 leukocyte populations in the lavage were identified
with the help of unsupervised clustering algorithms (self-organizing maps, consensus clustering
and t-distributed stochastic neighbour embedding) by their expression of the antigens ITGAM,
ITGAX, FCGR1, H2-AB1, SIGLECF, LY6C and LY6G. Absolute cell numbers were calculated with
absolute counting beads. An alternative qualitative representation of the inflammatory dynamics
is presented in Appendix, Figure 30. Wilcoxon rank sum test with Benjamini-Hochberg p-value
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Figure 27: Parental obesity does not alter immune cell dynamics during an endotoxin-induced
acute inflammation in the P70 male offspring lung. (continued)
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As expected, absolute counts of neutrophils (ITGAM+, LY6C+, LY6G+) peaked at
24 h after LPS instillation. The AM population (ITGAX+, FCGR1+, SIGLECF+) was only
slightly reduced by LPS during the first 48h of inflammation, followed by a full recovery
of absolute cell numbers 72 h after instillation. Inflammatory monocytes (ITGAM+,
FCGR1+, LY6C+), exudative macrophages (FCGR1+, LY6C+, H2-AB1+) and natural
killer cells (ITGAM+, LY6C+) were recruited to the airspace in a similar fashion to
neutrophils, peaking at 24 h after instillation. Cell dynamics of eosinophils (ITGAM+,
SIGLECF+), interstitial macrophages (ITGAM+, FCGR1+, ITGAX+, H2-AB1+), B cells
(H2-AB1+), inflammatory T cells (LY6C+), dendritic cells (ITGAM+, ITGAX+, H2-AB1+)
were similar to each other, with the highest absolute cell counts 48 h after LPS instillation.
While most of the aforementioned cell types were present in only small numbers in the
lung lavages/air space, only AMs and neutrophils reached absolute cell counts above
1E5. Flow cytometric analysis of BAL revealed no effect of parental HFD on dynamics of
mayor cells populations after pulmonary challengewith LPS inmale offspring. However,
challenged HF offspring mice presented 3.04-fold (median) lower absolute numbers
of eosinophils (ITGAM+, SIGLECF+) and 2.15-fold (median) increased numbers of
inflammatory B cells (LY6C+, H2-AB1+) 6 h after LPS instillation compared to the LF
control group. No differences in absolute cell counts of any of the 14 populations were
observed at steady state (0 h) between HF and LF offspring.
4.9 No evidence of long-term pro-inflammatory alveolar macrophage
priming by parental obesity
Even though no differences in cytokine release nor in cell dynamics in the air space
during endotoxin-induced acute lung inflammation was detected, the hypothesized
pro-inflammatory AM priming through parental diet-induced obesity could still
be present. Therefore, AMs from P70 female and male offspring were analysed
by qPCR in order to study their polarization characteristics at steady state (M0)
and their pro-inflammatory polarizability (M1). Bronchoalveolar lavage cells from
(LPS-)untreated HF and LF offspring were isolated, pooled (two mice per pool) and
platted in MH-S medium for purification by adherence. AMs were either M1 polarized
with 1 µg/ml LPS for 50 min or incubated in MH-S medium (M0 AMs). Pro- (M1: Il6,
Nlrp3, Cxcl2, Ptgs2, Ccl2, Il1a, Il1b, Il12b) and anti-inflammatory (M2: Retnla, Arg1,
Pparg, Chil3) marker expression was quantified by qPCR.
M1 polarization proved to be effective by the comparison of M0 and M1 AMs
(Appendix, Table 16). M1 AMs presented a clear increase in the expression of M1
markers compared to M0 AMs (p-value < 0.001) after incubation in medium containing
LPS.
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The comparison of marker expression of M0 AMs from offspring, grouped by sex,
presented no differences between parental diet groups. Parental diet-induced obesity
had no impact on the long-term ground polarization status of the offspring’s AMs at
steady state (Figure 28). After classical AM activation with LPS, a trend in decreased
pro-inflammatory gene expression was noticed in M1 AMs isolated from HF offspring
(Figure 29). However, differences in gene expression observed between M1 AMs from





















































P70 offspring's alveolar macrophages at steady state (M0)
Figure 28: Parental obesity has no effect on ground polarization status of AMs at steady state.
AMs isolated from bronchoalveolar lavages from 10-week old offspring mice at steady state were
pooled (2 animals per pool), adherence-purified and incubated in MHS-medium for 50 min
before gene expression analysis by qPCR. No difference in the expression of pro-inflammatory
(M1: Il6, Nlrp3, Cxcl2, Ptsg2, Ccl2, Il1a, Il1b, Il12b) nor pro-resolution (M2: Retnla, Arg1, Pparg,
Chil3) markers relative to three house-keeping genes (Actb, Hprt and Gusb) were observed
between HF offspring’s AMs and LF control groups at steady state (nfemale = 3, nmale = 5). Welch























































P70 offspring's M1-activated alveolar macrophages
Figure 29: Parental obesity has no effect on M1-polarizability of AMs by LPS. AMs isolated
from bronchoalveolar lavages from 10-week-old untreated offspringmice were pooled (2 animals
per pool), adherence-purified and incubated in 1 µg/ml LPS for 50 min before analysis by qPCR.
M1 polarizability of AMs was not affected by parental diet (nfemale = 3, nmale = 5). No difference
in gene expression of pro-inflammatory (M1: Il6, Nlrp3, Cxcl2, Ptsg2, Ccl2, Il1a, Il1b, Il12b)
nor pro-resolution (M2: Retnla, Arg1, Pparg, Chil3) markers relative to three house-keeping
genes (Actb, Hprt and Gusb) were observed between parental HF and parental LF control




The paradigm shift around tissue macrophage ontogeny, the ever-growing pandemic of
obesity and evidence of developmental origins of disease brought about by obesity led
to the formulation of the hypothesis presented in this work. This hypothesis states that
parental high-fat diet (HFD) induced obesity can have priming effects on developing
alveolar macrophages (AMs) of the offspring and lead to an adverse immune response
later in life.
AMs are not only the first line of defence at the air-tissue interface in the lung, with
the ability to initiate and resolve inflammation, but are also of utmost importance for
lung development and homoeostasis. AMs display self-renewal capabilities and are
long-lived. At tissue steady state, this tissue macrophage (TM) population is very
stable. Only less than 5% of the AM population is replaced at steady state by circulating
monocytes within 14 months of a mouse life[123].
Applying mouse models of maternal diet-induced obesity (DIO), recent
publications have described maternal obesity-dependent impairments in offspring
lung development[327,353]. Maternal obesity can induce the overexpression of
pro-inflammatory markers, which are not only observable in the mother’s circulation,
but spill over to the placenta[324] and even reach the foetal lung[354]. Additionally,
research on developmental immunotoxicity suggests a especially high sensitivity of MFs
to alterations by early life environmental insults and foetal programming[210].
In this thesis, the period of AM development was proposed to present a window
of vulnerability for programming effects by parental DIO. This hypothesis suggests
an impact of parental obesity on AM maturation which leads to a detectable
pro-inflammatory AM primed state and long-lasting adverse functions in the offspring’s
lung. It also implies that such long-term impairments become apparent later in life of the
mouse offspring, not only through a mal-development of their lungs, but also through a
defective inflammatory response to an LPS challenge.
Both dams and sires were expected to contribute to the proposed AMs
pro-inflammatory priming effects in offspring. Stress[270,271], pyroptosis and
pro-inflammatory activation[273] can build up in the adipose tissue of obese individuals
of both sexes and lead to high circulating concentrations of pro-inflammatory cytokines,
free fatty acids and glucose[252,278,279]. This pro-inflammatorymetabolic deregulation can
impair systemic metabolic, endocrine and immune functions which can be directly or
indirectly transferred to the developing offspring either through the placenta (placental
oxidative stress, inflammation and dysfunction) or through epigenetic mechanisms,
respectively.
The first step in the analysis of the role of parental obesity on the offspring’s lung
development andAMprimingwas the generation and characterization of amousemodel
of DIO.
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5.1 Mouse model of high-fat diet-induced obesity
In order to test the hypothesis presented in this thesis, a mouse model of DIO was
established employing the C57BL/6J mouse strain. Previous publications[418–420] as
well as experience from our cooperation partner Dr. Jan Rozman[421] have consistently
proven the high genetical susceptibility of this strain to metabolic and physiologic
alterations through diet, even more so than other mouse strains[422], e. g. BALB/c or
A/J[423,424].
Animals were fed with purified diets containing either 60 kJ% fat (HF) or 11 kJ% fat
(LF) for 12 weeks. To avoid confusion, it is important to note that the fat content of the
so-called “low-fat diet” conforms to the fat content of a standard mouse chow. This term
is used here to remark the comparison with the high-fat diet and in concordance with
previous literature presentingDIO studies using similar purified control diets[425,426]. For
future projects and publications, possibly the term “control diet/CD” would be more
suitable.
For thiswork, purified ingredientHF and LF dietswere employed and not grain-based
chow diet alternatives. Comparing the purified ingredient LF control diet with the
standard chow diet for instance, it can be observed that both diets present a very similar
energy content of around 10-13%KJ in form of fat[427,428]. However, primary components
of chow diets are natural ingredients, such as grains and meals. Therefore micro- and
macronutrient content does not always completely match between them. Additionally,
standard chow nutritional content can vary from batch to batch[429], complicating the
reproducibility of results.
The use of 60% kcal in form of fat for murine feeding has been criticized of being
of too high fat content[430]. This is especially because HFD does not reflect the normal
human dietary fat intake – neither the energy content in form of fat nor its fat source[431].
Often, only a single fat source (e. g. lard, as in the present study) is used. According
to NHANES, the typical human “western” diet contains around 35%, 49% and 16%
of energy from fat, carbohydrates, and protein, respectively[432]. 60% of energy as
fat might be tolerable for humans, however the difference to a normal rodent diet is
of a much greater magnitude. Nonetheless, the use of 60% HFD leads to faster and
more pronounced physiological and metabolic effects. This reduces the time in which
animals need to be fed, housed and maintained, diminishing the overall caging costs
and experimental time.
Mice on HFDwith 60% of its energy content in form of fat becomemore rapidly obese
than on diets with lower fat contents (e. g. 45% of energy from fat)[433,434]. Previous
studies have confirmed the higher efficiency of 60%HFD in inducing obesity in C57BL/6J
mice compared to other high-caloric diets that try to mimic unhealthy food consumption
in humans[431,435].
The so-called “cafeteria diet” is an example which includes along with chow diet
high palatable human food like chocolate, peanuts, corn-starch crackers and others[436],
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depending on the provider. The cafeteria diet has proven to be a relatively robust
alternative to the feeding of purified HFDs to induce obesity[437,438]. Probably the main
reason for this is that cafeteria diet provides a substantial amount of sugar and salt, which
increases appetite and excess food intake[439]. Of course, its employment could prevent
the solely use of a particular type of fat while inducing continuous hyperphagia and
increased energy intake. On the other hand, it can be a challenge to attribute induced
physiologic, metabolic and transgenerational effects to specific components, since such
diets are less well defined in terms of nutrient content and because of the presence of
several additives[431]. Nonetheless, previous studies from Dr. Stöger’s lab have shown
that HFD can more strongly induce increases in body composition parameters and lead
to an higher immune activation in C57BL/6J mice compared to a cafeteria diet[440], even
for feeding periods as short as six weeks. Additionally, rodents fed with a cafeteria diet
develop the greatest dysbiosis compared to other high caloric diets[431]. This effect by
itself can strongly impact immune homeostasis and lead to systemic diseases[441].
5.1.1 Effects of high-fat diet on the mouse body composition
The presented model of murine HF diet feeding showed to be very effective for inducing
body weight and body fat increases on parent animals from both sexes (Figure 6).
However, an obvious sexual dimorphismwas noticed, especially on gains of body fat and
body leanmass. While differences in fat mass betweenHF and LF groups were promptly
evident after one week of diet in males, these changes were not as fast nor were they as
pronounced for HF female animals. An increase of 49.3% in body fat (12.2% in body
weight and 6.7% in body lean mass) was observed between diet groups in males at week
12 after start of diet, while a 32.3% difference in body fat (10.2% in body weight, 3.5%
in body lean mass) was measured between LF and HF females. It was striking to notice,
that although males presented such marked differences in body fat measurements, no
changes in their lean body mass were evident by comparing diet groups. This was not
the case for female mice. HF female animals did indeed display increases in lean mass
compared to LF control groups. Curiously, no statistical significance for comparisons of
the parameters body weight and body fat between HF and LF females was reached at
weeks 7, 8 and 10 after start of diet. Nonetheless, differences in these body composition
measurements were large at the end of the 12-week feeding period (Figure 6) before
mating, which corroborated the presence of obesity during mating.
Longer feeding periods might have led to more stable weight and body fat differences
in female mice – possibly resembling more closely human obesity. In a protocol from
2012 by Wang and Liao[442], recommendations for diet induced obesity models include
diet times of 16 weeks to reach a full picture of obesity with adipocyte hyperplasia,
visceral fat deposition, increased body fat mass, signs of diabetes and hypertension[442].
However, other authors working with mouse models of DIO, specifically employing the
C57BL/6J strain, have applied very different periods of feeding times. Dieting periods
in current literature range from short-term feeding of only 3 days[443,444] to long-term
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diets of over 20 weeks, including studies with up to one year of dieting[445]. While short
diet periods lead to increases in body weight gains, body fat mass and insulin resistance,
longer dieting times are necessary to induce systemic inflammatory changes[443]. Again,
the onset and strength of the phenotypes induced by different dieting times will depend
on the specific mouse strain under study[446]. Interestingly, while C57BL/6J is said to be
highly sensitive toDIO, studies showan even higher sensitivity of other strains, including
C57BL/6N and 129P2/OlaHsd[446].
However not determined, it is possible that obesity inmales could have lead to reduced
activity (e. g. less movement in cages), promoting muscle mass loss. On the other
hand, if fat mass increases in females were not marked enough to reduce their activity,
augmented force production due to increased mass loads could have lead to muscle
mass gains[447]. Furthermore, obesity has shown to reduce circulating testosterone
levels[448,449] anddepress anabolic effects of insulin in the stimulation of protein synthesis,
contributing to loss of muscle mass[450]. Inflammatory adipokines like IL6 also exhibit
catabolic effect on muscle[451]. These results suggest possible sexual dimorphic effects of
DIO on muscle mass development in C57BL/6J mice.
Large variations in obesity phenotypes have been reported for C57BL/6J mice despite
their inbred and isogenic genetic status[452,453]. Especially the parameters body weight
and body fat were affected by such high variability, showing increased variance over
feeding time[453]. In this thesis, an increase in variance from 0.27 to 13.8 g2 between the
start of diet and after week 12 on diet was observed for HF male animals (from 0.59
to 8.19 g2 for HF females). Authors have also observed, that body lean mass remains
relatively stable along diet[453]. This resultswere also detected in the presentwork, where
in the case of HF males variances increased only from 0.2 to 2.2 g2 between week 0 and
12 on diet (0.22 to 1.14 g2 for HF females).
5.1.2 Impact of diet-induced obesity on sexual interest and mating
During mating of diet-treated parent mice, a qualitative difference in sexual activity
and sexual interest between diet groups was observed. This was not surprising, since
such effects were known to cooperation partners and since obesity has been associated
with reduced circulating testosterone[449]. Such reduction is partly brought about by
the increased expression of aromatase in adipocytes, an enzyme known to convert
testosterone to oestrogens[448].
Longer mating times were noticed for the HF group. The possibility of a too strong
decay in the sexual interest of mice could hinder breeding and consequently the analysis
of offspring. Especially male mice were qualitatively affected by HFD. In order to avoid
such decline, while achieving obesity in both sexes, a feeding duration of 12 weeks was
selected. It has already successfully been proven that such feeding time, implementing
similar contents of fat in diet (60 kJ%) and with the same mouse strain (C57BL/6J),
effectively leads to systemic symptoms of obesity and inflammation. These symptoms
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include increased body weight and fat, elevated blood concentrations of glucose and
decreased circulating levels of adiponectin[454] as well as diabetic cardiomyopathy
symptoms[455]. Additionally, this duration of 12 weeks overlapped with the time of three
to five months during which the mice were kept on diet before mating in the work of
Mayor et al.[327], which lead to increased placental pro-inflammatory gene expression
and changes in the offspring’s lung morphology (reduced maturation).
Alternatively to the experimental design for mouse feeding employed in this work,
only dams could have been fed with a HFD before mating with age-matched LF males.
However, the effect of parental HFD on increased offspring’s body weight is suggested
to be of additive nature[13,456]. Since a stronger priming effect of the metabolism and
immune system in offspring was expected when both parents belonged to the HF
group, a possible alternative could be the mating of non-matching aged mice. For
instance, females fed for 20 weeks mated with males fed for 10 weeks. However, due
to lack of housing space and because this was not the main question in this work, no
analysis of mating times nor combinations of different feeding periods were performed.
Such supplementary animal work was also avoided in order to follow the 3Rs guiding
principles for more ethical use of animals[457].
5.1.3 Immunological consequences of obesity at steady state
HF parent animals presented metabolic-driven systemic inflammation and
hyperglycaemia at the age of 25 weeks (Figure 7). While elevated pro-inflammatory
plasma cytokines CXCL1 and IL6 were observed in HF parent animals, other authors
have suggested additional increases in pro-inflammatory cytokines in the circulation, e.
g. IL1B and IL10, and TNF[412,458] with mouse models on similar diets. Such differences
could be partly attributed to genetic background of the animal model, differences in diet
composition – content of sugar, polyunsaturated fatty acids (PUFAs) and cholesterol –
and duration of HFD feeding.
Employing the mouse model of DIO used in this thesis, increased sample number
would most likely have lead to measurable differences in TNF concentrations (80 %
power: nfemale = 20; nmale = 27). Interestingly, if these cytokine measurements were
not grouped by sex, overall plasma TNF levels of HF animals resulted elevated during
statistical analysis (p = 0.035) compared to LF controls after multiple test correction.
Unfortunately, circulating levels of pro-inflammatory cytokines were not analysed at
the time point of conception due to the lack of animals, and in order to reduce
handling-related stress and prevent further reduction in mating efficiencies.
Lung homoeostasis can be dramatically altered by obesity, not only through mass
loading, but also through endocrine and metabolic factors. A cross-talk between the
adipose tissue and the lung based on the mutual influence through inflammatory factors
has been proposed[299]. Interestingly, even though the DIO model implemented in
this thesis lead to obesity, systemic inflammation and hyperglycaemia, the analysis of
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CXCL2, TNF (data not shown) as well as total protein concentrations in the airspace of
the lung (Figure 8) did not show any changes brought about by obesity at steady state.
These results provided no signs of gross alterations of the pulmonary air-tissue barrier
or strong pro-inflammatory activation of the lung tissue by obesity alone that could
be measured in BALF. Interestingly, even though the counts of alveolar macrophages
in bronchoalveolar lavages was reduced in obese male animals under basal conditions
(Figure 8D), the polarization status of these AMs did not show any differences in pro-
nor anti-inflammatory gene expression at steady state (M0, Figure 9). Nonetheless, a
trend of increased pro-inflammatory gene expression was observed on M0 AMs of both
sexes. Even though mRNA quantities did not reach detectable changes between diet
groups, this trend could be hint on the possible impact of AM homeostasis through
obesity-induced alterations in the adipose tissue-lung cross-talk.
5.1.4 Contribution of free fatty acids to systemic inflammation
Obesity is not only associated with a systemic low-grade inflammation, but also with
dyslipidaemia – hypertriglyceridemia and increases in free fatty acids (FFAs)[459]. It
has been shown that FFAs, specifically saturated ones[460], are capable of stimulating a
pro-inflammatory reaction and can thus contribute to the inflammatory state of obese
individuals. FFAs can bring about the activation of toll-like receptor 2 (TLR2) and
the TLR4 (canonical LPS receptor) signalling pathways[461]. Such induction leads to a
downstream activation of the nuclear factor kappa B (NF-𝜅B) transcription factor[462]
in order to elicit pro-inflammatory cytokine expression. Additionally, FFAs can cause
the induction of endoplasmic reticulum stress[463] and the stimulation of reactive oxygen
species (ROS) production[464]. An inhibition of the immune system to properly mount a
response to fight an infectionmight arise from the constant presence of pro-inflammatory
stimuli that reach the lung tissue.
Saturated fatty acids are an essential component of bacterial endotoxins – specifically
of the lipid A portion of LPS. Lauric, myristic and palmitic fatty acids constitute the
most common type of FFAs in the lipid A fragment[465]. Interestingly the deacylation
of these fatty acids from LPS results in loss of endotoxic activity[466]. Importantly, it
has been shown that their substitution bymono- or polyunsaturated counterparts blocks
the pro-inflammatory activity of LPS[467]. This denotes an additional important role of
saturated fatty acids in LPS-mediated signalling. Strikingly, partial structures resulting
from such deacylation can even inhibit responses to LPS in MFs without inhibiting its
uptake[468].
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5.2 LPS challenge of the parental generation
5.2.1 Selection of the in vivo LPS challenge model
Contrary to other models of acute lung injury, the LPS challenge presented in this work
targeted directly the lung. This was achieved by a local instillation of endotoxin into
the lung and not, like other works[469–472], indirectly over a intraperitoneal injection of a
very high concentration of endotoxin. The latter induces a systemic pro-inflammatory
challenge, affecting not only the lung, but every other tissue.
The LPS model established for this thesis did not aim to induce a lung injury. Most
importantly, the endotoxin concentration was selected low in order to avoid AM loss
due to excess necrosis[417] and a radical alteration of the AM microenvironment. Such
alterations would probably override the expected priming effects from parental obesity
on their offspring (discussed in Section 5.3.12 and Section 5.4).
In order to meet this criteria, while maintaining the pro-inflammatory activity of
the instillation solution, an initial dose response analysis in chow-fed C57BL/6J mice
was performed. This examination revealed a dose-dependent neutrophil recruitment
to the airspace with higher neutrophil counts for increasing LPS concentrations
(Figure 23A). Concurrently, macrophage counts decreased with greater concentrations
of LPS (Figure 23B). This was not surprising, since LPS has shown to induce AM necrosis
via Ca2+ influx upon TLR activation[417].
A dose of 0.1 𝜇g LPS per mouse induced a considerable level of acute lung
inflammation, characterized by an increase in the absolute numbers of neutrophils in
BAL, without macrophage depletion within 24 h after intratracheal instillation. Using
this model of mild LPS-induced acute lung inflammation, the effect of obesity and
obesity-induced low-grade inflammation on inflammatory dynamics in the lung was
analysed.
Relatively high variation in cell counts and protein concentrations were observed
during the examination of inflammatory dynamics in the lung (Figure 8). Different
sources of variability could be listed, including differences in body weights, lung
volumes, body fat mass, and systemic and local inflammatory states of the mice.
The LPS dose employed for the intratracheal instillation of 0.1 𝜇g per animal
corresponded to body weight-normalized doses between 1.9 to 3.8 𝜇g/kg, depending
on the specific body weight of the mouse (range: 26 - 52 g). It could be argued that the
use of LPS doses based on animal body weight could have led to more stable results and
less variation of measurements between animals.
In fact, estimations of the total surface area of mammals is based on their body
weights. Correlation studies suggest a value of 1 m2/kg body weight as a realistic
estimate of the lung surface in mammals[473]. However, when looking at a single species,
especially while looking at a single mouse strain, the strongest determinant of the lung
area of a subject will be its respiration state[474]. To date, there is no evidence of a
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correlation between lung volumes and the body weight of a mouse. Contrarily, weight
gain has a more complex relationship to lung volumes and function[303], especially
considering that changes inmediators produced by adipose tissue canmodulate the lung
function[475].
Since only local effects in the lungs were the target of the mild LPS challenge used in
these analyses, and because rather in the case of an expected systemic reactivity would
make sense to correct for the animal’s body weight, the decision of using the same
amount of LPS for every mouse challenged was taken. Additionally, a normalization of
cell count during the course of inflammation against bodyweight alone (data not shown)
actually lead to higher variations in the results. Unfortunately, a normalization against
lung weights was not possible, since lavage (introduction of PBS into the airspace) and
perfusion (introduction of PBS into the lung blood capillaries) were performed on the
mouse lungs.
5.2.2 The role of obesity in the course of endotoxin-induced acute lung
inflammation
Intratracheally LPS-challenged 30-week old HF male animals presented delayed
inflammatory dynamics with decreased counts of BAL neutrophils and macrophages
24 h after LPS instillation and increased cell counts of both types 72 h after the challenge
compared to LF controls (Figure 8). At this time point, a full resolution of inflammation
in the lungs of male animals was not completed. It would be very interesting to
measure the extent to which the shift of inflammatory dynamics occurs in these animals.
Especially intriguing would be to know if HFD on these males could have had chronic
lung implications after the challenge – in the form of a chronic inflammation or the
development of emphysema or fibrosis due to possible tissue damage through the
extended presence of inflammatory factors and neutrophils in the alveoli.
It is well known, that obesity is a risk factor for infectious lung diseases. Obesity
leads to increased susceptibility, severity, morbidity and mortality from viral lung
diseases[476–478]. Additionally, influenza vaccinations strategies have shown to be
less effective on obese individuals[479]. During the current COVID-19 pandemic
in 2020, obesity has also been identified as a mayor risk factor for hospitalization,
mechanical ventilation and mortality from an infection with the novel severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2)[480–482]. An inhibition of the immune
system to properly respond to an infection can be observed through reduced antiviral
and pro-inflammatory cytokine expression in the lungs of influenza-infected obese
mice[292,483,484]. Immune responses involved in the fight against viral and bacterial
infections are subject to different regulatory pathways[485]. However, the delay in
the inflammatory response in HF males during the in vivo LPS challenge (Figure 8B)
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suggests a similar hindrance of the immune system by the presence of obesity. Further
analysis of the distortion of immune responses by obesity could better help understand
this risk factor and improve treatment strategies of obese individuals during lung
infections.
Unfortunately, due to the low number of animals available for the analysis of
inflammatory dynamics in the lung, no further time points could be examined during
the LPS challenge. The evaluation of cytokine concentrations in the lung (BALF) of
these animals, specifically of CXCL2 and TNF (data not shown), did not exhibit any
noteworthy increases during the course of the inflammation. Further investigation of
the apparent lack of regulation of these cytokines in the LPS model made evident that
the incorporation of at least one additional earlier time point in the analysis was needed
in order to be able to recognize changes in these inflammatory factors. This modification
was therefore introduced in the evaluation of the offspring animals (Figure 24).
Female animals appeared to be protected from perturbations in inflammatory
dynamics during the LPS challenge. These animals showed no differences between diet
groups in BAL cell counts nor on BALF protein concentrations (Figure 8A, C and E), even
though obesity and a metabolic inflammation was present. Unluckily, no HF females
that did not go through pregnancy were analysed. It would be intriguing to find out,
if such protection originated from the female sex physiology (e. g. oestrogens) or was
specific to protective effects from the undergone pregnancy.
Studies from previous betacoronavirus outbreaks, e. g. of the so-called Middle
East respiratory syndrome-related coronavirus (MERS-CoV)[486] and SARS-CoV(-1)[487],
have shown a correlation between pregnancy andmore severe and fatal cases of infection.
Such results could be partly attributed to the bias toward a systemic Th2 dominance
(immune tolerance/suppression) found in pregnant women[488]. This Th2 bias is
necessary for foetal development and protection against foetal rejection[489,490], but leaves
the mother vulnerable to viral infections, which are more efficiently confronted by the
Th1 system[491]. During the postpartum period, a reversal of the Th2/Th1 balance
takes place[492]. The protective effect of pregnancy proposed here is subject of revision,
however, in case of a validation, it is conceivable that pregnancy and the immunological
changes brought about by it might act as a “resetting” event that leads to strengthening
of the immune system and to improved outcomes during an infection after such reset.
It would be intriguing to observe, if in the human population, women show similar
protective effects of an undergone gravidity against adverse effects of a SARS-CoV-2
infection.
It is important to remark, that no p-value correction for multiple comparison was
applied on the results from the LPS challenge data from parent animals (Figure 8). This
was not performed, since all comparisons were planed beforehand, sample sizes were
small, and rejecting the alternative hypothesis too readily by the use of for example the
conservative Bonferroni correction was avoided[493,494]. This correction method would
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have been especially severe in this analysis due to the use of the Wilcoxon test. This
non-parametric statistical test provides a lower statistical power when compared to e. g.
a standard parametric two sample t-test. This issue underlines the necessity of bigger
group sizes for future analyses of similar interventions in mice as well as the need of
validation of the presented results. Unfortunately, for this thesis, the use of larger animal
numbers was not possible.
5.2.3 No impact of obesity on alveolar macrophage M1 polarization
Alveolar macrophages are key effector cells in the initiation and resolution of lung
inflammatory responses[495]. To better understand the delay in the initiation of lung
inflammation observed during the LPS challenge of HF mice (Figure 8) and assess
the possible impact of obesity on the initial phase of M1 AM polarization, AMs were
examined by qPCR 50 min after in vitro incubation with LPS. At that moment, M1 AMs
showed very pronounced increases in pro-inflammatorymarker expression compared to
steady state AMs (Appendix, Table 14).
Previous work from Prof. Dr. Meiners’ and Dr. Stöger’s groups[496] show that
the in vitro M1 polarization of AMs for 24 h presents comparable increases in
pro-inflammatory gene expression when comparing M0 and M1 AMs to the differences
presented in this thesis 50 min after the start of polarization (Appendix, Table 14).
Additionally, time course analysis of in vitro M1 activation of MFs with LPS (and INFg)
by these groups[496] and others[497] for times between 0 and 24 h have shown a dynamic
M1 marker expression. In these studies, maximal increases in mRNA quantities were
capture at around 4-6 h. A subsequent decrease in pro-inflammatory gene expression
was observed until 24 h after incubation. In order to capture changes in AM polarization
as closely to the in vivo conditions as possible (ex vivo incubation presents a completely
different microenvironment compared to the lung), and because the polarization study
of AMs in this thesis aimed the description of the initial phase of M1 AM polarization
that could explain the delay of in vivo inflammation during the LPS instillation in obese
mice, the time point of 50 min after AM incubation with LPS was selected.
As expected, the M2 markers Pparg and Chil3 were not differentially expressed
between M1 and M0 macrophages. Furthermore, obesity, systemic inflammation and
increased plasma glucose levels in HF animals had no effects on the initial M1 AM
polarization in vitro. The similar expression in pro-inflammatory markers, especially
of Cxcl2, measured between M1 and M0 AMs 50 min after their incubation with LPS
could indicate that the delay in the initial influx of neutrophils was not directly caused
by the expression of the inspected pro-inflammatory molecules in AMs. Interestingly,
qPCR analyses of AMs isolated from C57BL/6J mice fed for up to a year with HFD did
not show any differences in the expression levels of polarization markers at steady state
either (data not shown).
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It would be intriguing to find out if the expression of M1 markers in AMs are affected
during later time points of the in vitro incubation with LPS. Especially interesting would
be an analysis of such expression during the time point of “maximal polarizability”
of AMs. As presented 2016 by Chen et al.[496] and Xie et al.[497], such maximum in
expression might be observed 4-6 h after the start of in vitro polarization with LPS.
Another possible explanation of the delayed inflammatory response in vivo could be
the smaller numbers of MFs observed in the lavages of mice at the time point 0 h of the
LPS time course. This would mean that, even if single AMs expressed the same amount
of pro-inflammatory factors, the overall concentrations in the lung would be reduced in
HF (male) animals.
5.2.4 M1 alveolar macrophage adherence to the lung epithelium
The cause for the reduction in AM counts in obese mice could also have been caused
by a stronger adherence of AMs to the lung epithelium. This adherence process
can be integrin 𝛼D-mediated (Itgad) and therefore dependent on the polarization
status of AMs[498]. M1 MFs demonstrate a higher expression of Itgad and therefore
stronger adhesive characteristics[498]. Interestingly, AMs presented a trend of increased
expression of pro-inflammatory genes at steady state (Figure 9). Further gene expression
analysis could provide information on effects of obesity on the regulation of Itgad and
possibly explain a stronger adherence of AMs in obese mice.
Yet another known process involved in AM binding to the epithelium is the
expression of gap junction protein 𝛼1 (Gja1). During endotoxin-induced lung
inflammation, M1 AMs can adhere to the alveoli and initiate immunosuppressive,
Ca2+-dependent intercommunication employing GJA1-based gap junctional channels to
the lung epithelium as communication route[130]. Impaired Gja1-mediated signalling in
AMs can impact the secretion of pro-inflammatory cytokines by epithelial cells (CXCL1,
CXCL5) and neutrophil recruitment to the airspace[130]. Such impairment could have led
to the observed alteration in BAL macrophages numbers in vivo. In addition to Idgad,
Gja1 could be an interesting research candidate for this model. Intriguingly, Gja1 have
shown to be involved in obesity-related processeswithin other organs, likewhite adipose
tissue beiging[499] and hypothalamic control of feeding behaviour[500]. For this reason it
could present an additional link between obesity and inflammation.
5.2.5 AM phagocytosis and the resolution of inflammation
An equally important, but often overlooked function of AMs, additionally to the
initiation of an inflammatory response in the lung, is the induction of its resolution.
Even though the analysis of polarization markers did not show any differential gene
expression between diet groups at steady state nor 50 min after LPS exposure, the
phagocytosis test implemented in this work displayed a reduced uptake of zymosan
particles by HF male AMs (Figure 11).
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It was not possible to distinguish with this assay alone exactly which mechanisms of
phagocytosis were perturbed byHFD. Possible impairments in phagocytosis could occur
for example in the uptake of particles, but also on the maturation of the phagolysosome
– specifically on its acidification. Both types of phagocytosis impairment would lead to a
reduced fluorescence in AMs and lower counts of pHrodo-positive AMs[415].
Even though the phagocytosis analysis presented differences between LF and HF
males, it is important to mention that only the uptake of particles was tested and
not the engulfment of apoptotic neutrophils. Differences in the latter would present
a direct explanation of the delay in resolution of inflammation observed 72 h after
the in vivo LPS challenge of obese male animals. In contrast to the phagocytosis of
bacteria, particulatematter or necrotic cells, efferocytosis of apoptotic cells runs “quietly”,
without evoking inflammatory or immunogenic reactions[501]. Most importantly, the
efferocytosis of apoptotic neutrophils by AMs promotes anti-inflammatory signalling
not only by preventing cell lysis of neutrophils and release of their content, but also
by acting as a strong inducer of anti-inflammatory and pro-resolution pathways in
macrophages[413].
5.2.6 Possible contributors to immune alterations during obesity
Taking into account that obesity can not only lead to a systemic low-grade
inflammation[278,279], but also dyslipidaemia[241], impairment of the endocrine functions
of the adipose tissue[253], and gut microbiome dysbiosis[268], three possible contributors
to the distortion of the lung’s inflammatory dynamics (Figure 8) could be listed:
immune cell exhaustion, endotoxin tolerance and deregulation of immunoregulatory
adipokines.
Immune cell exhaustion is a process characterized by a progressive and hierarchical
loss of effector functions following chronic exposure to pro-inflammatory signals[502].
Exhausted cells present decreased proliferative potential, attenuated cytokine
production, and diminished self-renewal capacity[502]. Additionally, exhausted
macrophages are characterized by an impairment of their phagocytic activity[503,504].
Immune exhaustion of AMs could be involved in the observed decrease in macrophage
counts in the lungs of HF males at steady state (Figure 8D) as well as to the delayed
initiation and resolution of inflammation (Figure 8B).
Endotoxin tolerance involves the continuous activation of TLR2 and TLR4
pathways on myeloid cells through repeated exposure to bacterial LPS. This
phenomenon is characterized by hyporesponsiveness to a subsequent pro-inflammatory
activation[505,506] and is thought to be an adaptive mechanism that protects from tissue
injury by repeated subjection to Gram-negative bacteria[507]. Since FFAs can act as TLR
agonists and because obesity can induce gut dysbiosis, increase gut permeability and
lead to leaking of LPS into the circulation (endotoxemia)[508,509], the question of possible
endotoxin tolerance in the presented mouse model of DIO arises.
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Lastly, adipokines have shown to play a pivotal role for the correct function of the
immune system. Adiponectin, for instance, facilitates the uptake of apoptotic cells
by MFs[510], but its concentration is reduced in C57BL/6J mice subjected to DIO[511].
Additionally, leptin is of great importance for the development and function of immune
cells[512,513], but obesity can lead to its deregulation and resistance, directly affecting
the lung immunity[514]. Importantly, AMs express the leptin receptor and the leptin
signalling pathway promotes their phagocytic activity[515]. During C57BL/6J DIO,
peripheral leptin insensitivity starts at week eight[516]. This is why (at least) leptin and
adiponektin could play important roles in an immune deregulation in the lung during
obesity.
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5.3 Intergenerational effects of diet-induced parental obesity
More often then not, the terms “intergenerational” and “transgenerational” are used
interchangeably. However, it is important to remark that a true transgenerational
epigenetic transmission stringently refer to phenotypic consequences that cannot be
attributed to immediate influences of a particular trigger (e. g. an environmental
exposure) on the altered organism. Specifically, only effects occurring in the
second generation (F2) for male-mediated or third generation (F3) for female-mediate
alterations after environmental exposure can be described as transgenerational
inheritance[358,359]. On the other hand, effects spanning shorter periods are described
as parental or intergenerational. The impact of parental obesity directly affecting the
developing embryo (F1) and the gametes that formed it is therefore defined as a parental
or intergenerational effect.
After the successful generation and characterization of a parental mouse model
of diet-induced obesity (DIO), the intergenerational effect of parental obesity was
analysed at three different time points in the offspring’s life. The first two – embryonic
day 18.5 (E18.5) and postnatal day 15 (P15) – were selected in accordance with
previous publications on the effects of maternal DIO on the placenta and the offspring’s
lung[324,327]. Additionally, an age of ten weeks (P70) was inspected for the study of
long-term effects of parental obesity at a young-adult[365] mouse age.
Following human developmental terminology, the denomination “embryo” indicates
a developing human between the time of implantation and the onset of bone marrow
generation in the humerus[517], i. e. around the ninth week after conception. Posterior
to this phase and until birth, the term “foetus” is used. Such distinction in the mouse
is however less strict. Since the term embryo can be applied to all stages of mouse
development between conception and birth[517], here “foetus” and “embryo” are used
interchangeably to describe E18.5 offspring.
5.3.1 Impact of experimental design on high-fat diet outcomes
The hypothesis proposed in this thesis as well as the constellation of analyses performed
on offspring were designed based on the premise that a high-fat diet (HFD) not only can
induce obesity in parent animals, but also induce placental inflammation and cause a
disruption of the normal lung development in offspring. I. e. parental HFD feeding was
expected to lead to the reproduction of results from previous publications (see Section 5),
especially of the findings from Mayor et al. from 2015[327].
Contrary to named publication, a HFD containing a higher fat content (60 %KJ
vs. 42 %KJ) and exclusively purified diets (low-fat diet vs. standard mouse chow) were
employed for the present work. This decision was made following suggestions from our
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cooperation partners at the German Mouse Clinic (see Section 2.3 and Section 5.1) and
because of the higher efficacy of such HFD in inducing obesity in mice. Additionally,
scientists have previously mentioned an impact of maternal DIO on the offspring’s lung
morphology employing purified diets[353].
Since a grain-based, standard mouse chow (like the one employed by Mayor et
al. as control diet) presents a completely different source of carbohydrates, has a
higher content in fibre and contains different plant chemicals, such as phytoestrogens
(isoflavones)[518], it is likely that spurious effects of parental diet on the offspring’s
physiology might arise not from parental obesity, but from differences in nutrient and
chemical content between diets. Such elements can modify endocrine functions[519,520]
and affect the gut microbiome[520]. It has been shown, that the latter can directly
modulate important immune functions in a sexual dimorphic manner[521].
Further differences between the two experimental designs included the possibly
reduced feeding period of parents (12 weeks vs. “3-5 months”), the earlier start of
parental feeding (directly after delivery at three weeks of age vs. “6–8 week old” mice),
the application of the DIO model on parents from both sexes (vs. only dams), and
potentially the use of a differentmouse genetic background (C57BL/6J vs. “C57/Bl6”, see
article “There is no such thing as a C57BL/6 mouse!”[522]). The presence of such differences
would lead to critical repercussions, since these not only can define the susceptibility of
animals to DIO[446], but also dictate specific immune responses[523–525].
5.3.2 No effects of maternal obesity on placental inflammation
As presented in Section 2.2, the main hypothesis of this thesis proposes that the period of
AMdevelopment can present itself as awindow of vulnerability for programming effects
by parental DIO.
Studies of maternal DIO have demonstrated alterations in the gene expression
and morphology of placentas from HF dams in a sexual dimorphic fashion[324,327,416].
Particularly, authors propose an increased expression in pro-inflammatory cytokines
after maternal HFD feeding, including higher mRNA levels of Ccl2, Il6, Il1b, Tnf and
Nrlp3[324,327,416].
Placental inflammation has shown to induce placental dysfunction and intrauterine
growth restriction, among other pregnancy complications[526]. Because the precursors of
the AMniche (foetalmonocytes) seed the lung before birth, it is very likely that placental
inflammation plays a critical role in the hypothesized pro-inflammatory priming of this
tissue macrophage (TM) population.
In this thesis, the analysis of the gene expression of inflammatory markers in the
placenta of E18.5 foetuses, including the genes mentioned above, displayed no effect of
parental diet (Figure 14). Even though a qualitative trend of higher expression levels of
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pro-inflammatory genes in placentas fromHF female embryos (Figure 14A) compared to
LF control placentas was observed, these differences did not reach statistical significance.
Such trend was not as clear for male embryos (Figure 14B).
Based on the findings of sexual dimorphic expression of pro-inflammatory molecules
in the placenta[324,327,416] as well as on the detrimental effects of placental inflammation
on foetal survival, in order to categorize this trend as biological relevant, differences in
the sex distribution of surviving offspring between diet groups could be expected. This
was however not the case (p=0.563, Fisher’s exact test).
Calculations of the number of samples needed to reach a statistical power of 80 %
using the observed standard deviation and difference in mean gene expression between
diet groups of female placentas resulted in sample sizes of 11 for Il12b, 16 for Nos2, 29 for
Nlrp3 and 38 for Il1b. Based on these estimates, it could be argued that higher samples
sizes or longer feeding times of damsmight have led to the observations demonstrated in
the work from Kim et al.[324]. It has to be noted however, that the disruption of placental
morphology, cell proliferation and the presence of inflammation in placentas detected by
these authors took place after merely 8 weeks of feeding purified diets (both HFD and
LFD).
Similarly to Mayor et al.[327], the fat content of the HFD used by Kim et al. was lower
(45% kcal as fat) compared to the present work, and the reportedmouse strain employed
was also “C57BL/6”. Because mouse strains with a C57BL/6N background display more
pronounced responses in the development of DIO upon HFD feeding[446], it is likely that
Kim et al. as well asMayor et al. havemade use of strains with such a genetic background
(6N).
Several studies have previously identified distinct phenotypic consequences based
on the specific genetic background of C57BL mice (6N vs. 6J)[446,527–529]. For instance,
comparing these two mouse strains, Bourdi et al. could demonstrate in 2011[528]
seriously contradicting findings of studies on liver injury. These discrepancies were
attributed solely to differences in the genetic background of these two “C57BL/6” mouse
strains[528].
Since Kim et al.[324] employed purified diets as in the case of this thesis, rather
the genetic background of the mice used and less the differences in diet composition
(standard chow vs. LFD) led to the inconsistencies observed in the placental
consequences of maternal DIO among the different studies presented.
5.3.3 No effects of parental obesity on systemic inflammation in offspring
Even though the gene expression analysis demonstrated no evidence of inflammation
in the placenta, these results did not exclude the possible emergence of systemic
inflammation in HF offspring after birth as a consequence of epigenetic inheritance.
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Nevertheless, in accordance to the negative results from the gene expression examination
in placentas, none of the ten inflammatory cytokines measured in the offspring’s
circulation after birth at P15 (Figure 15) nor at P70 (Figure 16) presented any differences
between HF and LF offspring groups.
Unfortunately, some of the observed cytokine concentrations were close to the
detection limit of the measurement system. This hindered their interpretability. For that
reason, the relevance of qualitative differences between parental diet groups, especially
of the apparently higher levels of INFg in P15 male offspring (Figure 15B) and the
seemingly higher concentration in IL4 in HF P70 female offspring (Figure 16A), could
not be clearly stated. Furthermore, since no standard control levels of plasma cytokines
from standard chow-fedmiceweremeasured, no conclusions on the effect of the purified
LFD on plasma cytokine concentrations in offspring could be made.
Cytokine measurements in offspring’s plasma were performed at steady state. It
could be imaginable that a “second hit” could expose systemic effects brought about
by parental DIO, which otherwise were not detectable during homeostasis. Systemic
challenges could include the intravenous injection of LPS to induce a systemic acute
inflammation aswell as a continuedHFD feeding regime, similar to theHF parents.
5.3.4 Parental obesity and foetal deaths
The causes for stillbirths have been extensively studies both in human and mouse.
Maternal stress caused by factors like air pollution[530], nutrient imbalance[531], cigarette
smoke[532], bacterial[533] or viral infections[534] and exposure to gold nanoparticles[535],
among others, have been previously described. Common to these environmental
exposure is the promotion of intrauterine stress. Such stress can alter the embryonic
homeostasis through malfunctions in nutrient, oxygen and waste exchange/transport
of the placenta[536]. Maternal obesity is also a well known predictor of pregnancy
complications like preterm birth[537], preeclampsia[538] and foetal deaths[317].
Rodent models of maternal DIO have demonstrated increased pro-inflammatory
gene expression, and altered morphology and vasculature of placentas from HF
dams[324,327,539]. These placental changes are thought to be responsible for poor neonatal
survival. Therefore, it was very surprising to notice that even though pro-inflammatory
gene expression in placentas from HF animals was not altered (Figure 14), HF embryos
presented a more pronounced resorption 18 days after conception than the LF control
groups (Figure 12A).
Inflammation has shown to induce placental dysfunction and intrauterine growth
restriction, among other pregnancy complications[526]. The possibility that any other
form of disturbance could have changed placental function or uteroplacental blood flow
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and led to the observed increase in foetal resorption could not be discarded. It is
plausible, that the loss in number of embryos could have stabilized nutrient and blood
flow to the surviving foetuses and prevented thereby the expected pro-inflammatory
phenotype in their placentas.
While HF dams exhibited 22% of miscarriages, only 4% of foetal sacks in LF dams
were resorbed (Figure 12A). This represented a relative risk of 5.6 for a HF E18.5 foetus
of dying (being resorbed) before birth compared with the LF group.
In order to quantify breeding efficiencies, the total number of living offspring at
weaning were assessed and divided by the total number of female mice mated. Breeding
efficiencies of 3.2 offspring per HF female and 3.9 for LFD control groups were observed.
Interestingly, the 18% decrease in foetal viability in the HF group could explain the 18%
reduction in breeding efficiency. This suggests that the time before birth presents the
highest risk of death for a HF offspring.
5.3.5 Effects of parental obesity on the offspring’s body weight
Reduction in foetal viability in HFmice has been previously observed byMayor et al.[327]
and by other authors[334,349,434,540,541]. Compared to their results, foetal weights did not
differ between diet groups in the present work (Figure 12B). This was surprising, since
manymodels of HFD in rodents have led to signs of foetal growth retardation/restriction
and to the phenotype “small for gestational age” in HF offspring[327,334,542–545]. Similar
effects as the ones observed in this thesis (no differences in weight) were noticed in other
animal models as well[347,348,546].
There have been many inconsistent reports on the effects of parental HFD feeding
on foetal growth[545] and offspring’s body weight outcomes[547], showing both
increased[349,548,549] and non-affected[325,348,550,551] foetal bodyweights. Such observations
took place in spite of increased fatmass, glucose intolerance and placentalmorphological
alterations in HF dams[325].
Not only the species, strain and age of the animal model[424], but also the duration
of feeding[453] and the specific composition of the animal’s diet, e. g. carbohydrate and
fat content[552–554], fat origin (animal vs. vegetal)[554,555], and the presence of mono- and
polyunsaturated fatty acids[556–558], can differently affect the metabolism and physiology
of the animal model and lead to variable intergenerational consequences. Therefore, it
can be expected that even small differences in rodent diets lead to the aforementioned
inconsistencies in physiologic and inter-/transgenerational outcomes.
Further efforts should continue to be made in order to standardize rodent models of
diet induced obesity. This is especially important since more often than not, the ultimate
goal of such models resides in their application in translational medicine. Since the
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numbers of rodent studies implementing similar fat contents as the one used in these
analyses –HFDwith 60% of its caloric content coming from fat, and LF control diets with
around 10 % of fat – are increasing[547,559], such standardized model of rodent obesity
might lead to more homogeneous results in future studies with C57BL/6J mice.
Writing a review article on the topic in 2019, Chistians et al.[545] described a
plausible relationship between maternal HFD feeding times and their effects on the
offspring’s body weight. While feeding mice a HFD (60 %) for 4–9 weeks prior to
pregnancy favoured larger foetal body weights, longer feeding periods tended to reduce
foetal growth[545]. This remains to be definitely validated, however, following this
hypothesis, the duration of the HFD used in this thesis could overlap with a period
“in-between”, where no foetal weight differences can be observed between HF and
control animals.
Similar to male E18.5 foetuses, no differences in body weights were observed in P15
male offspring nor at the age of P70 (Figure 13). Yet, body weights of P15 HF females
were reduced compared to the LF offspring control group (Figure 13A). This effect
appeared to be temporary, since a catch-up in weight followed, leading to comparable
body weights between parental diet groups at P70. Even though a trend in lower mean
weights for all HF groups compared to LF controls was visible, these differences were
not substantial.
Previous studies have shown that male offspring have a higher susceptibility to
transgenerational perturbations by parental diet[560–562]. It was striking to observe that
only the P15 female offspring group presented alterations in bodyweight due to parental
diet. Also interesting was the recovery in body weights until the age of ten weeks.
Unfortunately, no differential analysis of body composition parameters was performed
on offspring mice. Such data could help understand, if the catch-up observed was
due to increases in body fat or in all three body composition values. Since offspring
were exclusively fed with a LF control diet after weaning, the latter could rather be
expected.
5.3.6 Implications of parental obesity on the embryonic lung inflammatory and
developmental status
Developmental and/or inflammatory gene expression interrogation in foetal lungs by
qPCR demonstrated altered levels of Fgf10, Pparg, Bmp4 and Ccl2. While E18.5 HF
female lungs displayed increased mRNA levels of Fgf10 and Bmp4 and lower gene
expression of Pparg and Ccl2, these differences were only visible for Bmp4 and Ccl2 in
male foetal lungs (Figure 17).
Contrary to the results presented in 2015 by Mayor et al.[327] no differences in the
expression of Il1b nor of Nlrp3 were observed in the HF E18.5 lungs (Figure 17). The
results from Mayor et al. were conform with the previous publication by Bry et al.[563]
and Hogmalm et al.[564], who proposed that perinatal overexpression of Il1b in the lung
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can lead to respiratory insufficiency with increased postnatal mortality and impaired
postnatal growth. These authors suggested a disruption of alveolar morphogenesis in
the lungs of neonatal mice and increased expression of pro-inflammatory cytokines like
CXCL1, CXCL2 and CCL2, consistent with neutrophilic and monocytic infiltration of the
lungs. Intriguingly, the expression of the pro-inflammatory marker Ccl2 was decreased
by HFD in the present work. Also, levels of Cxcl2, Il1b and Il12b presented a trend of
lower expression in the HF group compared to LF control foetal lungs (Figure 17). This
was astonishing, since an opposite tendency was expected.
The expression of the nuclear hormone receptor and transcription factor (TF)
peroxisome proliferator-activated receptor gamma (PPARg) has been reported in a
number of pulmonary cell types, including inflammatory, mesenchymal, and epithelial
cells. PPARg expression is prominent in the airway epithelium in the mouse lung and its
deficiency results in defective postnatal lung maturation with enlarged airspaces[565]. It
also plays a role in the regulation of inflammation. Lungmacrophage Pparg deregulation
in a genetic model of obesity (db/db) has shown to increase host susceptibility to an
influenza virus infection in obese mice. These mice displayed attenuated lung antiviral
immunity, hampered recovery from the infection and reduced survival[566].
PPARg has an anti-inflammatory activity, promoting transcription of genes coding
for anti-inflammatory factors such as Arg1 and Clec10a[567]. It also inhibits the activity
(transrepression) of pro-inflammatory transcription factors like NF-𝜅B[568] and the
production of pro-inflammatory cytokines such as TNF, IL1b as well as other MF M1
markers like MMP9 and the macrophage scavenger receptor 1 (MSR1)[569]. PPARg
activation controls the function of several immune cells, including monocytes and
macrophages, acting as negative regulator of pro-inflammatory activation[568].
Importantly, the induction of PPARg is critical for the differentiation of AMs from
foetal monocytes[152], which, as mentioned before, play an important role in lung
development[211]. Based on the roles of PPARg, its central position connecting obesity,
immunity, metabolism and lung development is clearly recognizable. Therefore,
it was very striking to observe, that despite the presence of alterations in gene
expression of Pparg as well as Fgf10, Bmp4 and Ccl2, no relevant morphological
pathological alterations were visible during semiquantitative grading (Table 13) nor
after quantification by image analysis of maturity in E18.5 foetal lungs (Appendix,
Table 15).
5.3.7 Parental obesity does not necessarily induce a pro-inflammatory environment
during AM development
As presented in Section 2 and Section 5.3.1, the generation of the hypothesis of a
pro-inflammatory priming of AMs by parental obesity started from the premise that
the implementation of parental HFD feeding in mouse would lead not only to obesity
in dams and sires, but would also increase the expression of pro-inflammatory genes
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in placentas from obese dams as well as in the lungs from HF embryos. These
pro-inflammatory alterations were expected to cause the disruption of the normal lung
development in offspring observed byMayor et al.[327] aswell as induce the hypothesised
pro-inflammatory priming of AMs.
Because of the missing inflammation, both in the placentas as well as in the E18.5
offspring’s lung, especially the absent up-regulation of Il1b and Nlrp3, the assumptions
for this hypothesiswere violated. In case of a detection of alterations in lungdevelopment
or in the polarization AMs of HF offspring, a connection to a pro-inflammatory milieu
in the lung during AM maturation would not be possible.
5.3.8 Implications of parental obesity on the P15 offspring’s lung inflammatory and
developmental gene expression
Additionally to the altered expression of Fgf10, Pparg, Bmp4 and Ccl2 in the HF
embryonic lungs, parental DIO reshaped themRNA levels of Ccl2, Il1b, Pparg, Tnfrst11a,
and Wnt3a in the lungs from P15 offspring in a sexual dimorphic fashion (Figure 19).
Pparg, Ccl2 and Il1b expression levels in the P15 lungs were decreased by parental
HFD-induced obesity, but only in the male offspring’s lung. Parental HFD raised the
expression of Tnfrsf11a and Wnt3a in the P15 HF offspring lungs from both sexes.
Even though the presence of sexual dimorphism was observed in the altered gene
expression by parental obesity in both the E18.5 as well as the P15 lungs, no evident
trend in the impact of a specific offspring’s sex was observed. While differences in the
mRNA quantities in the offspring’s lungs were more evident in HF females during an
embryonic age compared to the LF control group (Figure 17), this was rather the case for
lungs from P15 male offspring (Figure 19).
Compared to the qPCR analysis of E18.5 lungs (Figure 17), it can be observed that
a less exhaustive interrogation of markers was performed for the P15 lungs. This was
decided, since most of the markers analysed in E18.5 lungs presented no differences in
the gene expression between diet groups. The strongest impact of parental obesity on
developmental signalling in the offspring’s lung was expected to appear during foetal
development. Additionally, the more comparisons are performed, the stronger the
burden due to multiple test correction is on the results from statistical comparisons. I. e.
the less genes are compared, the higher is the statistical power of the analyses that are
performed.
Interestingly, even though no increase in levels of Il1bmRNAwere observed in neither
the E18.5 nor the P15 offspring’s lungs, the expression of the anti-inflammatory marker
Pparg during both time points was decreased. Notwithstanding that the presence of a
decreasedPparg gene expression did not affect both sexes consecutively at during the two
time points analysed (compare Figure 17 and Figure 19), a consistent trend of its reduced
presence was evident.
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5.3.9 Impact of maternal obesity on the early postnatal lung maturation
It was striking to notice that parental obesity effects on marker expression were more
pronounced at the age of two weeks than during foetal development. Since solely LFD
was used to feed offspring, it could be expected that direct parental obesity effects would
diminish after birth and only priming/epigenetic effects would persist for a longer term.
Even though the offspring development is no longer under the influence of the maternal
intrauterine HF environment after birth, it has been shown, that nursing by foster HF
dams can as well induce physiologic changes in rodents[570]. HFD can directly impact
the composition of themother’s milk[571,572], especially in terms of fatty acid composition,
nutritional content and the presence of inflammatory mediators.
The neonatal age is a crucial developmental time point for the lung and for
alveolar macrophages. It is after the first breath that sacculi expansion concludes and
alveolarization takes place. At the age of two weeks, both classical and continued
alveolarization as well as microvascular maturation continue to progress[573]. The final
AM maturation takes place around this period of time, too[81]. In turn, deregulation
of the neonate’s nutrition can also present itself as a window of vulnerability for
developmental origins of lung disease[570].
Even though no clear pro-inflammatory conditions were detected in the placenta
nor in the E18.5 offspring’s lung, a possible connection between maternal obesity
and inflammation in the offspring after birth might be made. This would result
from alterations in the composition of the maternal milk. The transmission of
pro-inflammatory factors during this second window of vulnerability could affect the
final phase of alveolarization and AM maturation. Therefore, it would be fascinating
to evaluate the contribution of the maternal milk to the possible impact on these
developmental processes.
5.3.10 Transient delay in the final alveolarization by parental obesity
Additionally to gene expression analysis, P15 and P70 lungs were tested for
parental obesity effects in terms of their alveolarization. Histological examination by
design-based quantitativemorphometric stereology demonstrated increasedmean linear
intercept (Lm) measurements in P15 HF female offspring lungs compared to the LF
control group (Figure 18A). Lm is an estimator of the mean path within the alveolar
complex. As such, it represents an estimate of the internal alveolar surface area[574].
Contrary to the believe that Lm can represent the alveolar size, it rather characterizes
the entire acinar air space and not just alveoli[574].
Similar to the effect on weights of female offspring, parental obesity only transiently
affected Lm values at the age of P15. This pointed to a possible alteration of the final
lung alveolarization after birth. Lm values of P70 HF female were similar to their
corresponding LF controls (Figure 18B). No evident differences in Lm measurements
were observable for HF male offspring at any of the two ages. Even though a similar
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tendency as for P15 females of higher Lm values for the P15 HF male offspring was
observed, differences to LF controls did not reach statistical significance (for 80 % power,
the sample size needed would be of nMale,P15 = 41).
The observed changes on both the body weight as well as lung histology patterns
on HF female neonates resolved with age. As presented in Section 5.3.9, these sexual
dimorphic alterations in the lung structure of the HF female offspring might have
been actually caused by an altered content of nutrients and inflammatory factors in
the mother’s milk. Such alterations in the new-born feeding might be seen as a
“second hit”, which transiently affects both the offspring’s global weight gain and local
lung development. Cross-fostering HF offspring with LF dams could be employed to
corroborate this hypothesis.
It has been demonstrated, that lungs of mice can actually completely regenerate and
restore the lost lung volume and total alveolar area after a pneumonectomy within 21
days after the operation[575]. This fact supports the hypothesis of a complete catch-up in
alveolar development until the age of P70. It would be very intriguing to analyse possible
overlaps between pathways of regeneration and the alveolarization catch-up observed
after P15.
A drawback of this thesis was the small animal numbers employed. Larger sample
sizes could have increased the power of the statistical tests and better displayed group
variances. Even though the histological results suggested a possible delay in the final
phase of the offspring’s lung development, more studies would be needed in order to
understand the consequences of parental obesity on the neonatal lung development.
Additionally, since other parameters affected by parental diet could act as confounders
andbias the results from lungmorphology analyses, itwould be advisable to to take these
into account in possible follow-up experiments. Examples of them include body weight
and body size, but especially lung volume, size andweight – towhichmorphometry data
could be normalized against.
Similarly to the contrast between the results presented in this thesis and the
publication from Mayor et al.[327], several inconsistent outcomes of parental obesity on
the offspring’s lung development have been published. I. .e in a study of rat offspring
born to dams fed preconceptionally and during lactation with a HFD, Smoothy et
al. could not show any difference in Lm measurements in offspring at two weeks of
age[349]. Interestingly, these authors rather detected a trend of lower Lm sizes on HF
offspring. In spite of the low sample size (n = 4-6) implemented in the study, Smoothy
et al. interpreted this measurement as a possible increase in lung development due to
maternal HFD – an opposite effect to that displayed by Mayor et al.[327]
In accordance with the results presented in this thesis, MacDonald et al.[348] could
not show in 2017 any gross differences in lung structure or airway thickness at ten
weeks of age in a mouse model of maternal HFD either. In their study, no structural
differences in the offspring’s lung were observed, even after a second hit of HFD on the
109
offspring. Comparable negative results were presented also by Baack et al.[541] in a rat
model of maternal HFD. Even though the expression of surfactant protein Bwas reduced
bymaternal HFD feeding, no histological consequences were observed on the offspring’s
lung. These effects were analysed after birth and at three weeks of age.
Upadhyay et al. proposed 2019 to qualitatively have observed a detrimental effect
of parental diet on the E18.5 rat foetal lung[576]. Even though the study could show
the positive effects of time restricted feeding on HFD dams in terms of improved
placental oxidative stress, inflammation and apoptosis, the results presented did not
confirm a detrimental effect of parental HFD on the offspring’s lung development,
especially long-term consequences, since the mentioned effects were not quantified in
any form.
It is possible that the adverse effects of parental obesity on the offspring’s lung
observed in this thesis could have continued to be present or even worsen through a
continued HFD after weaning, similarly to the results from Heyob et al. from 2019[549].
In their study, these authors demonstrated a long-term impairment of the offspring’s
lung development. Not surprisingly, a second hit of HFD on the offspring presented
an additive detrimental effect. Unfortunately, no information about the mouse strain
employed was given by Heyob et al. (strictly speaking, this was not presented by Mayor
et al.[327] either, see article “There is no such thing as a C57BL/6 mouse!”[522]). Oh the other
hand, the effects proposed by Heyob et al.[549] appeared to be rather dependent on the
second HFD hit, since LF (CD, control diet) and HF offspring presented comparable
phenotypes after being fed with HFD (so called CD/HFD and HFD/HFD). Finally, is
also possible that the data presented by these authors did notmeet the assumptions of the
statistical algorithms selected, especially the assumption of normality and homogeneity
of variances, possibly leading to spurious results.
Unfortunately, Mayor et al.[327] did not analyse the lung morphometry from offspring
older than two weeks of age. However, these authors propose an arrest of the structural
and functional foetal lung maturation. Results from the present thesis, suggest rather
a transient delay in alveolarization due to parental obesity. Since this process of
alveolarization continues in mice until around P36[61], morphometric studies between
the first breath (P0) and P36 could help better understand effects of parental diet on the
final phase of lung development.
Summarising the presented literature, it can be noticed, that studies of the effects
of parental obesity on the offspring’s lung development do not always lead to results
congruent with the findings presented by Mayor et al. Not only differences in feeding
regimes are observable among the studies, but importantly, the inconsistent employment
of rodent genetic backgrounds. Further studies will be necessary to define a strain (e. g.
C57BL/6N) and feeding rules for the reproducible study of the impact of parental obesity
on the offspring’s lung development. Such findings could then be applied to translational
medicine research.
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5.3.11 Impact of parental obesity on leukocyte frequencies of the P15 lung
With the aid of flow cytometry, it has been shown that murine alveolar macrophages
appear in the alveolar space in the first week of life[81]. During this time, AMs finish
their maturation and differentiate into long-lived tissue macrophages in a process highly
dependent on CSF2[81]. In order to confirm the presence of mature AMs (ITGAX+,
FCGR1+, SIGLECF+), and test for differences in frequencies and expression of surface
markers by lung tissue leukocytes, whole lungs were analysed with a ten-colour flow
cytometry panel.
The analysis of flow cytometry data sets by means of unsupervised machine learning
lead to the recognition of eleven leukocyte (PTPRC+) populations (Figure 20). Among
them,mature alveolarmacrophageswith characteristic expression of adult AM signature
of ITGAX, ITGAM, FCGR1, SIGLECF was observed (Figure 25B). The expression
levels of these markers were not affected by parental obesity. Neither were extreme
contrasts measured in frequencies between parental diet groups (around 1 % difference,
Figure 21B)) in comparison with other leukocyte populations.
Notwithstanding that discrepancies in the relative cell numbers of AMs were present
between parental diet groups, their effects on the observed reduction in lung maturation
and bulk gene expression in lung tissue were not directly measured. Since differences in
the frequencies of AMs between parental diet groups were more pronounced in female
(1.5 %) than in male (1.2 %) offspring (Figure 21)) and contributed differently to the
overall contrast between diet groups (Person’s residuals of 8.9 and 6.5, respectively),
it could be imaginable that AMs might be partially responsible for the morphological
and gene expression divergence detected between offspring groups after segregation by
parental diet and sex. For this reason, the in-depth analysis of AMs between birth and
weaningwould be utterly valuable in the recognition of their contribution to the postnatal
lung development.
The more granular analysis of individual cells, e. g. by means of single-cell mRNA
sequencing, could better help identify functions of differentially observed leukocyte
populations in the lungs of HF pups. This technique could help describe the possible
contributions of the individual cell populations in the lung to the phenotypes observed in
offspring at twoweeks of age, especially the putative influence of AMs. Additionally, this
method could aid in further subdivision of the populations recognized by flow cytometry
and even spot other ones which were not detected with the antibody panel selected
(ITGAM, ITGAX, CD24A, PTPRC, H2-AB1, LY6C, LY6G, FCGR1, SIGLECF), including
epithelial cell populations.
A fascinating publication of such analysis was actually published a few months
before the submission of this thesis[577]. Employing single-cell mRNA sequencing,
Domingo-Gonzalez et al. studied the homeostatic and immune-modulatory functions
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of leukocytes in the developing mouse lung. They presented a single-cell atlas of the
C57BL/6J lung immune compartments and and examined the changes in leukocyte
populations at several time points between an embryonic (E18.5) and a weaning (P21)
age.
As expected, Domingo-Gonzalez et al. detected proliferative MFs during the
embryonic age of the mice. They additionally could show a remarkable physical
interaction between these MFs and the developing vasculature[577]. After birth, this
MF population faded and was replaced by a dynamic mixture of leukocytes that
included different macrophage subtypes, dendritic cells, granulocytes, and lymphocytes,
as detected during the flow cytometry examination of P15 lungs of this thesis. These
authors corroborated the context-specific functions of MFs in tissue remodelling,
angiogenesis, and immunity. Interestingly, they also recognised naive lymphocytes
that populate the lung at birth, which comprised 60 % of total immune populations, in
accordance to the results presented in this thesis.
Because of the limited resolution of the analysis of only ten surface markers, the most
prominently affected cell population by parental obesity (called here “T-cells”) could
not be further subdivided into other leukocyte subtypes. Following the results from
Domingo-Gonzales et al.[577], who could distinguish several lymphocyte populations,
including innate lymphoid cells (ILC2s), natural killer (NK) cells, B-cells and T-cells, it
could be argued that this “T-cell” population actually consists of several other leukocyte
cell types, like ILC2s. Importantly, the observed lymphocytes by Domingo-Gonzales et
al. maintained a naive phenotype until P21, which presented a skewed Th2 immunity.
This findings overlapped with results from Saluzzo et al.[165], who showed an AM M2
phenotype, promoted specially by ILC2-derived IL13 after the first breath.
Maternal obesity has been associated with increased susceptibility to wheezing
in early childhood[343,344] and asthma later in life[345]. The link between maternal
overnutrition and offspring’s innate airway hyperresponsiveness has been corroborated
in rodent models.[347,348] Eosinophils play a crucial role in the pathogenesis of asthma.
Eosinophilic asthma develops from complex immunologic and pro-inflammatory
mechanisms, mainly driven by Th2 responses (IL5, IL4, and IL13). Th2-mediated
airway eosinophilia derives from a intricate interaction between the innate and adaptive
immunity[578]. Importantly, the activity of both type 2 helper T (Th2) and type 2 innate
lymphoid (ILC2) cells play utterly important roles in the development of eosinophilic
allergic and nonallergic asthma[579].
Neither asthma nor eosinophils were themain research targets for this thesis, however,
these results could hint on the possibility of the here implemented C57BL/6J mouse
model of parental DIO in the study of asthma and other M2-related diseases. Lastly,
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further analysis of leukocyte populations in the lungs from diet-treated parents between
an embryonic age and weaning could further explain the contribution of individual
immune cell types to the observed morphological and gene expression differences
between parental diet groups at the age of P15.
5.3.12 No evidence of long-term pro-inflammatory AM priming at steady state by
parental obesity
The main hypothesis in this thesis states that parental obesity can induce a
pro-inflammatory priming of developing AMs. Here, the period of AM development
was proposed to present a window of vulnerability for M1 programming effects
by parental DIO. For this reason, pro-inflammatory consequences of the established
parental DIO on the offspring lung were studied, with especial emphasis on AMs.
An impact of parental obesity on AM maturation and priming was expected to be a
long-lasting.
In order to analyse these long-term effects and prevent an uninterrupted direct
influence from parental obesity through the placenta or the mothers milk, a young-adult
mouse age[365] of ten weeks was selected. Since diet alone did impact inflammatory
dynamics in the lungs of obese mice (Figure 8), offspring were exclusively fed a LFD
after weaning.
Under tissue homoeostasis, at least 95% of AMs have shown to be of foetal origin in
14months oldmice[123]. This further stresses the long life and self-renewal abilities of the
AM niche[81,91,95,96]. In the case that the hypothesised pro-inflammatory priming of AMs
has taken place as a consequence of parental obesity during AM development – either
perinatally through maternal obesity or prenatally through paternal obesity – primed
AMs were expected to remain present in the airspace of HF offspring.
In order to test for the presence of priming effects on AMs at steady state, these TMs
were isolated fromLF andHF offspring, and their pro- (M1) and anti-inflammatory (M2)
gene expression was analysed without any form of treatment (M0, Figure 28). During
the isolation process of cells from the airspace of HF and LF control mice at steady state,
no differences in cell numbers of AMs (Figure 26) nor any other cell type identified in
the lung lumen (Figure 27) were detected between parental diet groups. This pointed to
possible catch-up in leukocyte frequencies from the observed differences at an age of two
weeks until P70.
It is possible, that priming effects from parental diet could have had an effect on the
adhesion of AMs to the epithelium, leading to similar cell counts of lavaged cells. This
however is unlikely, since AMs from P70 offspring at steady state did not show any sign
of long-term impacts in their M1 norM2 gene expression (M0 AMs, Figure 28). A similar
analysis of whole lung leukocyte populations employed for the study of P15 offspring
could be employed for P70 animals to corroborate this.
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The absent differences in gene expression of M0 AMs as well as the comparable cell
counts observed between LF and HF P70 offspring did not present any evidence of
long-term pro-inflammatory AM priming at steady state by parental obesity.
5.4 LPS challenge of the offspring generation
5.4.1 No impact of obesity on alveolar macrophage M1 polarization
AM pro-inflammatory priming effects may remain “dormant” during homoeostasis
and become visible during inflammation of the lung. The hypothesis of this thesis
additionally stated that pro-inflammatory AM priming can lead to long-lasting adverse
functions in the offspring’s lung which might become apparent later in life through
a defective inflammatory response to an LPS challenge. Therefore, AMs from P70
female and male offspring were analysed by qPCR after their initial in vitro polarization
(“polarizability”).
Similarly to the polarization of AMs of parent animals, M1 activation of the offspring’s
AMs in vitro proved to be very effective after just a 50 min incubation period in medium
containing 1 𝜇g/ml LPS (Appendix, Table 16), presenting a clear increase in the expression
of M1 markers compared to M0 AMs (p-value < 0.001). However, comparisons of gene
expression betweenparental diet groups could not demonstrate anydifferences inmRNA
quantities of M1 nor M2 markers.
5.4.2 Lung inflammatory responses in offspring of obese parents
In addition to the in vitro polarization of AMs, the lungs of P70 offspringwere challenged
in vivo by the mild model of endotoxin-induced acute inflammation discussed in
Section 5.2.1. Contrary to the analyses during the challenge of parent animals (Figure 8), a
more exhaustive interrogation in the P70 offspring could bemade. For this, the dynamics
of the seven pro-inflammatory cytokines CSF2, CXCL1, CXCL2, CXCL5, IL1b, IL1a and
TNF aswell of SAA3were analysed at time points 0, 6, 24, 48 and 72 hours post instillation
(Figure 24). Additionally, the cell populations in the airspace during the challenge were
not examined by manual counting, but by means of flow cytometry (Figure 26 and
Figure 27).
During the in vivo challenge of offspring animals with endotoxin, the analysis
of cytokine secretion into the airspace demonstrated two different waves of
pro-inflammatory factors. The first one presented a very quick response, with
highest concentrations at 6 h after instillation. It is however possible, that even higher
concentrations were present in the lung during earlier time points of the challenge.
Especially for TNF, a strong peak at 6 h was observed. CXCL1, CXCL2 and IL1a
(and Il1b) demonstrated similar dynamics with peak concentrations at 6 h. On the other
hand, CXCL5 and SAA3 reached their highest concentration not at 6 h, but at 24 h after
instillation (Figure 24).
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Concentrations of the cytokine IL1b remained within the detection limit of the test
(Figure 24). These results appeared to accord with previous publications showing that
LPS induced acute lung inflammationdid not induce increases of IL1b in the air space[417].
Since the active form of IL1b was targeted by antibodies of the ELISA kit, these results
could suggest that inflammasomes (Caspase 1-activatingmulticomplex proteins) are not
involved in the LPS-induced acute lung inflammation. This absence of inflammasome
involvement was previously proposed by Dagvadorj et al. in 2015[417]. Interestingly,
experiments from Moreland et al. from 2001 additionally suggested that IL1b is not an
essential factor for the inflammatory response towards LPS in the lung[580].
On the other hand, these authors measured an increased gene expression after LPS
inhalation. In this thesis, the comparison between time points 0 h and 6 h (Figure 24) did
indeed display higher concentrations of the bioactive form of IL1b after LPS instillation
(p = 0.013, not split by parental diet). It would be interesting to analyse BALF
samples isolatedwith lower amounts of PBS or bymeans of other detections systemswith
higher sensitivity. This could help test for the involvement of the inflammasome during
an endotoxin-induced acute lung inflammation and distinguish possible differences in
concentrations of this cytokine in the lung due to parental diet effects as well as its
dynamics.
The family of CXC chemokines constitute essential ligands for neutrophil influx into
inflamed tissues[581]. Six hours after LPS instillation during the in vivo pro-inflammatory
lung challenge, HF male offspring presented a trend of lower concentrations of the
chemokine CXCL2 compared to the LF control group (Figure 24). This tendency
suggested the presence of a possible long-term alteration of AMs by parental diet, as
presented in the main hypothesis. Importantly, a similar trend was also present for the
Cxcl2 expression in M1 activated AMs from both male and female offspring (Figure 29)
and the number of neutrophils recruited to the airspace of challenged P70 offspring
(Figure 26).
The neutrophil-recruiting chemokine with the highest (not statistically significant)
difference in concentration between the HF and LF groups was CXCL5, followed by
CXCL2 and CXCL1. While the chemokine CXCL5 is expressed by AECII cells[582],
CXCL1[583] and CXCL2[584] are mainly expressed by AMs (and neutrophils)[585] after a
pro-inflammatory stimulation. A test revealed sample sizes needed of 6 and 10 to reach
a power of 80% for CXCL5 and CXCL2, respectively.
These observations were unexpected, since the hypothesis proposed in this thesis
was of an increased inflammatory response as a consequence to pro-inflammatory AM
priming by parental obesity. Additionally, MacDonald et al. could demonstrate in a
study from 2017[348] that offspring born to mothers on a hypercaloric diet present not
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only elevated airway resistance, but, importantly, increased neutrophil infiltrates at ten
weeks of age as well as increased levels of total BALF protein. In line with the hypothesis
presented on this thesis, results from MacDonald et al. suggest an increased baseline
presence of inflammatory cells in the air space and compromised air-tissue integrity in
the lung.
Similar to the results from the in vitro M1 polarization of their AMs, the statistical
analyses of data collected during the in vivo challenge of P70 male offspring displayed
no differences in the concentrations of the inflammatory factors secreted into the airspace
of the lung between parental-diet groups at any time point. Together with the negative
results from the qPCR analyses of AMs at steady state, these data could not corroborate
the hypothesis of a pro-inflammatory AM priming by parental obesity. Nonetheless, the
tendencies observed during both the in vitro and in vivo pro-inflammatory challenges
led to question these negative results. Higher animal numbers, but also the use of other
mouse strains with an alternative genetic background could help definitely accept or
reject the hypothesis presented here.
5.4.3 Cellular dynamics during the in vivo LPS challenge of the offspring
generation
Looking at the cellular fractions recognized during the lung inflammatory challenge,
it could be argued that two of the populations inferred by the analysis of the flow
cytometry data could not be present in the alveoli of the lungs: interstitial MFs and
resident monocytes. Both cell types are expected to reside within the interstitium of
the lung[586]. Historically speaking, the characterization and naming of different cell
populations has not only been done based on their histological localization at steady
state, but also on their function and expression of biomarkers.
The definition of cells populations by flow cytometry alone is exclusively based on the
expression of such biomarkers. For the identification of the different cell types presented
in this work, the expression patterns of lung cells previously described by Misharin et
al.[217], Ellis et al.[367] and Yu et al.[368] were employed (Figure 25B). Interestingly, both
interstitial MFs and resident monocytes displayed similar migration dynamics into the
airspace of the lung, presenting a peak in cell numbers at around 48 h after instillation
(Figure 26 and Figure 27). It would be interesting to trace these two cell types to better
understand their function and fate during lung inflammation. The presence of these
two leukocyte populations in the lung lumen is most likely of ephemeral nature. While
monocytes probably undergo apoptosis and are uptaken by AMs, mature interstitial
macrophages could rather differentiate into AMs or migrate back into the interstitium.
Additionally, while it is possible that their presence of resulted from an active migration
from the interstitium into the airspace, it is also likely that these cells were washed out
of the LPS-damaged tissue during lavage.
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The dynamics of dendritic cells (DCs) was also interesting to observe. While cell
numbers of ITGAM- DCs remained relative stable, ITGAM+ DCs reached a peak 48 h
after instillation with LPS (Figure 27). ITGAM+ DCs are known to migrate from the
blood into the lung in response to Cryptococcus neoformans[587] as well as to influenza[588]
or respiratory syncytial virus (RSV)[589] infections. This migration takes course in a
CCR2-dependent manner[590]. It has been shown that these cells play an important role
in the clearance of pathogens[587]. The measured dynamics of ITGAM+ DCs took place
in accordance with previous literature.
The observed dynamics of the 14 leukocyte populations detected by flow cytometry
during the LPS challenge support a correct differentiation of the cell types in the
airspace bymeans of unsupervised clusteringmethods. Even though suchmethods have
proven[374] to outperform manual gating of cell populations in terms of reproducibility
and accuracy, especially for the recognition of rare cell populations[375], the fidelity of
these methods depend on expert knowledge of the analyst. Such expert knowledge
is crucial for the correct assignment of cell type names to the identified clusters of
cells. Alternative methods include supervised and semi-supervised machine learning
methods[591]. Recent improvements in computational efficiency can even enable a fast
“online” inference of cell types and aid cell sorting, e. g. via deep learning[592]. A
downside of supervised methods however, is the need of rather big datasets in order
to train the models for achieving adequate prediction performance[593].
In order to corroborate the accuracy of the inferred cell types, both the comparison
with cell numbers frommanual gating (Figure 31) aswell as cell sorting experimentswere
performed. The analysis of flow cytometry data by means of manual gating resulted in
very similar numbers to the ones obtained by means of unsupervised machine learning
algorithms (data not shown). This was especially the case for cell populations with
high numbers in the airspace. AMs and neutrophils, the two most prominent cell
types in the alveoli during the LPS challenge, were detected with a similar fidelity
with both methods. The overlap of counts between the semiautomated method and
the manual gating process was lower for smaller cell populations, since their correct
manual detection was difficult. This comparison corroborated the superior performance
of unsupervised clustering for recognizing rare cell populations compared to manual
gating of flow cytometry data.
Unluckily, the characterization of cell types by means of cell sorting for the validation
of detection of leukocytes in the airspace was not possible. Two sources of cellular
stress hindered the successful sorting of whole lung cells: the stress caused by the lung
dissociation (treatment with the protease and mechanical dissociation through a filter)
as well as the mechanical shear burden implicated by the use of a 100 𝜇m nozzle. A
reduction of time between dissociation of the lung tissue and cell sorting as well as the
use of a 120 𝜇mnozzle for cell sorting to reduce shear forces on sorted cells could help in
future implementations of the manual gating strategy presented in this thesis for sorting
experiments of lung leukocytes.
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6 Outlook
The main hypothesis in this work suggested that the presence of a pro-inflammatory
developmental microenvironment induced by parental obesity can lead to an altered
AM development with pro-inflammatory programming consequences (priming). This
thesis was based on previous studies showing that metabolic and inflammatory changes
brought about by maternal DIO can extend to the placenta and expose the developing
foetus to a pro-inflammatory environment. This milieu is characterised by elevated
levels of free fatty acids[322] and placental macrophage activation, displaying increased
cytokine (Tnf, Il1b, Il6, Nlrp3, and Il10) expression[324,326–328]. Offspring to obese dams
present higher abundance of pro-inflammatory cytokines (IL6, IL17A, and IFNg) in
the circulation[324] as well as an increased expression of Il1b in the lung[354] at a foetal
age. Most importantly, Mayor et al.[327] showed in a mouse model of maternal DIO
an impaired foetal lung development with reduced structural maturation both at an
embryonic age as well two weeks after birth.
The hypothesis presented here was centred around AM, since studies on
developmental immunotoxicity[594] suggest a peculiar sensitivity of macrophage
populations to early life insults[210]. As presented in Section 1.4, AMs play multiple
crucial trophic and immune roles during and after lung development in order to
maintain tissue homoeostasis. Therefore, AMs might act as central players in the
impairment of the lung development in offspring. Taking into account the long life of
AMs[123,595], the isolated nature of this TMniche[99], and their self-renewal capabilities[81],
pro-inflammatory priming effects through parental DIO were expected to persist until a
young-adult mouse age[365] of ten weeks, even after feeding HF offspring exclusively a
control LF diet after weaning.
The experimental results presented in this thesis could not support the main
hypothesis of long-term pro-inflammatory priming effects of parental DIO on AMs of
HF offspring mice. These analyses did not provide evidence of consequences from
parental DIO on an endotoxin-induced acute inflammatory challenge of the ten-week
old offspring’s lung nor on the in vitro pro-inflammatory polarization of their AMs.
Importantly, the assumptions this hypothesis was based on were not met. No impact
on the pro-inflammatory gene expression in placentas from obese dams nor in the
lungs of their offspring were found. Consequently, the premise of a pro-inflammatory
environment during foetal AM development was not fulfilled.
To our knowledge, this is the first time a mild intratracheal LPS challenge is used
for the analysis of transgenerational diet-induced effects on the immune system of the
lung. Even though a limited number of animals were available for the experiments
presented in this thesis, they helped making very interesting findings. A peculiar sexual
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dimorphism could be recognized accompanying the outcomes observed from direct and
intergenerational diet-induced obesity. Further studies on sex-specific consequences
of (parental) DIO could help better understand possible protective factors against the
repercussions of obesity.
A transient delay in the final alveolarization phase of the HF offspring’s lung was
detected at two weeks of age. This delay was exclusive to the early postnatal phase and
was accompanied by differences in gene expression of inflammatory and developmental
markers as well as altered leukocyte population frequencies in the lung. Since these
effects were not observed a the embryonic nor at the young-adult mouse age selected,
it could be proposed, that an altered composition of the maternal milk might have
triggered these consequences. Cross-fostering HF offspring with LF dams could be
employed to corroborate this hypothesis. A more granular study of the process of
alveolarization in offspring between their first breath and 36 days after birth[61] could also
be performed to better understand effects of parental obesity on this final phase of lung
development. Moreover, the detailed analysis of leukocyte populations in the offspring
lung during this time, e. g. by means of single-cell mRNA analysis might better explain
the physiological consequences of the differences observed in cell frequencies between
parental diet groups.
Asmentioned in Section 5.3.1, differences between the experimental designs, especially
differences in the setup between this thesis and the work from Mayor et al.[327] could
explain discrepancies in the results obtained between the twoworks. Not only differences
in diet regimes, but most importantly possible differences in the genetic background of
the mice employed could help identify the specific (genetic) factors which prevented
placental and foetal inflammation.
The final aim of this study was not only to gain a better understanding of
intergenerational inflammatory consequences of parental DIO on mice, but support
future translational medicine studies to ultimately improve human health, quality of
life and longevity. Further research in the inter- and transgenerational effects of
developmental origins of health and disease as well as the effective communication of
past and future research outcomes on the topic, especially to the general public, could
help motivate the adoption of a healthier life style and help live a more fulfilling life
thanks to well-informed decisions made with future generations in mind.
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Appendix
This section contains tables and figures supplementary to the data already presented in
the main results part of this thesis.
In vitro alveolar macrophage polarization with LPS
Table 14: Assessment of gene expression differences after AM M1 polarization by qPCR.
AMs from untreated mice (n = 5-6) at 25 weeks of age were isolated by bronchoalverolar lavage
and purified by adherence. Cells either M1 polarized (classical/pro-inflammatory AMs) with
1 µg/ml LPS for 50 min or incubated in MH-S medium (M0 AMs). Gene expression of pro-
(M1: Cxcl2, Il12b, Il1b, Nlrp3, Saa3, Tnf) and anti-inflammatory (M2: Chil3, Pparg) markers was
analysed by qPCR. Polarization of AMs was successful with clear increases in gene expression
of M1 markers. Welch two sample t-test on log extsubscript10-transformed expression data with
Bonferroni p-value correction for multiple testing (8 comparisons): *** p.adj < 0.001.
Gene Marker mean.M0 mean.M1 sd.M0 sd.M1 p.value p.adj sig
Nlrp3 M1 0.13 5.28 0.04 1.13 2.69E-38 2.15E-37 ***
Il1b M1 0.05 52.11 0.03 16.17 8.01E-34 6.41E-33 ***
Tnf M1 0.37 43.66 0.22 11.23 1.84E-32 1.47E-31 ***
Il12b M1 1.37E-3 0.72 1.01E-3 0.42 4.02E-30 3.21E-29 ***
Saa3 M1 5.76E-3 1.66 7.37E-3 0.76 7.10E-30 5.68E-29 ***
Cxcl2 M1 0.2 160.49 0.18 35.01 5.92E-27 4.74E-26 ***
Pparg M2 0.56 0.42 0.24 0.1 2.10E-2 0.168
Chil3 M2 92.68 98.63 26.46 19.16 0.273 1
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Digital image analysis of offspring’s lung morphology
Table 15: Quantification of lung morphology parameters by digital image analysis. Images
from HE stained FFPE lung slides from E18.5, P15 and P70 offspring mice were acquired
and automatically segmented with Definiens Developer XD2 software at the the Core Facility
Pathology and Tissue Analytics (nE18.5 = 9, nP15 = 10, nP70 = 5-7). No signs of disturbances of the
morphology of the offspring’s lungs due to parental diet could be observed. Mean and standard
deviation for each diet, age and sex group. Wilcoxon rank sum test with Benjamini-Hochberg
p-value correction for multiple testing.
Age Sex Parameter LF HF p.value p.adj
E18.5 Female Alveolar area [𝜇m2] 4.55E5 +− 1.37E5 4.21E5 +− 8.92E4 0.79 0.92
E18.5 Female Border septum-air [𝜇m] 1.06E5 +− 2.57E4 1.03E5 +− 1.64E4 0.79 0.92
E18.5 Female Lung area [𝜇m2] 2.12E6 +− 4.14E5 2.20E6 +− 2.51E5 0.6 0.83
E18.5 Female n alveoli 519.11 +− 128.92 499.89 +− 84.93 0.69 0.9
E18.5 Female Ratio air/septum 0.27 +− 0.05 0.24 +− 0.05 0.19 0.39
E18.5 Female Septal area [𝜇m2] 1.67E6 +− 2.98E5 1.78E6 +− 2.16E5 0.54 0.77
E18.5 Male Alveolar area [𝜇m2] 4.72E5 +− 1.38E5 3.94E5 +− 5.75E4 0.29 0.58
E18.5 Male Border septum-air [𝜇m] 1.16E5 +− 2.29E4 1.00E5 +− 8.18E3 0.16 0.38
E18.5 Male Lung area [𝜇m2] 2.11E6 +− 2.59E5 2.19E6 +− 2.37E5 0.72 0.9
E18.5 Male n alveoli 523.78 +− 67.4 498.89 +− 51.65 0.19 0.39
E18.5 Male Ratio air/septum 0.29 +− 0.08 0.22 +− 0.04 0.08 0.23
E18.5 Male Septal area [𝜇m2] 1.64E6 +− 1.71E5 1.80E6 +− 2.34E5 0.16 0.38
P15 Female Alveolar area [𝜇m2] 1.50E7 +− 1.21E6 1.40E7 +− 2.24E6 0.38 0.7
P15 Female Border septum-air [𝜇m] 2.63E6 +− 4.18E5 2.32E6 +− 3.17E5 0.03 0.12
P15 Female Lung area [𝜇m2] 2.77E7 +− 2.19E6 2.50E7 +− 2.44E6 0.03 0.12
P15 Female n alveoli 1.20E4 +− 2.74E3 1.04E4 +− 1.87E3 0.03 0.12
P15 Female Ratio air/septum 1.19 +− 0.15 1.28 +− 0.21 0.43 0.7
P15 Female Septal area [𝜇m2] 1.27E7 +− 1.52E6 1.10E7 +− 7.41E5 0.01 0.12
P15 Male Alveolar area [𝜇m2] 1.26E7 +− 1.10E6 1.40E7 +− 1.25E6 0.02 0.12
P15 Male Border septum-air [𝜇m] 2.18E6 +− 4.18E5 2.18E6 +− 4.33E5 0.91 0.99
P15 Male Lung area [𝜇m2] 2.42E7 +− 2.08E6 2.48E7 +− 1.83E6 0.52 0.77
P15 Male n alveoli 1.00E4 +− 2.64E3 9.26E3 +− 2.55E3 0.43 0.7
P15 Male Ratio air/septum 1.1 +− 0.14 1.31 +− 0.13 0.01 0.12
P15 Male Septal area [𝜇m2] 1.16E7 +− 1.40E6 1.08E7 +− 9.60E5 0.12 0.34
P70 Female Alveolar area [𝜇m2] 1.47E7 +− 5.83E5 1.66E7 +− 1.49E6 0.04 0.12
P70 Female Border septum-air [𝜇m] 2.91E6 +− 1.24E5 3.25E6 +− 1.76E5 0.02 0.12
P70 Female Lung area [𝜇m2] 2.72E7 +− 1.17E6 3.03E7 +− 1.97E6 0.04 0.12
P70 Female n alveoli 1.49E4 +− 870.46 1.65E4 +− 895.68 0.02 0.12
P70 Female Ratio air/septum 1.18 +− 0.07 1.21 +− 0.07 0.4 0.7
P70 Female Septal area [𝜇m2] 1.25E7 +− 7.85E5 1.37E7 +− 5.15E5 0.04 0.12
P70 Male Alveolar area [𝜇m2] 1.83E7 +− 1.81E6 1.86E7 +− 2.32E6 0.72 0.9
P70 Male Border septum-air [𝜇m] 3.69E6 +− 2.86E5 3.59E6 +− 3.44E5 0.52 0.77
P70 Male Lung area [𝜇m2] 3.15E7 +− 2.68E6 3.19E7 +− 2.63E6 1 1
P70 Male n alveoli 1.70E4 +− 1.04E3 1.64E4 +− 1.71E3 0.83 0.93
P70 Male Ratio air/septum 1.39 +− 0.09 1.39 +− 0.18 0.94 1
P70 Male Septal area [𝜇m2] 1.32E7 +− 1.03E6 1.34E7 +− 7.99E5 1 1
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Inflammatory dynamics during LPS-induced acute lung inflammation
in P70 male offspring
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Figure 30: Visualization of inflammatory cell dynamics in form of two-dimensional
embeddings. Cell populations in the lavage of male animals were identified based on the
expression of the antigens ITGAM, ITGAX, FCGR1, H2-AB1, SIGLECF, LY6C and LY6G (see
expression pattern in Figure 25) using unsupervised machine learning. Lavage cells (each dot
represents a cell) were separated based on diet and time point of the lung inflammation in order
to better recognize cell dynamics on two-dimensional tSNE projections.
In vitro M1 polarization of alveolar macrophages from P70
offspring
Table 16: Effective AMpolarization by in vitro incubation with LPS.AMs from untreated mice
at 10 weeks of age (P70) were isolated by bronchoalverolar lavage and purified by adherence.
Pooled cells (2 animals per pool) were either M1-polarized (classical/pro-inflammatory AMs)
with 1 µg/ml LPS for 50 min or incubated in MH-S medium (M0 AMs). Gene expression of
pro- (M1: Il6, Nlrp3, Cxcl2, Ptsg2, Ccl2, Il1a, Il1b, Il12b) and anti-inflammatory (M2: Retnla,
Arg1, Pparg, Chil3) markers was analysed by qPCR. An effective polarization of AMs with clear
increases in gene expression ofM1markers was achieved by incubationwith LPS (n = 16). Welch
two sample t-test on log10-transformed expression data with Bonferroni p-value correction for
multiple testing (12 comparisons): *** p.adj < 0.001.
Gene Marker mean.M0 mean.M1 sd.M0 sd.M1 p.value p.adj sig
Cxcl2 M1 0.05 88.09 0.01 20.26 3.21E-38 3.85E-37 ***
Il1b M1 0.04 89.66 0.01 19.42 4.37E-36 5.24E-35 ***
Ptsg2 M1 5.78E-3 5.79 1.65E-3 1.2 3.43E-33 4.12E-32 ***
Nlrp3 M1 0.06 3.07 0.01 0.31 6.11E-31 7.34E-30 ***
Il12b M1 4.84E-4 0.96 3.17E-4 0.58 2.77E-25 3.32E-24 ***
Ccl2 M1 2.94E-4 0.04 8.65E-5 0.02 2.28E-24 2.74E-23 ***
Il1a M1 0.46 86.57 0.04 21.82 4.15E-24 4.98E-23 ***
Il6 M1 6.38E-4 11.16 1.23E-3 2.73 1.42E-18 1.70E-17 ***
Arg1 M2 1.58E-4 5.58E-5 8.87E-5 1.94E-5 7.77E-5 9.32E-4 ***
Pparg M2 0.41 0.5 0.04 0.11 5.55E-3 0.067
Retnla M2 1.49E-4 4.22E-4 2.37E-4 6.61E-4 0.056 0.677
Chil3 M2 20.77 22.57 4.34 4.66 0.241 1
123








































































































































Figure 31: Manual gating strategy for flow cytometric immunophenotyping of lung cells
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